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Abstract 
 
 
Synthetic biology is a relatively new discipline that incorporates biology and 
engineering principles. It builds upon the advances in molecular, cell and systems 
biology and aims to transform these principles to the same effect that synthesis 
transformed chemistry. What distinguishes synthetic biology from traditional 
molecular or cellular biology is the focus on design and construction of components 
(e.g. parts of a cell) that can be modelled, characterised and altered to meet specific 
performance criteria. Integration of these parts into larger systems is a core principle 
of synthetic biology. However, unlike some areas of engineering, biology is highly 
non-linear and less predictable. In this thesis the work that has been conducted to 
combat some of the complexities associated with dynamic modelling and control of 
biological systems will be presented.  
Whilst traditional techniques, such as Orthogonal Collocation on Finite 
Elements (OCFE) are common place for dynamic modelling they have significant 
complexity when sampling points are increased and offer discrete solutions or 
solutions with limited differentiability. To circumvent these issues a meshless 
modelling framework that incorporates an Artificial Neural Network (ANN) to solve 
Ordinary Differential Equations (ODEs) and model dynamic processes is utilised. 
Neural networks can be considered as mesh-free numerical methods as they are 
likened to approximation schemes where the input data for a design of a network 
consists of a set of unstructured discrete data points. The use of the ANN provides a 
solution that is differentiable and is of a closed analytic form, which can be further 
utilised in subsequent calculations. Whilst there have been advances in modelling 
biological systems, there has been limited work in controlling their outputs. The 
benefits of control allow the biological system to alter its state and either upscale 
production of its primary output, or alter its behaviour within an integrated system. 
In this thesis a novel meshless Nonlinear Model Predictive Control (NLMPC) 
framework is presented to address issues related to nonlinearities and complexity. 
The presented framework is tested on a number of case studies. 
A significant case study within this work concerns simulation and control of a 
gene metabolator. The metabolator is a synthetic gene circuit that consists of two 
metabolite pools which oscillate under the influence of glycolytic flux (a combination 
of sugars, fatty acids and glycerol). In this work it is demonstrated how glycolytic 
flux can be used as a control variable for the metabolator. The meshless NLMPC 
framework allows for both Single-Input Single-Output (SISO) and Multiple-Input 
Multiple-Output (MIMO) control. The dynamic behaviour of the metabolator allows 
 vi 
 
for both top-down control (using glycolytic flux) and bottom-up control (using 
acetate). The benefit of using MIMO (by using glycolytic flux and acetate as the 
control variables) for the metabolator is that it allows the system to reach steady 
state due to the interactions between the two metabolite pools.  
Biological systems can also encounter various uncertainties, especially when 
performing experimental validation. These can have profound effect on the system 
and can alter the dynamics or overall behaviour. In this work the meshless NLMPC 
framework addresses uncertainty through the use of Zone Model Predictive Control 
(Zone MPC), where the control profile is set as a range, rather than a fixed set 
point. The performance of Zone MPC under the presence of various magnitudes of 
random disturbances is analysed. 
The framework is also applied to biological systems architecture, for instance 
the development of biological circuits from well-characterised and known parts. The 
framework has shown promise in determining feasible circuits and can be extended 
in future to incorporate a full list of biological parts. This can give rise to new 
circuits that could potentially be used in various applications. 
The meshless NLMPC framework proposed in this work can be extended and 
applied to other biological systems and heralds a novel method for simulation and 
control. 
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1. Introduction 
 
Synthetic biology has acquired much interest in the last few years as a means of 
understanding how biological systems can be adapted or exploited to provide novel 
outcomes. Synthetic biology stems from the understanding of the biological system, 
coupled with engineering principles to make these systems more predictable. The 
term ‘synthetic biology’ was first introduced by Szybalski and Skalka (1978) and 
described how a new era in genetic engineering was emerging where genes could not 
only be described, but new genetic arrangements could be discovered and analysed. 
Modelling for design of engineered biological systems to predict system performance 
before fabrication is an important component of synthetic biology. In this sense it is 
similar to systems biology as they both rely heavily on computational modelling. 
The principles of synthetic biology are utilised in order to produce new biological 
entities such as gene circuits, enzymes, cells and new systems through redesign of 
existing well-characterised parts. This aspect distinguishes it from traditional 
molecular and cellular biology as these new parts can be tuned to meet specific 
performance criteria. Due to the nonlinearities present in biological systems there is 
limited knowledge on the parts within a biological system and how they interact. 
Whilst advances within biology have let to databases with well-characterised parts, 
such as the Biomodels database, there are still a lot of parts that have yet to be 
understood.  
One of the agendas of synthetic biology is the creation of new systems by 
building models and measuring differences between expected and observed data. 
Attempts made at manipulating living systems at the molecular level will lead to 
better understanding and therefore new types of biological components and systems. 
Biological systems have evolved and adapted to continue to exist, rather than being 
optimised for human understanding. Thoughtful redesign of these systems allows for 
simultaneous understanding and implementation of engineered systems that can be 
utilised for the purposes of producing energy, manufacturing chemicals, fabricating 
materials and processing information. Progress in the field of synthetic biology has 
been made practical by the advancement in two of its fundamental technologies, 
DNA sequencing and synthesis. Sequencing has increased the understanding of 
components and the natural organisation of biological structures, and synthesis has 
provided the ability to test the designs of new synthetic parts and systems.  
Synthetic biology has the potential to produce new and exciting products and 
as such has found application within a variety of industries such as healthcare, 
energy systems, nanotechnology, electrical engineering and genetic engineering. 
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Systems engineering in synthetic biology looks at how new products or new circuits 
in host cells can yield products beneficial to the pharmaceutical industry. One such 
example is the work by Ro et al. (2006) who found that a precursor to an anti-
malarial drug could be synthesised in engineered yeast cells (S. cerevisiae). Advances 
like this showcase how synthetic biology can aid in product manufacture, whereby 
the host cells act as reactors and produce high yields of the desired product. Not 
only would this decrease production costs, but if these systems are accurately 
modelled the waste normally seen in traditional manufacture processes can be 
decreased. Much work in the field has looked at genetic circuits, which have been 
characterised experimentally and redesigned using model based design principles. 
Systems such as the genetic toggle switch (Gardner et al., 2000), the repressilator 
(Elowitz and Leibler, 2000) and the gene metabolator (Fung et al., 2005) showcase 
how biological circuits can be modelled accurately based upon experimental data 
and analysis. Many of these circuits utilise E. Coli as a natural chassis for testing 
due to its ability to replicate easily and simple genetic system that can be 
manipulated easily. Each of the circuits mentioned have possible advantageous 
characteristics, such as the toggle switch being used as a logic gate in circuits, the 
repressilator exhibiting sustained limit cycles and highlighting the potential of 
constructing circuits from parts that are not found together naturally and the 
metabolator showing that in silico models can accurately correlate with experimental 
data.  
Whilst these systems have paved the way forward for advancement in the 
field of synthetic circuit engineering, there is a distinct lack of control of such 
systems. Much like in the case of the repressilator where the transcription rate of 
mRNA played an important factor in the outcome of the system, whereby it could 
either exhibit steady state or reach a sustained limit cycle, a control system would 
enable either of the two outcomes to be favoured and hence alter the system 
dynamics. Typically biological systems have not been controlled due to the fact that 
they are difficult to characterise, however for a well-characterised system it is 
possible to control its outcome using modelling. This thesis will demonstrate a novel 
framework for meshless control of biological systems. Specific aims of this work are 
listed as follows: 
 
1. Design of a new modelling methodology utilising a meshless framework that 
can control biological system outputs 
2. Comparison of the new framework to traditional methods for optimising 
dynamic systems 
3. Design of a model that can adapt to uncertainty within biological systems 
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1.1 Aims & Objectives 
 
The aim of this work is to design a new framework for solving dynamic nonlinear 
systems which utilises a meshless artificial neural network (ANN). Once developed, 
the framework will be applied to biological systems firstly to simulate, and then to 
control their outcomes through the use of nonlinear model predictive control 
(NLMPC). It is envisaged that the development of a new framework will herald a 
novel way of designing a controlling biological systems, and will pose as an 
alternative to traditional techniques. The objectives for this research are detailed in 
the remainder of this section, which explores the implications of developing the new 
framework. 
 
1.1.1 Design of a Meshless Framework for Control of Biological Systems 
 
As mentioned previously there have been many methods that have successfully 
modelled biological systems and their dynamic nature. However there has not been 
any system that has been able to control the outputs from these systems. Whilst the 
systems have correlated well with experimental data, there is a need for control of 
these systems as this can improve yield, alter dynamics and change the overall 
outcome. It is envisaged that the control model will improve the overall system 
output and can lead on to profound findings, especially through experimental 
validation. 
 
 
1.1.2 Comparison of the New Framework to Traditional Methods 
 
It is important that the new framework developed in this work can give similar 
results to traditional methods that have been utilised in previous research. One such 
method discussed briefly before is orthogonal collocation on finite elements (OCFE). 
The new meshless framework developed in this work works in a similar principle to 
OCFE, however it does not discretise within finite elements. Instead it has a time 
step that uses a rolling time horizon to solve the model. This work will showcase the 
differences between each approach and evaluate which is best suited for dynamic 
systems. 
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1.1.3 Adapting to Uncertainties in Biological Systems 
 
There are many uncertainties that can affect a biological system, ranging from 
changes in temperature, pH, inhibition of proteins, lack of feed source etc. This work 
will showcase how Zone MPC can be utilised to formulate a model that can adapt to 
external disturbances, which is important, as mathematical models of biological 
systems need to be feasible. Therefore any disturbance that the biological system can 
undergo in vivo needs to be replicated and taken account for in silico. This work 
takes a step forward in feasible models of biological systems through the use of 
random disturbance, with aims to create a model that is feasible both 
mathematically and experimentally. 
 
 
1.2 Thesis Outline 
 
The rest of the thesis is outlined as follows: 
 
Chapter 2: A review of synthetic biology 
This chapter will introduce the field of synthetic biology and discuss current trends 
in research. It will also discuss recent advances as well as potential scope for this 
work to fit in with the challenges faced in synthetic biology. 
 
Chapter 3: Development of the meshless framework 
This chapter will detail the new framework and show the mathematical concept of 
the meshless NLMPC. This chapter will also showcase how the framework can be 
verified using fourth order Runge-Kutta and show how it differs to the traditional 
method of OCFE.  
 
Chapter 4: A synthetic gene metabolator case study 
This chapter will introduce the case study used for this work and show how it 
integrates with the new framework. Results presented in this chapter will highlight 
key differences between using the meshless framework and OCFE to model the 
system. The concept of control will also be shown as well as optimising under 
disturbance. 
 
Chapter 5: Comparison of the new meshless framework with OCFE 
This chapter highlights the differences between the new meshless framework 
developed in this work and OCFE. The metabolator case study from the previous 
chapter is re-visited and a detailed comparison between results from the two 
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techniques is discussed. Smaller studies are also present within this chapter to 
showcase the benefits of each technique further. 
 
Chapter 6: Utilising the meshless framework for systems architecture 
This chapter will introduce how the meshless framework can be used to solve 
MINLP problems based on biological systems architecture problems. Essentially the 
framework is applied to find the optimal system from given biological parts, which 
act like building blocks for a biological circuit. The MINLP is converted to an NLP 
and solved using the developed ANN-RK4 framework. 
 
Chapter 7: Conclusions and future work 
This chapter will summarise the key contributions of this work and also detail how 
the framework can be used in future studies. 
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2.  Review of Synthetic Biology 
 
In this chapter the concept of synthetic biology will be introduced and discussed. 
The core principles as well as the general scope for the field will be reviewed and key 
achievements in literature will be cited. The overall aims of synthetic biology will 
also be outlined as well as how this project can help fill gaps within the literature. 
Synthetic biology is a branch of systems biology, which is an interdisciplinary 
field that looks at the complex interactions within biological systems. The main aim 
of systems biology research is to model and discover the various properties of cells, 
tissues and organisms by looking at metabolic networks or cell signalling pathways. 
A cellular network can be modelled mathematically using methods from chemical 
kinetics and control theory. Whereas systems biology looks at modelling a complete 
system through simulation, synthetic biology aims to forge new systems from 
existing pathways through synthesis or design of systems. A possible definition of 
the term ‘synthetic biology’ is the engineering of biological components and systems 
that do not exist in nature and the re-engineering of existing biological elements. It 
is determined on the intentional design of artificial biological systems, rather than on 
the understanding of natural biology. Much of synthetic biology is configuring new 
biological systems based on different parts of a cell. Each system is brought together 
and altered to work with one another to give new outcomes and products. These 
systems work well individually in vivo, but are not necessarily found in configuration 
with one another naturally. In many respects one of the greatest challenges in 
process design is to design a configuration that can produce chemicals in a reliable, 
safe and economical manner, whilst also producing a high yield and little waste 
(Seider et al., 2010). Synthetic biology has similar aims in the sense that a system is 
designed to have a more desired outcome and is tested against the existing model or 
design.  
 
 
2.1 The Aims of Synthetic Biology 
 
Synthetic biology is essentially the engineering of biology. It involves the synthesis of 
complex systems, which are either biologically based or inspired, to perform 
functions that do not appear naturally. It is believed that this approach can 
manifest into a rational and systematic design of systems that can help to address 
major challenges faced currently and in the future. Possible applications of synthetic 
biology could include creation of systems to generate power (such as biological fuel 
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cells), nano-scale biological computers (like lab on a chip), new medical applications, 
biosensors for healthcare, new approaches for cleaning waste and even security 
applications. Previously biologists have sought to understand existing biological 
systems, and in doing so have acquired profound knowledge on the construction and 
functions of these systems. The aim of synthetic biology then is to design 
components in a standardised manner and combine these to construct novel genetic 
devices, metabolic pathways and optical or electronic devices. It is now becoming 
easier to synthesise gene and large DNA fragments due to recent advances in 
biology, so the standardisation of biological parts gives greater understanding on 
how these components can be put together in a bacterial chassis. Due to the 
complexity of synthetic biology it is necessary to utilise skills from a variety of 
experts including engineers, biologist, chemists and physical scientists. Together they 
are able to design cells, create enzymes and introduce new biological modules that 
can be used in a wide variety of industries including pharmaceuticals (Pieru et al., 
2005; Ro et al., 2006), biological fuel cells (Yong et al., 2011), polymers (Verdezyne, 
2011) and even tissue engineering (Hu et al., 2008). The key features of synthetic 
biology are on different levels of living system and are summarised below: 
 
 Engineering complex living systems containing components of artificial 
biologically compatible and functional structures which can be maintained 
through the natural cell life cycle. 
 Deployment of artificial regulators in circuits with designed functions rather 
than simple single regulator modifications. 
 Using artificially regulated genes used for structural changes or catalysts 
within both existing and artificial pathways.  
 Production of artificial molecules as primary or secondary gene products. 
 
The artificial molecules produced through synthetic biology can be separated into 
macromolecules and small molecules as follows: 
 
 Macromolecules: For intracellular use as catalysts or extracellular as 
molecular sensors, building blocks for complex subcellular structures or for 
other functions e.g. RNAs or enzymes. 
 Small molecules: For use as biological drugs, building blocks for chemical 
synthesis, or for the purpose of engineering of more complex nanotechnology 
for different applications. 
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Synthetic biology can integrate with many related and interdisciplinary fields of 
science and technology, a summary of which is presented in figure 2.1. The field of 
synthetic biology covers many areas from other fields and utilises the knowledge 
gained from these fields to enhance system understanding and design. Biology, in 
particular bio-informatics, is used to gain understanding of the system through the 
use of novel software. This software can also aid in systems biology as it allows 
simulation of the biological entities and can aid in deeper understanding of the 
dynamics of the system. Engineering technologies are important and are utilised by 
synthetic biologists in order to design new systems, both in silico and in vivo. The 
knowledge gained from molecular biologists on the structure and functions of 
macromolecules (e.g. proteins, enzymes and nucleic acids) is vital in order to ensure 
that the systems designed through synthetic techniques are biologically feasible. 
Lastly nanotechnology allows for characterisations of the small molecules present 
within biological systems and yields greater understanding of their functions. From 
an engineering viewpoint synthetic biology can describe both top down approaches, 
such as creation of de novo artificial life, and bottom up approaches such as genetic 
engineering. The differences of both of these approaches will be discussed in section 
2.1.1 and 2.1.2. 
 
 
Figure 2.1: Synthetic Biology and its integration in related fields of science and technology 
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2.1.1 Top-Down Synthetic Biology 
 
The theory of artificial carbon based life has been a subject of interest in recent 
years. The observations made in macro and microorganisms in nature show that it is 
possible to emulate life processes and could potentially create artificial life in the 
future (Grant, 1991). The theory looks at how artificial components of biological 
functionality can be integrated into synthetic systems which have the necessary 
qualities to sustain life. In this fashion, by looking at the system in greater detail by 
delving deeper into the system mechanics and processes, a top-down approach is 
generated. Each system is explored, and sub-systems are characterised until a 
greater understanding is achieved. This knowledge is then applied to other similar 
systems and processes are evaluated before they are altered.  Although this is still in 
an early developmental phase, there have been certain areas where it has shown 
promise, such as the artificial leaf by Nocera (2011). This also has benefit for the 
advancement of nanotechnology to emulate living systems by applying natural 
nanostructures into systems that could process features of living systems. This is a 
goal of many nanotechnologists as they move towards the minimal cell (Luisi, 2002; 
Rasmussen et al., 2004). A prerequisite for such systems would be that at least one 
component of the synthesis precursors for the minimal cells should be able to self-
maintain a life cycle, and the fusion product should behave in the same way. It is 
foreseen that the eventual goal of this research would be to combine the artificial 
minimal cells with a natural biological system, such as human beings, and has the 
potential to eradicate disease, correct genes and even cure chronic illness.  
 
2.1.2 Bottom-Up Synthetic Biology 
 
The main area that utilises the bottom-up approach to design in synthetic biology is 
genetic engineering. This approach differs from top-down as it pieces together a 
system from known parts, thereby giving rise to more complex systems. An artificial 
DNA sequence is one that has been modified by human influence so that it is no 
longer naturally occurring, and the main challenge is to achieve this without losing 
functionality. It is regarded that having a variety of sequences is crucial to have 
different functionalities, or even create new functionality. With regards to this there 
are three main areas where functionality plays a role; regulation of function, 
regulated function for specific control and sensor function. Whilst there are many 
different applications for the generation of recombinant cells through genetic 
engineering, the location of the point at which simple recombinant DNA experiments 
end and synthetic biology begins is up for discussion. Firstly, most recombinant 
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DNA experiments in the past were performed for the sole purpose of understanding 
biological functions such as: 
 
 The regulation of cell function, pathways and structure. 
 Structure-function relationships e.g. affinity, binding ability etc. 
 Catalytic properties such as kinetic behaviour, sensitivity and selectivity as 
well as qualitative features such as stability, temperature and pH. 
 
Although the DNA constructs that were engineered for this purpose were stable, 
increased knowledge of how the wild type function works has made these constructs 
obsolete. There are however many successful experiments of genes for bio production 
in organisms such as fungi, cell cultures, microorganisms, plants and some transgenic 
animals (Sorensen and Mortensen, 2005). These experiments typically produce small 
proteins, and there is debate on whether or not this is considered synthetic biology 
due to the simplicity of the resulting proteins. In order to define if the small proteins 
developed in this way are considered synthetic biology one has to look at the 
purpose for which the protein is intended as some are used for a systems biology 
application. Generally systems biology is the analysis of how regulatory and sensor 
functions control natural pathways and how they interact at the systemic level. 
With the increasing knowledge about systemic behaviour however, synthetic biology 
has the opposing intention, whereby it aims to design artificial pathways to optimise 
regulation or extend the catalyst capabilities of systems to gain a technical solution. 
These technical solutions include the use of mathematical models as simulation 
algorithms to create information for optimisation. Synthetic biology therefore applies 
solutions to biological systems in order to alter or influence their function towards a 
desired optimum, by generating artificial designs that are compatible with biological 
functions at a molecular level. 
 
 
2.2 Current Trends in Synthetic Biology 
 
Synthetic biology aims to utilise existing biological systems and alter their function 
in order to forge novel systems that can help to combat issues across various sectors 
in science and engineering. As such there are a number of advances in recent years 
that showcase the breadth and scope for synthetic biology, as well as the benefits of 
the emerging field to tackle grand challenges of current interest. This section will 
detail advances in the field of synthetic biology and detail key findings from 
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breakthrough research that can impact on healthcare, energy systems, material 
engineering and genetic engineering. 
 
 
2.2.1 Synthetic Biology Applications in Healthcare 
 
Healthcare and pharmaceuticals is one of the most applicable fields that will utilise 
technologies created by synthetic biology. Many biological systems can be altered to 
give new functions or products and these have significant uses within healthcare. 
Prominent cases for the production of pharmaceuticals can be seen in research from 
Pieru et al. (2005), who showed how E. coli could be used to produce an antibiotic, 
Erythromycin C, and an anti-malarial drug Artemisinin from Ro et al. (2006) who 
highlighted the benefits of using synthetic biology for pharmaceutical manufacture. 
The success of the latter has sparked interest in exploiting bacteria for large scale 
production of pharmaceuticals and has the potential to replace traditional methods. 
Further research into application for healthcare in synthetic biology has looked at 
the production of biosensors. Instances include recent developments of biological 
markers for detection of diseases in the gut (Kotula et al., 2014) or probiotics for 
urinalysis and cancer detection (Danino et al., 2015). Kotula et al. (2014) engineered 
a bacterial strain of E. coli to secrete biomarkers in response to flora in the gut, 
which would in turn diagnose any intestinal issues or diseases within the subject. 
Artificial biosensors are important in healthcare as they can be exploited to interact 
with both organic and inorganic molecules, and can respond to external influences 
such as temperature and light to generate signals (Hellinga and Marvin, 1998; 
Nivens et al., 2004). Similarly, work by Danino et al. (2015) showed how using E. 
coli Nissle 1917, a probiotic, could be formulated as an oral dose for metastatic 
detection in the liver of rats. This profound research can be extended in future to 
allow for personalised cancer testing in patients and can revolutionise the treatment 
of such cancers. The concept of attacking cancer cells using engineered bacteria has 
also been researched for colorectal cancers by Anderson et al. (2006). The concepts 
developed within this research were coupled with research from Xiang et al. (2006) 
to produce a gene promotor that could re-programme the human commensal gut 
bacterium Bacterioides thetaiotaomicron in response to stimuli in mice (Mimee et 
al., 2015), which has benefits for cellular sensing as well as localised treatment at the 
primary target site. This is largely due to the fact that the engineered construct does 
not trigger an immune response and so can integrate with the host cell without 
causing long term damage. However, scale-up of such systems is required for more 
complex gut flora.  
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Much research focusses on the use of a bacterial chassis for delivering a novel 
construct or system into a host system. However immune-centric cells like T cells 
can also be exploited as vectors for synthetic biology. Due to their nature as innate 
immune cells they have the ability to be used in treatment of cancer and 
immunological diseases. Two well known cases of T cells as vectors for synthetic 
biology are presented in research by Kalos and June (2013), who utilised T cells for 
cancer immunotherapy, and June and Levine (2015), who showed how T cells can 
also be used to treat HIV. Both of these cases demonstrate the usefulness of 
synthetic biology constructs as powerful tools for treatment and eradication of both 
acute and chronic diseases. Furthermore, antibiotic therapies can also be produced 
using engineered bacteria that can attack pathogens within the body to help 
eradicate infections. Microbes can be used to treat pathogens such as Pseudomonas 
aeruginosa (Saeidi et al., 2011) or used as adjuvants for antibiotic therapies (Lu and 
Collins, 2009; Krom et al., 2015). The future perspective of these technologies affect 
the medical and pharmaceutical industries, with enabling technologies such as de 
novo synthesis of genes and stem cells, manufacturing of drugs outside of cells and 
traditional chemical synthesis becoming obsolete to an extent. 
 
 
2.2.2 Synthetic Biology Applications in Genetic Engineering 
 
Much like the constructs made for healthcare applications, whereby bacteria or cells 
were engineered to attack diseases in vivo; genetic engineers are using similar 
principles to help re-programme cells to correct gene disorders, as well as exploiting 
both RNA and DNA as sources for this manipulation. As synthetic biology involves 
a paradigm shift from molecular biology to ‘modular biology’ (Hartwell et al., 1999) 
there is much effort in designing artificial regulatory components that exhibit 
technical features. The intention is to generate sets of biologically compatible 
switches that are composed of only a few parts but can create varieties of different 
circuits (Gardner et al., 2000; Endy and Yaffe, 2003; Wall et al., 2005). Their 
functional characteristics are intended to be optimised and the behaviour of these 
switches is intended to be predictable (Atkinson et al., 2003). In order to achieve 
predictability of single components in gene assemblies different regulators are needed 
to those in nature. This can be either regulating complex schemes of networks 
integrating many signals to form different circuits, or providing improved 
productivity for the purpose of high throughput product yield. In order to 
understand biological functions previous genetic engineering experiments looked at 
changing regulatory parameters that depend on or affect the DNA itself, or on the 
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protein whose function is to bind to DNA (Buchler et al., 2003; Alper et al., 2005). 
Regulation of the function of RNA (Isaacs and Collins, 2005) is effective mostly on 
the translation level of cellular function and the stability of molecules like RNA and 
proteins. Degradation rate of these molecules are important and have also been 
studied (Buchler et al., 2005). Approaches for synthetic biology rely on more than 
just the modification of a single regulatory parameter, such as complex networks 
that can control more than one genetic function for regulated synthesis of products 
(Elowitz and Liebler, 2000; Butler et al., 2004; Campbell, 2005).  
Recent activity in using synthetic biology for genetic engineering has looked 
at the use of synthetic mRNA for re-programming of cells (Warren et al., 2010) and 
genome activation and repression though CRISPR/Cas methods (Kiani et al., 2015). 
Both of these have the ability to alter the genetic makeup of the cells they are 
treated against and has given geneticists a promising avenue to further research for 
future applications. Another highly regarded field is regenerative medicine, whereby 
cells are modified to forego the usual cell cycle and correct any disorders that the 
cell may induce. Although this is in its infancy for synthetic biology (Davies, 2016), 
there has been promising research to use such technology for therapeutic application 
(Lienert et al., 2014). A global project looked at the creation of a fully functioning 
synthetic chromosome (Annaluru et al., 2014). This achievement utilised the 
knowledge of the S. cerevisiae chromosome III and synthesised a smaller designer 
eukaryotic chromosome called synIII. As the first of its kind the research provides 
ground-breaking insight into how bacteria can be utilised for synthetic constructs for 
eukaryotic genomes. The potential applications for engineered products include the 
optimised productions of xeno-biomolecules such as therapeutic proteins, biologics, 
enzymes, antibodies, fine chemicals or biobased commodities (Straathof et al., 2002; 
Panke et al., 2002; Panke and Wubbolts, 2002, Panke et al., 2004; Panke and 
Wubbolts, 2005). The enzymatic biotransformation of chemicals from artificial 
educts to generate product is under tremendous study and is expected to impact 
greatly on the future of ‘green’ chemistry as it intends to replace traditional chemical 
production (Muller, 2004; Panke and Wubbolts, 2005).  
Genes are also not the only target to create a shift in biological function, and 
research is looking into designing whole microorganisms that can be used in both 
industrial and clinical applications (Yokobayashi et al., 2002; Ferber, 2004). 
Engineered circuits however can have difficulty in deployment beyond the lab as 
they require controlled environments in order to function. Research by Pardee et al. 
(2014) showcased how a paper-based cell free system can be used as an abiotic 
distribution method for synthetic biology technologies. They show how this novel 
system can be used as a colorimetric band detector, much like litmus paper, for in 
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vitro diagnostics, including glucose detection and Ebola virus sensors. This 
technology shows how synthetic biology is able to produce an efficient and relatively 
inexpensive technology that can adapt to have many uses. This is the key advantage 
of using synthetic biology within the field of genetic engineering and the promise of 
new and exciting products that utilise the advances from previous research can 
potentially solve the myriad of problems faced by geneticists today. One key ethical 
advantage is that many of the constructs are formulated in bacteria, and so can 
circumvent the use of animal models.  
 
 
2.2.3 Synthetic Biology Applications in Material Engineering 
 
The fast growing field of material engineering is a prime candidate for synthetic 
biology, as the biological constructs can provide a fast, efficient and low-cost 
alternative to traditional manufacturing techniques. Different applications can be 
designed for complex regulatory schemes and these in turn can be used to produce 
enzymes, small molecules in a cell reactor and products that are produced in vitro or 
in vivo. Furthermore, whilst these systems have to have some level of basic 
functionality, they must also have an effect on more complex biological functions, 
such as programmed pattern formation of multicellular systems, organs and 
organisms (Basu et al., 2005). This approach can be applied in the future for tissue 
engineering, stem cell therapy, drug delivery and regenerative medicine. Recent work 
in tissue engineering ranges from synthetic bone (Hu et al., 2008) to artificial blood 
vessels (Ma et al., 2010) and bladder smooth muscle (Tian et al., 2010). Advances in 
this field have also produced various materials like biopolymers from E, coli 
(Kelwick et al., 2015) and biomaterials from bacterial cellulose (Florea et al., 2016). 
These materials can have a myriad of uses and cement synthetic biology as a 
plausible option for large scale manufacture. More research into using this technique 
for production of organic tissues and polymers is highly sought after and in years to 
come the commercialisation of these materials will be more viable, therefore 
providing materials at a much faster rate than current methods. 
 
 
2.3 In Silico Synthetic Biology 
 
Design of biological systems is useful in accelerating the evolution of certain systems 
and can be used to substitute for natural genetic rules. The advancement of this 
research relies heavily on computers and bioinformatics and there are now a large 
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number of computer algorithms for the analysis of biomolecule sequence and 
structure related issues. Initially, computing was used to find sequence motives for 
nucleic acids and protein structures, and algorithms enabled the design of single 
biomolecular components, such as RNA and glycoproteins. Structural and sequence 
data, as well as functional data, were collected from experimental results and stored 
in databases (Palsson, 2002; Mester et al., 2004; Adai et al., 2004). This created data 
and information for the rational design of molecules that can be manipulated by 
changing structure, specificity and selectivity (Bathelt et al., 2002). Other 
algorithms have been developed for the simulation of designed evolution based 
processes (Fox, 2005). In order to design gene regulatory circuits the basic principles 
of systems and networks must be understood and the main task of systems biology is 
to gain this understanding by modelling the natural systems using data from the 
‘omic’ projects (Venter et al., 2003). Systems biology software, in contrast to 
bioinformatic software, is not focussed on the analysis and design of single 
components of a regulatory system but the analysis of all of the components. This is 
possible in silico through computational studies of gene networks creating in numero 
molecular biology (Arkin et al., 1998; Hooshangi et al., 2005). The simulation of 
cellular behaviour is composed in virtual environments (Slepchenko et al., 2003), 
however most algorithms in biocomputing are secondary to experiments and 
research is being undertaken to separate in silico synthetic biology from databases of 
experimental algorithms (Ruben and Landweber, 2000; Schmidt et al., 2004).  
In Silico synthetic biology focusses on the design of artificial regulatory 
systems and circuits. It moves towards the simulation of predictive artificial 
molecular processes on the molecular and genomic level, and the level of regulatory 
circuits of total pathways (Hasty et al., 2002; Isaacs et al., 2003; Francois and 
Hakim, 2004). Software packages should provide tools for the design of regulatory 
circuits and individual components. Research aiming at providing the data for this 
has become the subject of intense development, with the most advanced being the 
registry of standard biological parts (MIT, 2016). The registry offers a 
standardisation of biological parts, which have been characterised through research 
from geneticists, biologist and engineers. This was the subject of interest in research 
by Dasika and Maranas (2008) who utilised the registry to find parts that could 
potentially form circuits. They developed software, called OptCircuit, which takes 
data from parts and by using algorithms set by user requirements, to form circuits 
that have the potential to be biologically feasible. The work carried out by the team 
behind OptCircuit showcased how the software can be used to form constructs 
similar to the gene oscillator from Gardner et al. (2000). Furthermore the software 
has shown it is able to form a genetic decoder through the use of logic gates, as well 
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as a concentration band detector for green fluorescent protein. Much of the research 
into in silico synthetic biology has looked at creating models based on experimental 
data and analysis. Whilst these models are accurate in depicting the biological 
system, there is a lack of design based on modelling techniques. Systems like the 
Goodwin oscillator (Lutz and Bujard, 1997), the Repressilator (Elowitz and Leibler, 
2000), the metabolator (Fung et al., 2005) and the mammalian oscillator (Tigges et 
al., 2009; Tigges et al., 2010) all were firstly constructed in the laboratory before 
they were modelled. This is largely due to the fact that many of the processes within 
these constructs had not been quantified and the dynamics of the systems were not 
yet fully realised. However the work from these researchers gave accurate models of 
these systems, which can now be used as a basis for design. This thesis will showcase 
the use of these systems for design and control of biological systems, which has not 
been achieved before.  
 
 
2.4 Summary of ‘Synthetic Biology’ 
 
Synthetic biology can be defined as the boundary between biological and engineering 
sciences in which technical approaches are employed to provide novel applications. 
All current, or intended applications, focus on the design of artificial living systems, 
such as specialised cells for bioproduction of molecules for in vivo or in vitro use. 
The key features of synthetic biology are on different levels of living systems: 
 
1. Deployment of living systems to engineer complex patterns containing 
components of biologically compatible and functional assemblies, which are 
managed through continued life cycles. 
2. Artificial assemblies of regulators with designed functions rather than simple 
modifications. 
3. Functional assemblies of artificial pathways by modified genes with either 
structural or catalytic function. 
4. Production of artificial molecules as primary or secondary products: 
a. Macromolecules: Like RNA or enzymes, for intracellular use as 
catalysts, or extracellular use as molecular sensors. 
b. Small molecules for use as biological drugs, chemical synthesis or for 
nanotechnology engineering or more complex units for different 
applications. 
 
Chapter 2 Review of Synthetic Biology 
 
17 
 
Therefore the first word, ‘synthetic’, describes the synthesis of artificial and natural 
components forming a new artificial living system. As technology for systems design, 
synthesis and optimisation mature, there will be rapid growth in the capabilities of 
synthetic systems which can have a wide range of applications. The secondary 
intention of synthetic biology is the deployment of highly functional artificial 
assemblies of designed regulatory circuits for effective highly controlled production of 
natural products, biochemicals and xenobiotics (Herrera, 2005). The intended 
application of in vitro synthetic biology products is highly regarded as truly novel 
science. These applications need to use parts, compounds or building blocks which 
are provided by in vivo synthetic biology, which cements this as an indispensable 
prerequisite for providing materials for synthetic biology applications. The field is 
objective driven and is not primarily a discovery science as it builds on current 
understanding, whilst also simplifying some of the complex interaction 
characteristics of natural biology. It also looks at design based engineering of 
systems based on biological functions and laws, and aims to provide new functions 
that are not present in nature.  
The next section (Section 2.5) will detail these systems and discuss their 
strengths and weaknesses, as well as showcasing the development of oscillators 
within the field of synthetic biology. 
 
 
2.5 Synthetic Gene Oscillators 
 
Gene oscillators are primary candidates for synthetic biology approaches as they 
benefit greatly from technology discovered within the field. Research focus is on 
model based design and validation, with some performing experiments to test the 
theory. Trends in the data show that there are unique ways in which an oscillator 
can be constrained, characterised and dynamically implemented (Purcell et al., 
2013). There are two paradigmatic types of networks that are of interest in the 
scientific community; switches and oscillators (Tyson et al., 2008), and over the 
years there have been numerous designs that have been proposed for both in 
prokaryotic and eukaryotic cells. This section will review the characteristics of the 
various different oscillators that have been published and highlight the advantages 
and disadvantages. The complexities of the oscillators range from the very early 
Goodwin oscillator (Goodwin, 1965) to more recent oscillators that have been 
constructed within mammalian cells (Tigges et al., 2010).  
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2.5.1 The Goodwin Oscillator 
 
The Goodwin oscillator, Goodwin (1965), was the first synthetic genetic oscillator to 
be studied and is also the simplest. It comprises of a single gene that represses 
(inhibits) itself (Figure 2.2a). Whilst early theoretical work was promising, it is only 
recently that models have been used to characterise and study the oscillator. These 
models use ODEs (Mueller et al., 2006), delay differential equations, DDEs, (Smith, 
1987) and stochastic simulations using the Gillespie algorithm (Bratsun et al., 2005; 
Gillespie, 2007; Stricker et al., 2008). The presence of oscillations within the 
Goodwin network were confirmed using in silico experiments using various 
techniques. An example of which (Stricker et al., 2008) showed a detailed simulation 
that correlated well with in vivo work. It was shown that oscillation decay over time 
when predicted with a deterministic model, but persist when the Gillespie algorithm 
is applied. This does however only occur under certain conditions and suggests that 
noise within the system is parameter dependent. A robust period does however arise 
and was later confirmed by Lewis (2003). Given the nature of the oscillator it was 
deemed important to construct it in vivo for further study. This used a PLlacO-1 
promoter (Figure 2.2b), which is repressed by LacI (Lutz and Bujard, 1997) and is 
capable of giving transcription, where DNA is converted into RNA, at high levels 
when unrepressed and produces a negative feedback loop. The results were 
consistent with simulations, however, oscillations for both simulations and 
experimental results were highly irregular, thereby making this oscillator difficult to 
utilise. Figure 2.2b shows a typical schematic of a gene system, and is common in 
many biological papers; it essentially shows the promotor and corresponding gene, 
but these schematics can also be used to show gene-inducer, promotor-inducer, gene-
gene and gene-transcript pairs. 
 
 
Figure 2.2: a. Topology of the Goodwin Oscillator showing gene A, b. in vivo implementation of the 
oscillator (Lutz and Bujard, 1997).  
 
 
 
a. b. 
lacI 
A 
PLlacO-1 
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2.5.2 Repressilators 
 
Repressilators (Elowitz and Liebler, 2000) can be thought of as extensions to the 
Goodwin oscillator as they are defined as a regulatory network of one or more genes 
with each gene repressing its successor in the cycle (Mueller et al., 2006). 
Repressilators are capable of producing periodic oscillation and have been modelled 
extensively using ODEs (Elowitz and Liebler, 2000; Mueller et al., 2006), DDEs 
(Smith, 1987; Wang et al., 2005) and discrete stochastic simulations using the 
Gillespie algorithm (Yoda et al., 2007). Repressilators can also be seen in other fields 
of study such as in neuroscience where cyclic networks of neurons, referred to as 
neural ring networks, are present and in electronics where a cycle of an odd number 
of NOT gates are referred to as a ring oscillator (Pasemann, 1995).  
 
Figure 2.3: a. Three-gene repressilator topology (A, B, C) where each gene represses its successor in 
the cycle, b. in vivo implementation of the three-gene repressilator where LacI represses tetR through 
PLlacO-1, TetR represses λ cI through PLtetO-1 and cI represses LacI through λ PR completing the cycle. 
All genes contain an ssrA sequence tag to promote rapid degradation. 
 
Network topologies can be symmetrical as shown in research by Elowitz and Liebler 
(2000) and Mueller et al. (2006); however, these networks are difficult to replicate in 
vivo due to the fact that each gene has identical parameter sets. However, a three 
gene repressilator (Figure 2.3) was constructed in vivo using LacI from E. Coli, TetR 
from the Tn10 transposon and cI from the λ phage (Elowitz and Liebler, 2000). 
Within this network LacI represses transcription of tetR, TetR represses 
transcription of cI and cI closes of the cycle by repressing lacI. The repressilator was 
copied into a lac operon deficient strain of E. Coli and it was shown that 40% of the 
cell exhibited oscillations. Oscillations were periodic and had unique characteristic 
whereby they were not governed by cell division, indicating that the network is 
decoupled from the cell division cycle, but oscillations stopped when E. Coli was in 
stationary phase, thereby indicating that the dynamics are coupled with global 
A 
B C 
a. b. 
lacI 
λ PR 
λcI 
P
LlacO-1
 
tetR 
P
LtetO-1
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regulation and effects of cell growth and division (Elowitz and Liebler, 2000). The 
repressilator became the first synthetic genetic oscillator to be successfully 
implemented in vivo, however, due to the fact that less than half of the cells 
experienced oscillation, it lacked robustness. Improvements to the design have been 
studied by Tsai et al. (2008), where adding a positive feedback loop expands the 
region in parameter space over which the core repressilator oscillates thereby 
enhancing robustness. This addition also allows the repressilator to exhibit greater 
range of frequencies for given amplitudes and increases its potential in more complex 
synthetic networks.  
 
 
 
2.5.3 Amplified Negative Feedback Oscillators 
 
The Goodwin oscillator and the repressilator are both formed using repressive links, 
however network topologies can be formed where genes can activate one another, 
where one gene promotes (amplifies) its own transcription through positive self-
feedback loop as well as activating another gene. The second gene also represses the 
first gene forming a negative feedback loop (Figure 2.4). There are various different 
topologies that can utilise this amplified negative feedback loop including repression 
by transcriptional control (Guantes and Poyatos, 2006), repression through 
dimerization (Hilborn and Erwin, 2008) and repression by proteolysis (protein 
breakdown) (Guantes and Poyatos, 2006; Conrad et al., 2008).  
 
 
2.5.3.1 Repression by Transcriptional Control 
 
These networks have been simulated using both ODEs and the Gillespie algorithm 
by Atkinson et al. (2003), Guantes and Poyatos (2006) and Conrad et al. (2008). 
Simulations from Guantes and Poyatos (2006) showed that oscillations occurring 
from a saddle-node bifurcation (SNIC) have extended regions with high activator 
and repressor concentrations, which therefore provide longer periods. Immediately 
after the bifurcation it was also shown that an increase in the ratio of activator and 
repressor degradation rates causes the period to decrease and plateau. The work by 
Atkinson et al. (2003) showed the only type of oscillator with amplified negative 
feedback which can be implemented in vivo (Figure 2.4b). The system shows 
damped oscillations in a system after Hopf bifurcation with a cell doubling time of 2 
hours, which is considerably longer than the Repressilator described previously. The 
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network was implemented in vivo and consisted of the activator, NRI, and the 
repressor, LacI, and was achieved by fusing glnG, which encodes NRI, to a control 
region based on a glnA promotor. The design intended to take advantage of DNA 
looping; during activation phosphorylated NRI (NRIp) interacts with RNA 
polymerase via a DNA loop, while during repression, LacI bound to the operators 
also forms a loop, thereby ensuring stable repression. The two loops are antagonistic 
and formation is mutually exclusive. Results from single cell observations showed 
initially that three damped oscillations were present, which also exhibited similar 
amplitude and frequency as simulated results. This is promising for the case of 
having systems with repression via transcriptional control, however further analysis 
into the applicability of the model in single-cells is required as cells have weak 
stochastic coherence with the model.  
 
 
Figure 2.4: a. Amplified negative feedback topology, with repression by transcriptional control. Gene 
A activates its own transcription as well as gene B, whilst B represses transcription from A. b. in vivo 
implementation of repression by transcriptional control (Atkinson et al., 2003). 
 
 
2.5.3.2 Repression by Dimerization 
 
Proteins can undergo dimerization and this process can repress genetic oscillators 
through sequestration as proteins from the first gene can dimerize with proteins from 
the second (Barkai and Leibler, 2000). This network topology (Figure 2.5a) has been 
modelled using ODEs (Vilar et al., 2002; Hilborn and Erwin, 2008), SDEs (Hilborn 
and Erwin, 2008) and Gillespie simulations (Barkai and Leibler, 2000; Steuer et al., 
2003; Hilborn and Erwin, 2008), but has not been implemented in vivo. The extent 
of the oscillations has been studied and describes the evolution of the repressor and 
activator-repressor complex. These in silico models have been shown to give 
qualitatively the main features of complete models where oscillations have been 
shown to exist over broad ranges, which suggest robustness, however only in the 
presence of intermediate repressor degradation (Vilar et al., 2002). It has been 
A B 
a. b. 
glnG 
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observed that the repressor degradation plays an important factor into the period of 
oscillations and has been determined that lower degradation rates increase the 
period, which is to be expected. Amplitude of the oscillations were sensitive to the 
transcription and translation rates and the periods were predicted to around 20 
hours, which is comparable to the model from Atkinson et al. (2003). In this system 
noise plays a more consequential role and expands the oscillatory parameter region 
to generate stochastic coherence. The approximate models mentioned are lower order 
and determine if a system can oscillate, however they can fail to show more subtle 
features such as stochastic coherence.  
 
 
Figure 2.5: a. Amplified negative feedback topology, with repression by dimerization, where red genes 
show the first gene and blue genes show the second gene in the repression process. Solid lines 
represent direct transcriptional control and dashed lines represent repression by dimerization. b. 
Amplified negative feedback topology, with repression by proteolysis. Here dashed lines represent 
repression by proteolysis. 
 
 
2.5.3.3 Repression by Proteolysis 
 
Another implementation of amplified negative feedback where repression is obtained 
through degradation of the protein from the first gene by proteases encoded by the 
second (Figure 2.5b) was researched by Guantes and Poyatos (2006) and Conrad et 
al. (2008), and was simulated using ODEs as well as the Gillespie algorithm, but has 
again not been implemented in vivo. Oscillations in networks reported by Guantes 
and Poyatos (2006) showed that the activator required significantly faster dynamics 
than the repressor, and this was achieved through faster degradation and translation 
rates for the activator. The oscillations exhibited a finite frequency, which increases 
as the activator dynamics become faster than that of the repressor, and can reach 
plateaus of greater magnitude than networks with repression by dimerization. 
Changing the network from nonlinear transcriptional repression via dimerization to 
linear repression via proteases yields an oscillator with high frequency, low 
amplitude oscillations and stronger stochastic coherence. This highlights how a small 
A B 
a. 
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change in the repression mechanism can have a large effect on the dynamics and 
overall function.  
 
 
2.5.4 Synthetic Mammalian Oscillators 
 
A requirement for amplified negative feedback oscillators is that the activator 
presents faster dynamics than the repressor. This is the same effect as adding a 
delay in the negative feedback loop as both allow the activator concentration to 
reach a significant level before repression overtakes, thereby allowing sustained 
oscillations. Research from Tigges et al. (2009, 2010) looked into the effect of having 
a delay in the negative feedback loop and how it will affect oscillations in vivo. 
These synthetic oscillators are the only ones to be implemented in eukaryotic cells 
and herald a new form of topology that can host more complex networks (Figure 
2.6). The oscillator comprises of two genes with transcription (formation of proteins) 
occurring from both. The transcription is translated and the resulting protein is fed 
back into itself and promotes both transcription and the activation of the second 
gene. The novelty comes from the second gene which activates transcription from 
the first gene, however it is not translated into a protein, but rather hybridizes with 
the transcript and represses protein production at translation completing the 
negative feedback loop. In this sense the protein from the second gene is inhibiting 
the first gene and stops protein formation as it combines with any product from the 
first gene. The important step of note is the addition of a delay in the negative 
feedback loop which causes the repression. Simulations using ODEs showed that the 
system is sensitive to gene dosage, but remains robust to changes in mRNA and 
protein degradation. Control is achievable by inhibiting activation by the first 
protein and allowed for a switch mechanism on the oscillations. Undamped 
oscillations were present and periods altered depending on the delay in the negative 
feedback, while cell-cell variability was reported as confirmed by stochastic 
simulations. Oscillations matched predictions and showed that this network can be 
suitably tuned to user preference. Lower frequency variants of the synthetic 
oscillator network (Tigges et al., 2010) were also constructed, which use direct 
interference of smaller proteins instead of full protein chains. Here the oscillations 
presented a period of 26 hours, and are considerably longer than any other synthetic 
network, however this network is not robust as only 18 percent of cells exhibited 
oscillations. These oscillators do however provide valuable insight into the 
relationship between gene dosage and dynamics and could potentially allow users to 
fine tune network outputs.  
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Figure 2.6: Topology of the synthetic mammalian oscillator. Gene A promotes is own transcription, 
and also activates gene C, which promotes transcription of RNA B (antisense A). RNA B represses A 
by hybridization and the translational level. Solid lines represent direct transcriptional control, while 
dashed lines show the repression by sense-antisense hybridization.  
 
 
2.5.5 Robust Oscillators 
 
The oscillators described so far have not been able to demonstrate robustness, which 
in synthetic biology is having all cells display the same responses and behaviour, 
with the percentage of oscillating cells being low, or not reported. However, 
robustness is vital in synthetic networks especially if they are to become components 
in larger synthetic systems, or interface with natural systems (Lu et al., 2009). A 
robust oscillator (Smolen et al., 1998) comprises of two genes. The first, gene A, 
promotes its own transcription and that of the other gene (gene B). Gene B inhibits 
itself and the transcription from gene A. It is this self-inhibiting loop on the second 
gene that differentiates this topology (Figure 2.7) from the amplified negative 
feedback oscillators. ODE models of this can be found in Smolen et al. (1998), Hasty 
et al. (2002) and Stricker et al. (2008). Oscillations arise in this network due to the 
activator degradation rate being two to three times faster than the repressor. The 
Smolen oscillator (Smolen et al., 1998) is robust and highly tunable, with oscillations 
ranging over various time periods and as quickly as 13 minutes. The characteristic 
robustness and tenability provide both reliability and utility, which can be exploited 
in the construction for future synthetic networks. The rapid oscillatory behaviour 
appears to occur because of the negative feedback loop added to what is simply an 
amplified negative feedback topology, and if realised in vivo could expand the 
applications of this oscillator. Work from Stricker et al. (2008) showed a more 
complex network utilising a higher dimensional model that expressed two limit 
cycles simultaneously, and both the model and in vivo implementation showed 
complimentary results. Results showed that the oscillations were fine-tuned over a 
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wide range of conditions, with possibility to extend the region by tuning parameters. 
Over 99 percent of cells displayed oscillations in accordance with simulations, and 
these findings are a clear demonstration of robustness.  
 
 
 
Figure 2.7: Robust oscillator topology (Smolen et al., 1998). Gene A activates its own transcription 
and that of gene B also, while gene B represses its own transcription and that of gene A. 
 
 
2.5.6 The Metabolator 
 
The metabolator (Fung et al., 2005) was the first oscillator that incorporates 
metabolic oscillations within the network topology. It comprises of two genes where 
one gene produces an enzyme that converts one metabolic pool (M2) to another 
(M1), and its production is activated by M2. The second gene produces an enzyme 
that converts M1 into M2 with its production being repressed by M2. As a 
comparison to the other topologies seen (Figure 2.8a) two genes, A and B, activate 
one another as well as self-repress by increasing or decreasing the metabolite pool, 
M2. Within Figure 2.8b, the negative feedback link from gene A to itself via gene C 
is equivalent to gene A repressing itself in the topology shown in Figure 2.8a. Solid 
lines represent direct transcriptional control whilst dashed lines ending with a bar 
show indirect repression. Dashed lines ending with an arrow represent both indirect 
and direct repression depending on the circuit dynamics. The implementation of this 
topology in E. Coli (Figure 2.8b) was modelled using ODEs, a detailed explanation 
of which will be presented in Chapter 4. Oscillations were observed in 60 percent of 
cells with a period of around 45 minutes and lasts approximately 4 hours. It is 
important to note that this network showed cell division to be un-correlated with 
oscillatory behaviour, which indicates that the dynamics are de-coupled from the cell 
cycle. The in vivo observations show that the dynamics of this network can be 
predictably controlled using external metabolite sources. For an in depth analysis of 
the metabolator the reader is referred to Chapter 4 of this thesis. 
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Figure 2.8: a. Conceptual schematic topology of the metabolator network. Gene A represses itself 
whilst also promoting gene B, which in turn can repress itself as well as activate gene A. b. 
Implementation topology of the metabolator.  
 
 
2.5.7 Summary of Synthetic Oscillators 
 
Section 2.5 has dealt with the plethora of synthetic genetic networks that have been 
reported in literature. The evolution of these networks from the Goodwin oscillator 
to more recent Smolen oscillators has been discussed and a summary of all oscillators 
mentioned is shown in Table 2.1. Whilst it would be expected that one could 
compare the oscillators that have been published, there currently does not exist a 
characterisation standard that can be utilised to do so. This is because of the 
different networks and how they function. Some networks self-repress, whilst others 
have genes in sequence that supress one another. It is difficult therefore to 
characterise these networks using conventional techniques, and so comparison is 
difficult. Furthermore, reported characteristics can vary significantly between 
oscillators. For instance the number of oscillating cells, which is a good indicator of 
robustness, is only reported in half of the in vivo implementations of the different 
topologies discussed in section 2.5. With the exception of mammalian oscillator 
(Tigges et al., 2009) which was implemented in eukaryotic cells, the remainder are 
constructed within prokaryotes. Of those reported, the prokaryotic systems are easy 
to manipulate and the mechanisms of gene regulation are simpler than that of the 
mammalian oscillator. This simplicity is key to allowing the system to be predictable 
as the essential features of the system to be easily captured. Oscillatory periods vary 
A B 
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significantly from 13 minutes (Smolen et al., 1998) to 26 hours (Tigges et al., 2010), 
and the reasons for this is unclear, however, the systems are able to be tuned with 
different factors than can affect system output e.g. temperature, small molecule 
concentration and plasmid dosage.  
Modelling of these networks has been predominantly predictive and often in 
agreement with in vivo results, with model parameters determined through 
heuristics. Simpler models are used to determine the potential for oscillations, 
whereas more complex models are developed to obtain more comprehensive 
qualitative and quantitative predictions of the network behaviour. Detailed models 
have shown advantages in determining complex behaviour, as seen in the case of the 
Smolen oscillator (Smolen et al., 1998) where the co-existence of limit cycles was 
observed. However, a key point is to consider that complex models should not 
detract from the fact that these behaviours have not been realised in vivo, and it is 
important to test if they are an artefact of increased model detail rather than due to 
the dynamics of the network.  
Robustness is still a significant issue for synthetic oscillators, even in light of 
the robustness demonstrated by the Smolen oscillator (Smolen et al., 1998). 
Although many of the networks are de-coupled from the cell cycle, there are 
networks that exist that have not yet been fully characterised. There is potential for 
interference from the host cell, which could explain the relatively low numbers of 
oscillating cells observed. The case of the Repressilator (Elowitz and Leibler, 2000) 
demonstrates this theory as the oscillations within the three gene network were 
halted by the system going into the stationary phase (where the growth rate and 
death rate of the cells is equal). Most of the networks also utilise mutated genes, or 
gene topologies where one has been removed, to avoid interference, however as the 
topologies become larger the number of interfering components also increases. 
Predicting how a network will function if subjected to high level interference from 
host cells is paramount to the success of synthetic oscillators. For the Repressilator, 
work by Goh et al. (2008) looked at addressing this issue. They found that non-
specific interactions forming coherent couplings are more likely to maintain 
oscillations and non-specific interactions that have a regulatory affect are also likely 
to maintain oscillations. The effect of cell cycle such as changes in volume and levels 
of host cells for network function are also being considered (Tuttle et al., 2005; Yoda 
et al., 2007).  
There is also increasing amount of research into coupled genetic oscillators, 
focussing mainly on repressilators (Ullner et al., 2007; Zhou et al., 2008). These 
networks have predominantly been studied in silico, however recently coupling has 
been used in vivo to give cells that can display synchronised oscillations (Danino et 
al., 2010). It is envisaged in future work that combinations of these technologies will 
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aid in the design and implementation of networks that are reliable, tunable and 
robust, which can then be incorporated into new synthetic genetic regulatory 
networks. 
The networks and oscillators detailed in this section have all shown how 
synthetic biology aids in designing systems. However, although all of the oscillators 
mentioned are well characterised, have been studied in the laboratory and have been 
simulated using mathematical models, there has been little research in terms of 
controlling the system outputs. The gap in literature regarding control of oscillators 
and subsequent design is something that will be addressed in this work. It is 
envisaged that by controlling these systems one can increase production of a useful 
product, control system oscillation and re-configure the network to provide new 
products. In terms of the work that will be presented in this thesis, control is used 
to optimise the system outcomes, and in the case of the Metabolator (Chapter 4) it 
is used to alter system dynamics to a pseudo-steady-state.  
 
 
2.6 Summary 
 
This chapter has detailed the various aspects of synthetic biology and how it can be 
applied for a variety of different problems ranging from grand challenges to simple 
alternatives to commonly used methods. The next chapter will look at how synthetic 
biology has been adapted for modelling various biological systems and the methods 
used to achieve this. 
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Table 2.1: A summary of the oscillators discussed in section 2.5 
Name 
Feedback 
Mechanism 
Noise Effect 
in vivo 
Implementation 
Oscillation 
Characteristic 
Robust Aspects Tunable Aspects References 
Repressilator N negative Amplitude variation, 
enlarged oscillatory 
parameter range, stochastic 
coherence 
Prokaryotic Period: 16%-40 min Dynamics are 
decoupled from cell 
cycle 
Dynamics are coupled 
to cell growth 
Elowitz and Leibler 
(2000) 
        
Goodwin 1 negative Enlarged oscillatory 
parameter region, irregular 
oscillations 
Prokaryotic Period: ~ 30 min Period is resistant to 
IPTG 
N/A Stricker et al. (2008), 
Muller et al. (2006) 
        
Amplified negative 
feedback transcription 
2 positive, 1 
negative 
Weak stochastic coherence, 
damped oscillations 
Prokaryotic Period: 10/20 hours N/A Period and amplitude 
via cell doubling 
Atkinson et al. (2003), 
Guantes and Poyatos 
(2006) 
        
Robust 2 positive, 2 
negative 
Bi-modal oscillations, 
stochastic coherence 
Prokaryotic Period: 13-58 min Decoupled from 
doubling time and cell 
cycle 
Period by controlling 
IPTG, arabinose and 
temperature 
Stricker et al. (2008) 
        
Metabolator 3 positive, 2 
negative 
Amplitude variation Prokaryotic Period: 45%-10 min. 
Lasted ~ 4 hours 
Decoupled from cell 
cycle 
Oscillations can be 
switched on/off by 
influx or efflux rates 
Fung et al. (2005) 
        
Mammalian 3 positive, 1 
negative 
Cell-cell variability at low 
gene dosage, additional 
oscillations at high dosage 
Eukaryotic Period: 17%-71 min N/A Period and amplitude 
through changes in 
gene dose 
Tigges et al. (2009) 
        
Low-frequency 
mammalian 
2 positive, 1 
negative 
N/A Eukaryotic Period: 26%-8.5 
hours 
Period is insensitive to 
relative plasmid dosage 
N/A Tigges et al. (2010) 
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3.  Solution Strategies for Dynamic Models 
 
This chapter will look at the various simulation strategies that can be employed in 
optimising dynamic models, in particular models that utilise ordinary differential 
equations (ODEs). Due to the dynamic nature of biological systems it can be 
increasingly difficult to accurately simulate processes within a mathematical model. 
Typically systems that are well characterised and have been researched extensively 
will have their dynamics realised in ordinary differential equations. A brief 
discussion of how ODEs are formed are shown in section 3.1, leading on to the 
various NLP and MINLP formulations seen in literature (section 3.2). The 
remaining sections deal with the formulation of the various models used in this 
study and are summarised as follows: 
 
1. The ANN approach for solving ODEs is presented in section 3.3. This is used 
to simulate the processes and provides the basis for nonlinear model predictive 
control (NLMPC). 
2. Using fourth order Runge-Kutta (RK4) to verify the results of the neural 
network approximator for differential equations (ANN-ODE) formulation is 
shown in section 3.4, with an example of how the performance of coupling the 
two methods provides optimal results shown in the example problem (section 
3.4.1). 
3. OCFE is formulated and presented in section 3.5 and is used to compare 
results obtained from the ANN-RK4 model to highlight the advantages of 
using both verification methods. 
4. The NLMPC formulation is shown in section 3.6 and how it couples with the 
ANN-ODE model. 
5. Zone NLMPC is formulated and presented in section 3.6.2. 
 
 
3.1 Ordinary Differential Equations (ODEs) 
 
Ordinary differential equations have been used extensively to model dynamic 
processes. Within the realm of synthetic biology some choice examples of the use of 
ODEs have modelled problems regarding drug resistance (Xu et al., 2007) and virus 
dynamics (Komarova and Wodarz, 2010). The general form of ODE’s are presented 
in equations 3.1-3.3: 
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 𝑑𝑍𝑗(𝑡)
𝑑𝑡
=  𝑓𝑗(𝑍(𝑡), 𝜃, 𝑡)          𝑗 ∈ 𝐽 
(3.1) 
 
 𝑍𝑗(𝑡 = 0) = 𝑍𝑗
0          𝑗 ∈ 𝐽 
(3.2) 
 
 𝑡 ∈ ⌊0, 𝑡𝑓⌋ (3.3) 
 
where 𝑍 is the 𝐽 dimensional vector of the state variables in the given ODE system, 
time points are represented by 𝑡 and 𝜃 is the vector of parameters. 
 
 
3.2 NLP and MINLP Models 
 
This section will discuss nonlinearities in models that often arise due to the dynamic 
nature of systems and their solution strategies using nonlinear and mixed integer 
programming. Whilst they can be modelled using several techniques and can often 
rely on systems that utilise several techniques in various stages, they are increasingly 
being modelled using nonlinear techniques. These techniques are of particular 
importance for biological systems and play an important role in the case studies 
throughout this thesis. The structure of nonlinear and mixed integer optimisation 
models are described by Floudas (1995) and take the following form (Equation 3.4): 
 
 min
𝑥,𝑦
𝑓(𝑥, 𝑦) 
s.t.                            ℎ(𝑥, 𝑦) = 0 
𝑔(𝑥, 𝑦) ≤ 0 
𝑥 ∈ 𝑋 ⊆ ℜ𝑛 
                         𝑦 ∈ 𝑌              Integer 
(3.4) 
 
Where 𝑥 is a vector of 𝑛 continuous variables, 𝑦 is a vector of integer variables, 
ℎ(𝑥, 𝑦)  =  0 are 𝑚 equality constraints, 𝑔(𝑥, 𝑦)  ≤  0 are 𝑝 inequality constraints, 
and 𝑓(𝑥, 𝑦) is the objective function. This type of formulation can consider a number 
of optimisation problems through elimination of its elements. If the set of integer 
variables are empty and the objective function constraints are linear, then this 
becomes a linear programming problem. If however the set of integer variables are 
not empty and the objective function contains nonlinear terms and constraints then 
an MINLP problem is formed. If the objective function contains nonlinear terms as 
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well as or in lieu of nonlinear terms in the constraints, and the integer variables are 
empty, then an NLP problem is formulated. Nonlinear programming (NLP) is used 
often with ODEs to construct models, as presented by Tamimi and Li (2010). This 
research looked at combining a collocation method with a multiple shooting method 
to create a nonlinear model predictor control (NLMPC) of fast systems. The 
multiple shooting method is used to discretely analyse the dynamic model, and the 
optimal control problem is transformed to an NLP problem.  
 
 
3.2.1 Review of MINLP Applications and Methods 
 
Mixed integer nonlinear programming (MINLP) has provided solution techniques for 
many different types of models. It provides a way of modelling dynamic processes 
and can been used to model proteins and enzymes. Protein modelling has gained 
interest in recent years and research from Lienqueo et al. (2009) looked at how 
computer-aided design (CAD) could be used to select polypeptide tags that can be 
used for recombinant protein purification processes. The aim was to select the best 
polypeptide tag from a comprehensive list of commonly used tags, and in doing so 
also to maximise the purification process profit. The model used was a simplification 
of the model proposed by Simeonidis et al. (2005). The model and its solution 
method were implemented in GAMS and the SBB solver was used. It was seen that 
as the purity level of the protein increased the number of infeasibilities in the GAMS 
solution also increased. This is expected as the optimisation problem becomes harder 
to implement and therefore cannot find feasible solutions for every tag.  
Solutions for MINLP problems have also been researched in the energy and 
refinery industries. A genetic algorithm solution method in MATLAB can be useful 
in optimising hydrogen refinery systems, as demonstrated by Khajehpour et al. 
(2009). The research looked at minimising hydrogen waste into fuel gas within the 
hydrogen network systems of refineries. The research was based on a superstructure 
method described by Hallale and Liu (2001). It was seen that this sort of 
methodology became complex when dealing with large networks and could cause the 
problem to be unsolved. It was deemed vital to remove some of the improper 
complexities and simplify the assumptions without losing the accuracy. Reducing the 
superstructure required the examination of the variables and eliminating those that 
were unrealistic. This step was crucial in reducing the computational time and 
ultimately led to faster results. The model was then applied to a case study refinery, 
and the optimisation of this proved that production of hydrogen reduced by 22.6% 
thus leading to a saving of approximately $1.19 million annually.  
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3.3 Artificial Neural Networks (ANNs) 
 
Artificial neural networks (ANNs) are systems made up of nodes and weighted 
interconnections, which possess the ability to process information based on the 
dynamic effects that inputs have on the system (Baughman and Liu, 1995). They 
can be labelled as surrogates of a process system that can create mapping sequences 
between input and output datasets obtained from the process. The mapping between 
the input and outputs is achieved using historical data to train the network, which 
is utilised to create the architecture required to predict process outputs for any data 
that is not used as the training set. Due to their nature, ANNs are highly desired as 
tools for efficiently mapping and capturing nonlinear properties of process systems 
(Hornik et al., 1989; Pourboghrat et al., 2003). The general format for an ANN 
structure is presented in Figure 3.1, which shows a typical feedforward ANN. The 
relationships between the input layer, the hidden layer and the output layer are 
connected with weighted links and the nodes have biases, both of these aspects 
represent the system parameters (Prasad and Bequette, 2003). The ANN receives 
information through the input layer and processes the information to send to the 
hidden layer. The hidden layer computationally processes the information further 
and sends this data to the output layer which provides the information of the 
process system. Generally the nodes in the input layer receive information from the 
training/validation datasets, whilst the nodes in the hidden and output layers 
receive information directly from the nodes in the preceding layer of the network.  
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Figure 3.1: Typical structure of a feedforward artificial neural network (ANN) 
 
A typical ANN relies on solving NLP formulations and their form has been described 
by Dua (2010), given by equations 3.5-3.9: 
 
 
min
𝑎,𝑏,𝑤,ℎ,𝑊,𝐵,𝑢
𝐸1 = ∑(ȗ𝑘 − 𝑢𝑘)
2
𝑁0
𝑘=1
 
(3.5) 
 
Subject to: 
 
 
𝑎𝑗
1 = ∑ 𝑤𝑗𝑖
1𝑥𝑖 + 𝑏𝑗
1
𝑁𝑥
𝑖=1
   𝑗 = 1, … , 𝑁ℎ 
(3.6) 
 ℎ𝑗
𝑙 = tanh(𝑎𝑗
𝑙)    𝑙 = 1, … , 𝑁ℎ (3.7) 
 
𝑎𝑗
𝑙 = ∑ 𝑤𝑗𝑖
𝑙
𝑁𝑛
𝑖=1
ℎ𝑗
𝑙−1 + 𝑏𝑗
𝑙     𝑗 = 1, … , 𝑁𝑛    𝑙 = 2, … , 𝑁ℎ 
(3.8) 
 
𝑢𝑘 = ∑ 𝑊𝑘𝑖𝑛𝑗
𝑁ℎ +
𝑁𝑛
𝑖=1
𝐵𝑘    𝑘 = 1, … , 𝑁0 
(3.9) 
 
Here (3.5) represents the ANN prediction error objective function, (3.6) represents 
the activation variables of the first hidden layer, (3.7) indicates the nonlinear 
𝑤𝑚𝑙 
𝑏𝑚 
𝑣𝑚 
𝑁1 
𝑁𝑗 
Input Layer Hidden Layer Output Layer 
𝑡𝑖 
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transformation of the activation variables, (3.8) represents the activation variables of 
the remaining hidden layers, and finally (3.9) represents the ANN output. Where 𝑥𝑖 
denotes the input values to the network, 𝑖 = 1, … , 𝑁𝑥 shows the number of inputs, 𝑁𝑛 
indicates the linear combinations of these inputs and gives the activation variables, 
1
ja , where 𝑁ℎ is the number of hidden layers. The superscript 1 denotes the index of 
the first hidden layer. Weights are given by 𝑤𝑖𝑗 and the biases by 𝑏𝑗. These 
activation variables are then transformed non-linearly to give l
jh , which is the 
output of the hidden layer. This then becomes the input of the next hidden layer. 
The outputs of the last hidden layer, Nh
jh , are combined to provide the outputs, 𝑢𝑘. 
The number of nodes in the output layer is given by 𝑁0 and 𝑤𝑘𝑖, and 𝐵𝑘 are the 
weights and biases respectively. The desired output for the system is indicated by ?̂?𝑘 
and training of the network can be employed as minimisation of the error function, 
𝐸1.  
Applications of ANNs have looked at synthesis problems (Basri et al., 2007) 
which utilise ANN frameworks for estimation capabilities of response surface 
methods (RSM), in the synthesis of palm-based wax ester. Wax esters are used 
commonly in the pharmaceutical, cosmetic and lubricant industries due to their 
excellent wetting agent properties. They can be produced artificially from enzymatic 
hydrolysis of palm oil. In order to optimise this process RSM was used, which is an 
effective statistical technique for developing, improving and optimising a complex 
process (Bas and Boyaci, 2007). RSM is a collection of statistical and mathematical 
techniques that is used to define relationships between the responses and 
independent variables. In doing so it can generate a mathematical model that can 
view the independent variables either alone or in a combination with the process. 
This method utilises a known optimal structure of the ANN. However ANNs are 
capable of having various structures as they can contain multiple hidden layers. This 
can make finding the optimal configuration difficult, however, in work by Dua 
(2010) a mixed-integer approach (MIPANN) was utilised to find the optimal 
configuration of a neural network. It was noted by Hornik et al. (1989) that a 
successful network is one that can approximate highly-linear processes through 
postulating an interconnected network structure. Dua (2010) looked at introducing 
0-1 binary variables to indicate the presence or absence of nodes and 
interconnections. The objective was to minimise the overall structure and in doing so 
minimise the error between the ANN prediction and desired output. This MIPANN 
approach is advantageous as it can produce a simplified structure and can eliminate 
nodes and interconnections that are not required for an optimal solution. This in 
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turn also reduces the computational effort on the system to find the solution. The 
simplified model was tested using three examples, all of which provided excellent 
correlation in data and optimal solutions seen. It was seen that although the process 
of training using an MIPANN model is more complex than a traditional ANN, the 
model could be used for on-line processes, where a simpler structure is easier to 
maintain.  
The next section will look at the verification methods that can be employed to 
verify solutions from ANNs. 
 
 
3.4 ANN Based Solution of ODEs and Runge-Kutta Verification 
 
Artificial neural networks have also been used to solve ODEs and other types of 
dynamic problems as seen in research from Fogel et al (1995), Ge and Zhang (1999), 
Prasad and Bequette (2003) and Goh et al. (2008). Significant research into utilising 
ANNs to solve ODEs and partial differential equations (PDEs) for initial and 
boundary value problems is presented in Lagaris et al. (1998). The use of an ANN as 
a solution technique for ODEs has a number of advantageous features, such as: 
 
 The ANN solution provides a continuous differentiable form that can be 
utilised in subsequent calculations. The solution therefore can be accessed at 
any point within the domain (Lagaris et al., 1998; Wojciechowski, 2012).  
 The ANN provides a solution that requires little memory space and is 
compact (Parisi et al., 2003; Caetano et al., 2011). 
 The dimensionality of the problem can easily be increased through the 
addition of new input nodes in the ANN (Wojciechowski, 2012). 
 Mesh points or spaced collocation points are not required to find the solution 
of the ODEs (Wojciechwoski, 2012). 
 
In a paper by Filici (2008) a single-layer ANN is utilised to solve ODEs. This neural 
approximator, in the form of a feed-forward perceptron (Lagaris et al., 2000), aimed 
to solve systems of ODEs for the whole interval. The perceptron is a linear 
combination of differentiable functions and their derivatives with respect to the 
inputs will therefore be well defined. In the model the initial value problems are 
solved by means of an ANN. A cost function is extended in the model to obtain an 
approximate solution to these problems. The model was assessed against other 
techniques such as the Runge-Kutta-Fehlberg (RKF7) integration method (Fehlberg, 
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1969). It was seen that in cases where the criterion of validity held up, the model 
was capable of reducing the approximation errors in both of the sets used to train 
and test the samples. The iterations showed small error and the trained network 
successfully approximates the solution of the initial value problem. 
Further work by Dua (2011) looked at ANN modelling could be used to 
approximate parameter estimations of ODEs. Typically parameter estimation of 
ODEs can take on one of two methods. Either the optimisation problem can be 
decoupled from the integration of the differential equations, or these equations can 
be converted into algebraic equations and integrated into the overall problem. 
However these approaches have the main limitation that one can get trapped into a 
local optimum and may fail to find the global optimum. Also with integration of 
ODEs often the whole data set is taken into account. If a data set is quite large then 
this can put extra strain on computing the solution. As mentioned earlier the use of 
an ANN will reduce the data set and computational effort. An ANN model was 
created and tested around a series of sub-problems. The method proposed for 
decomposition based approach in order to calculate the optimum solution was 
divided into three stages. An ANN was obtained for the data set, then it was used 
to form a simplified optimisation problem to obtain the parameter estimates, and 
finally these estimates were used as initial starting points to calculate the solution. 
Within this work the ANN methodology for solving ODEs was utilised. In 
order for the solution for the ODEs to be verified, a fourth order Runge-Kutta 
transformation (RK4) was used. Here, this method is used to give approximations to 
the ODEs, and is used in combination with the ANN framework (Equations 3.5-3.9). 
A brief description of the RK4 based approach (Lagaris et al, 1998) is presented 
next which is coupled with the work by Dua and Dua (2012) who profound the 
following trial solution for ODE problems: 
 
 
𝜀1 =  min
𝜃,𝑥(𝑡)
∑ ∑{
𝑗∈𝐽𝑖∈𝐼
?̂?𝑗 (𝑡𝑖) − 𝑧𝑗(𝑡𝑖)}
2 
(3.10) 
 
subject to: 
 𝑑𝑧𝑗(𝑡)
𝑑𝑡
=  𝑓𝑖(𝑧(𝑡), 𝜃, 𝑡)            𝑗 ∈ 𝐽 
(3.11) 
 𝑧𝑗(𝑡 = 0) =  𝑢𝑗
0          𝑗 ∈ 𝐽 (3.12) 
 𝑡 ∈ [0, 𝑡𝑓] 
(3.13) 
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where 𝑧 is the 𝐽-dimensional vector of the state variables from the ODE system, 
?̂?𝑗(𝑡𝑖) is the experimentally observed values of these state variables at time points 𝑡𝑖 
and 𝜃 is the vector of the parameters that are estimated such that the error, 𝜀1, 
between the observed and predicted values from the model are minimised. The 
solution for the ODE model from equations 3.11-3.13 can be given by an ANN 
(Lagaris et al., 1998). If an ANN is considered with 𝑙 inputs, a single hidden layer, 
𝑚 nodes within the hidden layer and a linear output, the output from the ANN is 
given by: 
 
 
𝑁 =  ∑ 𝑣𝑚𝜎𝑚
𝑚
 
(3.14) 
 
𝜎𝑚 =  
1
1 +  𝑒−𝑎𝑚
 
(3.15) 
 
𝑎𝑚 =  ∑ 𝑤𝑚𝑙𝑥𝑙 + 𝑏𝑚
𝑙
 
(3.16) 
 
where  𝑤𝑚𝑙 is the weight from the input 𝑙 to the hidden node 𝑚, 𝑣𝑚 is the weight 
from the hidden node 𝑚 to the output of the network, 𝑏𝑚 represents the bias and 
𝜎𝑚 is the sigmoid transformation. The 𝑘th derivative of the output with respect to 
the 𝑙th input is given by: 
 
 𝛿𝑘𝑁
𝛿𝑥𝑙
𝑘 =  ∑ 𝑣𝑚𝑤𝑚𝑙
𝑘 𝜎𝑚
(𝑘)
𝑚
 
(3.17) 
 
where  𝜎𝑚
(𝑘)
 represents the 𝑘th derivative of the sigmoid. For the ODE model given 
in equations 3.11-3.13, 𝑘 = 1 and the inputs 𝑥𝑙 are given at time points 𝑡. A trial 
solution for the ODE model is given by: 
 
 𝑧𝑗
𝐴𝑁𝑁 =  𝑧𝑗
0 + 𝑡𝑁𝑗 
(3.18) 
 
where the ANN model (𝑁𝑗) is considered for each trial solution 𝑧𝑗
𝐴𝑁𝑁. In order to 
satisfy the initial conditions (3.11), the trial solution (3.18), is constructed as follows:  
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 𝑑𝑧𝑗
𝐴𝑁𝑁
𝑑𝑡
=  𝑁𝑗 + 𝑡
𝑑𝑁𝑗
𝑑𝑡
  
(3.19) 
 
where (𝑑𝑁𝑗)/𝑑𝑡 is given by equation 3.17 where 𝑥 = 𝑡 and 𝑘 = 1. This therefore 
means that the solution for the ODE model (3.11-3.13) for given values of 𝜃 can be 
formulated as the following nonlinear programming (NLP) problem (Lagaris et al., 
1998): 
 
 
𝜀2 =  min
𝑧𝐴𝑁𝑁,𝑁,𝜎,𝑤,𝑣,𝑎,𝑏
∑ ∑ {
𝑑𝑧𝑗
𝐴𝑁𝑁(𝑡𝑖)
𝑑𝑡
− 𝑓𝑖(𝑧(𝑡𝑖), 𝜃, 𝑡𝑖)}
2
𝑗𝑖
 
(3.20) 
 
subject to equations 3.14-3.19, where 𝑣 is the weight from 𝑚 = 1, … , 𝑀 hidden nodes 
to the 𝑗-th output node, 𝑎 is the activation level computed from Equation 3.16 and 
𝑏 is the nodal bias.  
 
To ensure a robust numerical convergence the fourth order Runge-Kutta (RK4) 
method verifies the solution of the dynamic equations obtained by using the ANN 
method. In general an initial value problem is set and then a step-size is chosen. The 
method utilises four transformations, and in averaging the four increments, greater 
weight is applied to the midpoint. The weight is chosen such that 𝑓 is independent 
of 𝑧 and in doing so the differential equation is transformed to a simple integral. The 
generic equations for this method are presented below: 
 
 𝑧𝑘+1 =  𝑧𝑘 + 𝑤1𝑘1 + 𝑤2𝑘2 + 𝑤3𝑘3 + 𝑤4𝑘4 
(3.21) 
 
where k1, k2, k3 and k4 have the form: 
 
 𝑘1 = ℎ ∙ 𝑓(𝑡𝑘, 𝑧𝑘) 
𝑘2 = ℎ ∙ 𝑓(𝑡𝑘 + 𝑎1ℎ, 𝑧𝑘 + 𝑏1𝑘1) 
𝑘3 = ℎ ∙ 𝑓(𝑡𝑘 + 𝑎2ℎ, 𝑧𝑘 + 𝑏2𝑘1 + 𝑏3𝑘2) 
𝑘4 = ℎ ∙ 𝑓(𝑡𝑘 + 𝑎3ℎ, 𝑧𝑘 + 𝑏4𝑘1 + 𝑏5𝑘2 + 𝑏6𝑘3 ) 
(3.22) 
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The RK4 method involves using an appropriate step size to converge to the same 
optimal solution as the ANN framework. This was researched using trial and error 
and an investigation to find the best step size to use in the model was performed 
and it was found that smaller step sizes, e.g. 0.001, had greater chance to find the 
correct solution. The same objectives and simulation conditions are applied to the 
RK4 and the ANN, therefore allowing the RK4 implementation to verify the results 
from the ANN. The ANN framework contained 7 nodes in the hidden layer, which 
was found to be the optimal configuration through previous investigations performed 
when testing the model on case examples, which are illustrated throughout this 
thesis. The following section will detail an example of the technique and showcase 
how the ANN-RK4 framework can be applied to a set of ODEs.  
 
 
3.4.1 Example ANN Problem 
 
In order to test the ANN framework in its ability to solve ODE’s a simple example 
was chosen from the Mathworks website. A simple nonstiff system describing the 
motion of a rigid body without external forces was considered. The system is set out 
with the following ODE’s: 
 
 𝑑𝑦1
𝑑𝑡
= 𝑦2𝑦3                      𝑦1(0) = 0 
(3.23) 
 𝑑𝑦2
𝑑𝑡
= −𝑦1𝑦3                   𝑦2(0) = 1 
(3.24) 
 𝑑𝑦3
𝑑𝑡
= −0.51𝑦1𝑦2           𝑦3(0) = 1 
(3.25) 
 
This was solved in MATLAB using the ‘odeset’ command and the results are 
presented in Figure 3.2: 
 
Chapter 3 Solution Strategies for Dynamic Models 
 
41 
 
 
Figure 3.2: The motion of a rigid body without external forces 
 
As can be seen in the graph the system displays a periodic wave motion. This 
system was then modelled and solved in GAMS using the ANN-RK4 framework and 
results are seen in Figure 3.3. The results from the GAMS implementation show the 
same periodic wave motion as the MATLAB results. There is however a slight 
disagreement, especially when looking at the results of 𝑦3, which starts to decrease 
in magnitude. Furthermore the periodic wave motion of all the rigid bodies start off 
being similar, up to t=5, but after this the results differ. This could be attributed to 
the ANN trying to converge to an optimal solution which involves converging he 
oscillations of each body. The results do show that the ANN-RK4 framework is 
capable of modelling ODE systems, and therefore can be used in further studies of 
dynamic systems. 
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Figure 3.3: The motion of a rigid body without external forces using the ANN framework in GAMS 
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The following section will detail how ANNs can be embedded into control problems 
through the use of nonlinear model predictive control (NLMPC), which is used as a 
framework for several case studies throughout this thesis as a means of controlling 
dynamic systems. The following section will now discuss another verification method 
for the ANN framework known as orthogonal collocation on finite elements (OCFE) 
and discuss how it is integrated with the ANN. 
 
 
3.5 Orthogonal Collocation on Finite Elements (OCFE) 
 
Orthogonal collation on finite elements (OCFE) is a solution method for problems 
whose solution has steep gradients and is applicable to time dependent problems. It 
uses a combination of ODEs and algebraic equations, and therefore can be seen as a 
more complex solution methodology when compared to others, such as RK4. The 
method divides the domain into finite elements, and sets the residual to zero at 
collocation points interior to the elements. Figure 3.4 shows the general outline of 
OCFE. 
 
 
Figure 3.4: Example of OCFE transformation. Here 𝒖 is the control variable, 𝒉𝒊 is the length of the 
element 𝒊 and the length of the horizon is defined by the period 𝒕𝒊−𝟏 to the final point 𝒕𝒇. Both 𝒚 and 
𝒛 are state variables. 
 
The following monomial basis representation of OCFE describes how the 
optimisation problem can approximate the state and control variables through the 
finite elements method (Biegler, 2007): 
u 
y 
z 
ti-1 ti tf 
h
i
 
Finite Element, i 
Collocation Points Mesh Points 
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𝑍𝑖 =  𝑧𝑖−1 + ℎ𝑖 ∑ Ω𝑞 (
𝑡 − 𝑡𝑖−1
ℎ𝑖
)
𝑑𝑧
𝑑𝑡𝑖,𝑞
𝐾
𝑞=1
 
(3.26) 
 
where: 𝑧𝑖−1 is the value of the differential variable at the beginning of the element 𝑖, 
ℎ𝑖 is the length of the element 𝑖, 𝑑𝑧 𝑑𝑡𝑖,𝑞⁄  is the value of the first derivative in 
element 𝑖 and collocation point 𝑞 and Ω𝑞 is a polynomial of order 𝐾 which satisfies: 
 
 Ω𝑞(0) = 0       for 𝑞 = 1, … , 𝐾 
Ω𝑞
′ (𝜌𝑟) = 𝛿𝑞,𝑟     for 𝑞, 𝑟 = 1, … , 𝐾 
(3.27) 
 
where: 𝜌𝑟 is the location of the 𝑟th collocation point within the element. Continuity 
of the differential profiles is achieved by enforcing: 
 
 
𝑧𝑖 =  𝑧𝑖−1 + ℎ𝑖 ∑ Ω𝑞(1)
𝑑𝑧
𝑑𝑡𝑖,𝑞
𝐾
𝑞=1
 
(3.28) 
 
In addition to this the algebraic and control variable profiles are approximated using 
Lagrange representation and take the form of: 
 
 
𝑦(𝑡) =  ∑ ψ𝑞 (
𝑡 − 𝑡𝑖−1
ℎ𝑖
) 𝑦𝑖,𝑞
𝐾
𝑞=1
 
(3.29) 
 
 
𝑢(𝑡) =  ∑ ψ𝑞 (
𝑡 − 𝑡𝑖−1
ℎ𝑖
) 𝑢𝑖,𝑞
𝐾
𝑞=1
 
(3.30) 
 
where: 𝑦𝑖,𝑞 and 𝑢𝑖,𝑞 indicate the values of the algebraic and control variables 
respectively in element 𝑖 at collocation point 𝑞, and ψ𝑞 is a Lagrange polynomial of 
degree 𝐾 that satisfies: 
 
 ψ𝑞(𝜌𝑟) = 𝛿𝑞,𝑟        for 𝑞, 𝑟 = 1, … , 𝐾 (3.31) 
 
As seen from equation 3.26, the differential variables must be continuous throughout 
the time horizon, while the algebraic and control variables can be discontinuous at 
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the boundaries of the elements. It also allows bounds on the differential variables 
that are enforced at the element boundaries through 𝑧𝑖 and can be further enforced 
at collocation points by including point constraints. This method is best utilised 
with the Radau collocation points method (Hairer and Wanner, 1999), which is 
preferred as it allows constraints to be set at the end of each element and allows the 
system to stabilise efficiently if high level ODEs are present in the model. 
Investigations in this work that utilise OCFE as a means of comparing against the 
ANN-RK4 framework (Chapter 5) utilise Radau collocation as the dynamic 
synthetic biology systems studied are highly nonlinear in nature. Essentially the 
concentration at the points interior to elements are taken and the tridiagonal system 
is solved to give the points at all the collocation points. The derivatives at any 
collocation point can then be evaluated by knowing what element we are in using 
the orthogonal collocation matrices. In general the solutions become better when 
more finite elements are used, and this is typical of all numerical methods that use 
piecewise approximations. The advantages of the finite elements method over 
tradition orthogonal collocation are that it can be used for smaller time scales as the 
solution is steep and a global polynomial (in orthogonal collocation) requires many 
terms to approximate the solution.  
Expansion on the collocation method was researched by Chang et al. (1979) 
where the unknown solution is expanded with a series of functions, which are often 
polynomial, and can include unknown parameters. The expansion is substituted into 
the differential equations to form the residual, which is set at zero at the collocation 
points. These equations then provide the parameters for the expansion. The method 
is used as a comparison to the Galerkin criterion, where the residuals are usually 
piecewise polynomials defined over small regions (elements) and are zero elsewhere. 
It is a precursor to the finite elements method, which was later, applied by Carey 
and Finlayson (1975). The advantage of the collocation method is that the equations 
are easier to set up and solve when compared with the Galerkin method. The 
following section will detail an example problem to showcase how the OCFE 
framework functions with the ANN. 
 
 
3.5.1 Example OCFE Model 
 
A simple isothermal CSTR (Sistu and Bequette, 1995) was modelled using the ANN-
RK4 modelling framework (Dua, 2006) and OCFE with a view to compare the 
results and analyse which verification method can achieve good results without 
compromising computational effort. The system is described in equations 3.32-3.34. 
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 𝐴
𝑘1
→ 𝐵     𝐵
𝑘2
→ 𝐶     2𝐴
𝑘3
→ 𝐷 (3.32) 
 
 𝑑𝑥𝐴
𝑑𝑡
= −𝑘1𝑥𝐴 − 𝑘3𝑥𝐵
2 + (𝑥𝐴𝐹 − 𝑥𝐴)𝑢 
(3.33) 
 
 𝑑𝑥𝐵
𝑑𝑡
= 𝑘1𝑥𝐴 − 𝑘2𝑥𝐵 − 𝑥𝐵𝑢 
(3.34) 
 
where: 𝑥𝐴 and 𝑥𝐵 are the state variables representing the concentrations of 𝐴 and 𝐵 
resprectively, 𝑥𝐴𝐹 = 10 mol litre
-1 is the concentration of 𝐴 in the feed, 𝑢 is the 
dilution or feed rate, 𝑘1 = 50 hr
-1, 𝑘2 = 100 hr
-1 and 𝑘3 = 10 litre (mol hr)
-1. The 
objective is to maintain 𝑥𝐵 = 1.0 and this can be achieved for two steady state 
solutions of the model equations: {𝑥𝐴,  𝑥𝐵 , 𝑢} =  {2.5, 1.0, 25} and {6.67, 1.0, 233.33}, 
which are the optimum solutions to the problem; the first solution is preferred as it 
requires a lower dilution rate. The following objective function (Equation 3.35) was 
analysed by Meadows and Rawlings (1997) for various values of 𝛾1, 𝛾2 and 𝛾3, which 
are weights in the system, as well as different control and prediction horizons.  
 
 
𝐽 =  ∫ 𝛾1[𝑥1(𝑡) − 2.5]
2 + 𝛾2[𝑥2(𝑡) − 1.0]
2
𝑡+𝑇
𝑡
+ 𝛾3[𝑢(𝑡) − 25]
2𝑑𝑡 
(3.35) 
 
For the example the model equations were discretised using Euler’s method and the 
controller was given a sampling time of 0.002 hrs, a horizon length of 10,  𝛾1= 
𝛾2=1000 and  𝛾3 = 1. The feed rate, 𝑢, is given the bounds 0 ≤  𝑢 ≤ 500. The results 
for the ANN-RK4 method are presented in Figure 3.5 and the results from the 
OCFE method are shown in Figure 3.6. 
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Figure 3.5: Controller performance for the ANN-RK4 model, horizon length 10, step size 0.002,  𝜸𝟏= 
𝜸𝟐=1000,  𝜸𝟑 = 1 and 0 ≤  𝒖 ≤ 500. Solved in GAMS using SNOPT solver, Intel Core™2 Duo CPU 
2.8 GHz with a total solution time of 00:33:45 hours for 100 iterations. 
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Figure 3.6: Controller performance for the OCFE model, horizon length 10, step size 0.002,  𝜸𝟏= 
𝜸𝟐=1000,  𝜸𝟑 = 1 and 0 ≤  𝒖 ≤ 500. Solved in GAMS using SNOPT solver, Intel Core™2 Duo CPU 
2.8 GHz with a total solution time of 00:00:27 hours for 100 iterations. 
 
As shown in Figures 3.5 and 3.6 the OCFE model is able to solve the problem at a 
faster CPU time, as well as providing results that exactly match the set points. The 
objective function is minimised to the order of 1x10-16 which indicates a good 
convergence for the model. Whilst the ANN-RK4 model is also able to solve the 
problem, the use of collocation points over the traditional RK4 modelling system 
here gives a better solution. It is known that OCFE is superior to RK4 as it 
discretizes at multiple points within the given horizon, therefore the resulting 
solution is more precise. The trade-off between using either of the verification 
methods depends mainly on two factors, the CPU time (or computational effort) and 
the final solution. At times it can be said that a less precise solution can be preferred 
if the computational effort is significantly lower than the more precise method. This 
ultimately will save both time and money and hence can be considered to be the 
optimal method for problem verification. Further analysis of using the ANN/RK4 
and OCFE methods will be looked at in chapters 4, 5 and 6 and the advantages of 
both will be discussed. Further investigation into the dynamic systems studied in 
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this thesis involved control of the system outputs, and hence a control strategy was 
employed to achieve this and will be discussed in the following section. 
 
 
3.6 Model Predictive Control (MPC) 
 
Model predictive control is also referred to as moving horizon control. The 
optimisation algorithm tries to determine the process dynamics at each control 
interval by calculating input values that meet the control requirements. The control 
system feedback is handled by model updates at each time interval, and the iterative 
process is looped until the defined control objectives are met.  
In general the root of many of the algorithms used for control is the receding 
horizon approach described in the following steps (Garcia et al., 1989): 
 
1. The open loop optimal control problem is solved at the present time step 𝑘 
when 𝑧𝑐0 =  𝑧𝑐(𝑘). Using past control inputs, the plant outputs are predicted 
over the discrete time intervals from the present system state to the prediction 
horizon, 𝐻𝑝, i.e. 𝑧𝑐(𝑘 + 1) to 𝑧𝑐(𝑘 +  𝐻𝑝). 
2. The predicted value at any point, 𝑧𝑐(𝑘 + 𝑚), where 𝑚 = 1, … , 𝐻𝑝, depends on 
the previous control moves and the planned control moves. 
3. The planned control moves, Δ𝑢(𝑘 + 𝑛), where 𝑛 = 1, … , 𝐻𝑐−1, implemented 
over the control horizon, 𝐻𝑐, are computed by minimisation of the MPC 
objective function, which is usually quadratic. This function accounts for the 
deviation of the output variables from the set points and the control steps. 
Although MPC calculates the vector of planned control moves, only the first 
control step, 𝑢(𝑘), is implemented. 
4. The MPC applies a feedback strategy by reducing the error between the 
measured process variables and the predicted values. These steps are 
continued throughout the various sampling times and are known as the 
receding horizon strategy (Figure 3.7). 
 
Linear MPC problems have been the major usage of MPC techniques (Lee and 
Cooley, 1997; Mayne et al., 2000; Qin and Badgwell, 2003), however, the inherent 
nonlinearities in chemical processes together with tightly imposed process constraints 
and economic considerations, mean that linear models are inadequate at defining the 
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dynamics of such systems. This has given rise to nonlinear model predictive control 
(NLMPC) algorithms. 
 
 
 
Figure 3.7: Conceptual representation of the NLMPC modelling principal (Bequette, 2009). 
 
Model predictive control (MPC) solution approaches are based on the idea of solving 
on-line a finite horizon open-loop control problem subject to usual constraints and 
system dynamics. It operates as an open-loop optimal control strategy (Qin and 
Badgwell, 1997; Allgower et al, 2004) with feedback delivered by a disturbance 
estimate, which accounts for model uncertainty (Bequette, 1991). There have been 
various different forms of MPC developed ranging from dynamic matrix control 
(DMC) (Cutler and Ramaker, 1980) to quadratic DMC (Garcia and Morshedi, 
1986), which incorporates all process constraints. Clarke et al. (1987) even proposed 
a generalised predictive control method. A more generic form of control can also be 
found in Lee and Sullivan (1988), which highlights the benefit of having a generic 
structure that can infer many different types of control processes.  
Work from Mujtaba et al (2006) showed how three types of nonlinear control 
strategies, generic model predictive control (GMC) (Lee and Sullivan, 1988), direct 
inverse model predictive control (DIC) and internal model predictive control (IMC) 
could be implemented with neural networks. The work looked at obtaining the 
optimal reactor temperatures for operability, whilst also tracking these temperatures 
on-line. The neural networks act as the dynamic estimator for heat release and as 
the controller for the batch reactor through the implementation of the control 
techniques. The GMC strategy uses nonlinear models of the process in order to 
determine the control action. The advantage for the batch reactor is that this 
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strategy provides feedback control of the rate of change of the control variable, here 
being the temperature change, and therefore can be used directly as the control 
variable for the on-line operation. Furthermore the relationship between both the 
feedforward and feedback control is stated within the GMC algorithm. For the DIC 
strategy, the inverse model of the process acts as the controller with the process 
without any feedback. Therefore in this case the neural network has to output the 
control parameters for the target set point. Finally the IMC strategy has both the 
forward and inverse models utilised directly as elements in the feedback loop. It is 
similar to the DIC approach, however the forward model is placed in parallel to the 
plant and caters for model mismatch, and the error between the plant output and 
neural network is taken from the set point before being fed back into the inverse 
model. Robust analysis of these models, where the process or operating parameters 
were changed indicated that the GMC controller was able to accommodate the 
changes better than the DIC and IMC controllers. It was deemed the better choice, 
but it was also mentioned that given a priori training for the neural networks that 
they could also function as robust controllers to cover all possible conditions that 
the process can undergo. 
Further work on MPC strategies for simultaneous control and optimisation of 
batch processes was researched from Rossi et al. (2014). The real-time methodology 
they developed, the simultaneous model-based dynamic optimisation and control 
methodology (SMBO&C), solves the dynamic real time optimisation coupled with 
nonlinear model predictive control (NLMPC), whilst simultaneously re-optimising 
the same batch time of operations to maximise yield. Firstly the initial number of 
control variables and the length of each interval are assigned as input data. Starting 
from a general time point where the process is known to be working the optimal 
variable profiles and optimal residual operational times are estimated through the 
optimisation framework. The optimal values of the manipulated variables are 
implemented and the initial time for the next control move is calculated. The 
control system stops if the control interval is zero, as this indicates that the optimal 
operation time has been reached. The overall algorithm is based on the differential 
and differential-algebraic solvers and optimisers in BzzMath (Buzzi-Ferraris and 
Manenti, 2012). The SMBO&C algorithm is capable as an optimisation tool, and can 
drive a discontinuous profile towards profitability, as well as simultaneously 
controlling the random perturbations entering the controlled system. 
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3.6.1 Nonlinear Model Predictive Control (NLMPC) 
 
Nonlinear model predictive control (NLMPC) works based on the MPC strategy 
outlined in the steps shown equations 3.36-3.44. It embeds a nonlinear model for 
prediction and optimisation, which helps deliver better control performance (Roman 
et al., 2009). The usage of nonlinear models is beneficial if comprehensive first 
principle models are obtained as performance can be enhanced. If a comprehensive 
model is not available then it is advisable that other control strategies should be 
utilised, as it may be difficult to obtain good nonlinear models using system 
identification techniques (Allgower et al., 2004). The stability of the closed loop 
system is a core prerequisite for optimal performance. A system is deemed unstable 
if the output response does not remain bounded towards the end of the prediction 
horizon. The NLMPC method for control is given by the general form as follows 
(Bequette, 1991): 
 
 
 
min
𝑢(𝑘),…,𝑢(𝑘+𝐿−1)
Φ(𝑢) = ∫ 𝑒2𝑑𝑡 = ∑ (𝑥𝑖(𝑡𝑘) − ?̂?𝑖(𝑡𝑘))
2
𝑘+𝑅
𝑖=𝑘+1
𝑡𝑘+𝑇𝑝
𝑡𝑘
 
(3.36) 
Subject to: 
 𝑑𝑧
𝑑𝑡
= 𝑓(𝑧, 𝑢, 𝑝) 
(3.37) 
 𝑦𝑚 = 𝑔(𝑥) 
(3.38) 
 𝑢𝑚𝑖𝑛 ≤ 𝑢(𝑖) ≤ 𝑢𝑚𝑎𝑥 
(3.39) 
 𝑢(𝑖 − 1) − ∆𝑢𝑚𝑎𝑥 ≤ 𝑢(𝑖) ≤ 𝑢(𝑖 − 1) + ∆𝑢𝑚𝑎𝑥 
(3.40) 
 𝑢(𝑖) = 𝑢(𝑘 + 𝐿 − 1)      for all    𝑖 > 𝑘 + 𝐿 − 1 (3.41) 
 𝑥𝑚𝑖𝑛 ≤ 𝑥(𝑡) ≤ 𝑥𝑚𝑎𝑥 
(3.42) 
 𝑦𝑚𝑖𝑛 ≤ 𝑦(𝑡) ≤ 𝑦𝑚𝑎𝑥 
(3.43) 
 𝑥(𝑘) = 𝑥𝑘 
(3.44) 
 
The objective function (3.36) is the sum of the squares of the residuals between the 
model predicted outputs (𝑥(𝑡)) and the set point values (?̂?(𝑡)) over the prediction 
horizon of 𝑅 time steps. The optimisation decision variables are the control actions 𝐿 
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time steps into the future, and it is assumed that after the 𝐿th time step that the 
control action is constant (3.41). Equations (3.39) and (3.40) relate to the absolute 
and velocity constraints on the manipulated variables. State and output variables 
are included in equations (3.42) and (3.43). The dynamic model constraints in 
equation (3.37) are difficult to determine, and so proper initial conditions for the 
state variables at the beginning of the prediction horizon must be chosen (3.44). The 
model outputs (𝑦𝑚) are a function of the state variables in equation (3.38); however 
a correction must be applied to 𝑦𝑚 to obtain a better prediction of the outputs, ?̂?𝑖 
(Bequette, 1991). In this work, the ANN framework (Section 3.3, Equations 3.10-
3.20) is then embedded into the NLMPC formulation and the resulting equations are 
presented in Equations 3.45-3.54.  
 
 
min 𝐸𝑀𝑃𝐶 =  ∑ 𝑄𝑧(𝑧𝑐
𝑝𝑟𝑒𝑑(𝑘) −  𝑧𝑐
𝑠𝑝(𝑘)
𝐻𝑝
𝑘=0
)2 +  ∑ 𝑄𝑢(𝑢(𝑘) −  𝑢
𝑠𝑝(𝑘))2
𝐻𝑐
𝑘=0
 
(3.45) 
 
{𝐸𝑂𝐷𝐸 =  ∑ ∑{
𝑑𝑧𝑗
𝐴𝑁𝑁(𝑡𝑖)
𝑑𝑡
−  𝑓𝑗(𝑧(𝑡𝑖), 𝑢, 𝜃, 𝑡}
2
𝑗𝑖
} ≤ 𝜉𝐴𝑁𝑁 
(3.46) 
 
𝑁𝑗 = ∑ 𝑣𝑚𝜎𝑚           ∀𝑗= 1, … , 𝐽
𝑚
 
(3.47) 
 
𝜎𝑚 = 
1
1 +  𝑒−𝑎𝑚
 
(3.48) 
 
𝑎𝑚 = ∑ 𝑤𝑚𝑙𝑡𝑙 +  𝑏𝑚
𝑙
 
(3.49) 
 𝑧𝑗
𝐴𝑁𝑁 =  𝑧𝑗
0 +  𝑡𝑁𝑗 
(3.50) 
 𝑑𝑧𝑗
𝐴𝑁𝑁
𝑑𝑡
=  𝑁𝑗 + 𝑡
𝑑𝑁𝑗
𝑑𝑡
 
(3.51) 
 𝑑𝑁𝑗
𝑑𝑡
=  ∑ 𝑣𝑚𝑤𝑚𝜎𝑚
𝑚
 
(3.52) 
 𝑧𝐿𝑜 ≤ 𝑧(𝑘) ≤  𝑧𝑈𝑝 (3.53) 
 𝑢𝐿𝑜 ≤ 𝑢(𝑘) ≤  𝑢𝑈𝑝 (3.54) 
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Where 𝑁𝑗 = ANN model and 𝑧𝑗
𝐴𝑁𝑁 = trial solution, 𝐻𝑝 = prediction horizon, 𝑧𝑐 = 
controlled variables (in the metabolator examples shown, Figures 4.7-4.10, this is 
AcCoA), 𝐻𝑐 = control horizon (the same as 𝐿 in equation 3.41), 𝑢 = manipulated 
variables (in the examples for the metabolator, Figures 4.7-4.10, this is Vgly) and 𝑠𝑝 
= set points (the values that the system will track). Equation 3.45 relates to the 
tolerance (ξ) of the ANN and aims to reduce the error in ODE calculation. From the 
ANN, 𝑧 = the J dimensional vector of the state variables in the ODE system, 𝜃 = 
vector of the given parameters, 𝑤𝑚𝑙 = weight from input 𝑙 to hidden node 𝑚, 𝑣𝑚 = 
weight from hidden node to output, 𝑏𝑚 = bias and 𝜎 = sigmoid transformation. The 
concept of NLMPC is graphically shown in Figure 3.7. Equation 3.36 explains how 
control is imposed on the system, and this is extended to both the manipulated and 
control variables in equation 3.45, where each entity is given a set point to track, 
and the solution is the least squared error between the observed values and the set 
points. Having set points imposed on the control variable (as shown in equation 
3.45, and illustrated in chapter 4, figures 4.10 and 4.16) can help to restrict variation 
in the control values, however, it is not required and the control variable can act 
freely within the system.  
There are several methods that can be used in order to handle ODE equality 
constraints with a constrained nonlinear optimisation program (Bequette, 2009): 
 
I. Sequential solution – Iteratively solving the ODE’s as an ‘inner loop’ to 
evaluate the objective function. 
II. Simultaneous solution – Transforming the ODE’s into algebraic equations 
which are then solved as nonlinear equality constraints in the optimisation. 
III. Intermediate solution – Transforming the ODE’s to algebraic equations 
which are solved as an ‘inner loop’ in order to evaluate the objective 
function. 
IV. Linear approximation – Approximating either by a single linearisation over 
the prediction horizon, or by linearisation at a number of times steps within 
the prediction horizon.  
 
The method in this study employs the use of finding the simultaneous solution. This 
solution technique results in more decision variables since the value of the state 
variables at each collocation point are included in the decision. This method also 
does not require the constraints to be satisfied at each iteration; therefore a faster 
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convergence is achieved to find the optimum. Another form of this method has been 
used by Cuthrell and Biegler (1987) and is known as sequential quadratic 
programming (SQP). The advantage of this system is that the state-variable 
constraints are easily handled; however a disadvantage to this could potentially 
mean that the convergence can occur at an infeasible point. Patwardhan et al. 
(1990) used NLMPC to evaluate the effect of parameter uncertainty and 
manipulated-variable of an exothermic CSTR (continuous stirred-tank reactor) and 
compared their results with state linearisation and linear control. The conclusion of 
this work was that the NLMPC demonstrated superior performance in the presence 
of error in the model parameters and the process was brought to the set point 
without offsetting the steady state. They found that the NLMPC dealt with the 
constraints of the system in an explicit manner without compromising the quality of 
the control objective. The concept of NLMPC is presented in Figure 3.8, where the 
set points for the system are shown in Figure 3.8a and the resulting response of the 
control variable to achieve the set points is shown in Figure 3.8b. This is 
representative of the type of control strategy used within this thesis for the dynamic 
systems studied. 
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Figure 3.8: Conceptual representation showing the outcome of a deterministic design performance, a. 
desired nominal state (or output) variable profile X (where X = 𝒙̂𝑵), b. computed profile of the 
optimal control or input variable, u.  
 
The CSTR example presented in section 3.5.1 is re-visited with the aim to add 
control to the system and fix the outputs. The fixed values for each of the entities 
are as follows; 𝑥𝐴  =  2.5, 𝑥𝐵  =  1.0 and 𝑢 =  25.0.  The results for the ANN-RK4 
formulation and the OCFE formulation are presented in figures 3.9 and 3.10 
respectively. It is noted here that the results for the OCFE formulation (Figure 3.10) 
show little difference to the set points, and this is because the set point is reached 
within a single iteration of the model. In order to see the effectiveness of the OCFE 
when compared to the ANN-RK4 formulation, disturbance was added to the system 
a b 
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in the form of a uniform disturbance over a given range (0.01-1), and added to the 
RHS of equations 3.33 and 3.34. The results for this are presented in figures 3.11, for 
the ANN-RK4 formulation, and 3.12 for the OCFE formulation. As shown in figure 
3.12 the OCFE formulation is able to track well even under considerable disturbance 
in the system, however when looking at the control performance when tracking the 
control variable 𝑢 and the feed rate of 𝑥𝐵, there is discrepancy between the observed 
and set data. The formulation is unable to track the set point for 𝑥𝐵 and remains 
close to the desired set, but does not reach it throughout any of the iterations. This 
is due to the disturbance itself and causes the OCFE formulation to lose the ability 
to track well. The ANN-RK4 formulation results (Figure 3.11) do not show the same 
discrepancies, and is still able to track the feed rate of 𝑥𝐴 well. The results show that 
the set points for both 𝑥𝐴 and 𝑥𝐵 are reached, with discrepancy from the set points 
only noticed for the control variable 𝑢. When comparing both formulations on their 
ability to track the control variable (Figure 3.13) it is noted that for the OCFE 
formulation the system does not actually achieve the set point for the control 
variable, unlike the ANN-RK4 formulation. This is due to the disturbance added to 
the system being large and the OCFE formulation being unable to reject the 
disturbance at each finite element. Furthermore there are more fluctuations for the 
OCFE formulation than the ANN-RK4 formulation. This provides a theory that the 
ANN-RK4 formulation may provide a more optimal solution method for ODE 
systems under disturbance. Although the total time taken for each model shows that 
the ANN-RK4 formulation takes more time, for cases with and without disturbance, 
it also provides accurate results, especially when disturbance is present. Therefore it 
is a feasible solution technique and further solidifies this work from a theoretical 
standpoint.  
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Figure 3.9: Controller performance for the ANN-RK4 model, horizon length 10, step size 0.002,  𝜸𝟏= 𝜸𝟐=1000,  𝜸𝟑 = 1 and 0 ≤  𝒖 ≤ 500. Solved in GAMS 
using SNOPT solver, Intel Core™2 Duo CPU 2.8 GHz with a total solution time of 00:05:22 hours for 100 iterations. 
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Figure 3.10: Controller performance for the OCFE model, horizon length 10, step size 0.002,  𝜸𝟏= 𝜸𝟐=1000,  𝜸𝟑 = 1 and 0 ≤  𝒖 ≤ 500. Solved in GAMS using 
SNOPT solver, Intel Core™2 Duo CPU 2.8 GHz with a total solution time of 00:00:38 hours for 100 iterations. 
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Figure 3.11: Controller performance for the ANN-RK4 model under disturbance, horizon length 10, 
step size 0.002,  𝜸𝟏= 𝜸𝟐=1000,  𝜸𝟑 = 1, 0 ≤  𝒖 ≤ 500 and 𝟎. 𝟏 ≤ 𝒅 ≤ 𝟏.0 Solved in GAMS using 
SNOPT solver, Intel Core™2 Duo CPU 2.8 GHz. Total solution time = 00:04:17 hours for 100 
iterations. 
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Figure 3.12: Controller performance for the OCFE model under disturbance, horizon length 10, step 
size 0.002,  𝜸𝟏= 𝜸𝟐=1000,  𝜸𝟑 = 1, 0 ≤  𝒖 ≤ 500 and 𝟎. 𝟏 ≤ 𝒅 ≤ 𝟏. 𝟎. Solved in GAMS using SNOPT 
solver, Intel Core™2 Duo CPU 2.8 GHz. Total solution time = 00:00:19 hours for 100 iterations. 
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Figure 3.13: Comparison of the ANN-RK4 formulation with the OCFE formulation for the CSTR 
example under disturbance. 
 
 
3.6.2 Zone NLMPC 
 
Further strategies linked to NLMPC involve extending the framework to include 
Zone NLMPC (Grosman et al., 2010; Ferramosca et al., 2010) where the objective 
function relates to reducing the error between two set points, an upper and lower 
limit, and the optimal solution residing within this range. This is advantageous as 
the control is implemented within a range rather than a fixed set point, therefore 
allowing more flexibility within the system (Ferramosca et al., 2010). The Zone 
NLMPC strategy is highlighted in equation 3.55, where the NLMPC formulation 
(equation 3.36) is altered to an NLP optimisation problem for zone control.  
 
 
min
𝑢(𝑘),…,𝑢(𝑘+𝑙−1)
𝛷(𝑢) =  ∑ ((𝑦𝑠𝑝.𝐻(𝑖)
𝑘+𝑅
𝑖=𝑘+1
−  𝑦𝑝𝑟𝑒𝑑(𝑖))
2 + (𝑦𝑠𝑝.𝐿(𝑖) −  𝑦𝑝𝑟𝑒𝑑(𝑖))
2) 
(3.55) 
 
Where 𝑦𝑠𝑝.𝐻 = set points upper limit and 𝑦𝑠𝑝.𝐿 = set points lower limit. For the case 
when uncertain parameters, 𝜃, are present in the system the derived performance is 
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given by a ‘tube’ represented by ∆𝑛−
+  deviation from the nominal value 𝑥𝑁, as shown 
in Figure 3.14, which also shows the concept of Zone NLMPC.  
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Figure 3.14: Conceptual outcome of a robust design performance under uncertainty 
 
 
3.6.3 Restricting Velocity of the Control Variable 
 
It is possible to restrict the velocity of the control variable, which allows the output 
to be more refined and less noisy. This is advantageous if the control variable is used 
in practice to modify the system outputs, and in terms of a biological system, can 
greatly affect experimental application of a system. Therefore simulations in this 
study were trialled with a velocity constraint, (𝐷𝑢), where 𝑢 can represent the 
control variable, and is used to constrict the velocity as well as minimise the error 
between the given velocity and the constrained velocity as seen in equation 3.56. 
 
 𝐷𝑢 = 𝐷𝑢(𝑛𝑑) − 𝐷𝑢(𝑛𝑑 + 1) (3.56) 
 
 
3.6.4 Solvers 
 
All NLMPC and Zone NLMPC problems in this study are solved using the Sparse 
Nonlinear Optimiser (SNOPT) (Gill et al., 2005), CONOPT3 (Drud, 1985) and 
KNITRO (Byrd et al., 2006) and were solved in GAMS. The solver provides 
rigorous control of the optimisation sequence to ensure convergence and makes 
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provision for infeasible sub-problems. They all solve nonlinear problems but have 
some distinct differences, which will be discussed in this section. 
 
 
3.6.4.1 SNOPT 
 
SNOPT utilises quadratic approximations at every interval until the solution is 
found. It does not require specified initial points as the solver will optimise and find 
the most appropriate starting point through a feasible path method. As such it may 
require more computational effort and time as it has to search for an appropriate 
starting point. However, once this is achieved it is capable of solving complex 
nonlinear models and as will be shown in Chapters 4 and 5, gives accurate results for 
both the developed ANN framework and OCFE. 
 
 
3.6.4.2 CONOPT3 
 
CONOPT3 utilises a generalised reduce gradient method, which linearises the 
nonlinear model and eliminates variables until it finds a solution. It can be deemed 
faster than SNOPT as it converts the NLP into an LP with each iteration, and 
generally LP problems are simpler to solve. However, CONOPT3 is highly 
dependent on initial values, and if these values are not optimal, CONOPT3 can get 
stuck in local optimal solutions and may not provide the global optimal value. As 
shown in Chapters 4 and 5, CONOPT3 is capable of solving many of the models in 
the case studies, however is unable to reject disturbance in some cases. 
 
 
3.6.4.3 KNITRO 
 
KNITRO utilises yet another method for solving nonlinear models, the interior point 
method. The NLP is converted into an augmented problem through transformation 
of the constraints, and it is this augmented function that is solved. KNITRO defines 
the feasible space and stays within this to find the solution to the augmented 
problem through minimisation of the augmented objective function. It is capable of 
solving less complex nonlinear models, however, as shown in Chapter 5 it is unable 
to deal with complex problems, like the Metabolator, especially in cases where 
disturbance is added. 
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3.7 Summary 
 
This chapter has detailed the various methods that can be used to simulate and 
optimise dynamic models. The artificial neural network framework that has been 
utilised for case studies within this thesis has been presented and outlined. 
Furthermore the methods of fourth order Runge-Kutta and orthogonal collocation 
on finite elements, which were been used to verify the solution of the neural 
network, have been outlined. Lastly control of dynamic systems has been discussed 
and the frameworks for nonlinear model predictive control and zone nonlinear model 
predictive control have been introduced and outlined.  
The next chapter in this thesis will look at a prominent case study of the 
metabolator (Fung et al., 2005) and how the frameworks presented in this chapter 
have been applied.  
 
Chapter 4 A Gene Metabolator Case Study 
 
61 
 
4. A Gene Metabolator Case Study 
 
4.1 The Metabolator 
 
In this chapter the first case study that utilises the ANN-NLMPC approach to solve 
for a dynamic biological system will be introduced. Work by Fung et al. (2005) 
detailed a metabolator, which is a biological process that uses Acetyl Co-Enzyme A 
(AcCoA) and produces acetate as a product. The metabolator integrates 
transcriptional regulation into metabolism of Escherichia Coli (E. Coli). The 
conceptual design of the metabolator consists of a flux-carrying network with two 
inter-converting metabolite pools (M1 and M2) catalysed by two enzymes (E1 and 
E2), whose expressions are negatively and positively regulated by M2, (Figure 4.1). A 
high input metabolic influx into M1 drives conversion to M2, and as a result E1 is 
expressed over E2. However, accumulation of M2 causes a repression of E1 and 
upregulates E2. When the backward reaction rate exceeds the sum of the forward 
reaction rate and the output rate, M2 level decreases and M1 level increases. In this 
case E1 is expressed yet again and E2 is degraded, returning to its first stage. 
Conversely, if the input of flux is low, M2 does not accumulate sufficiently fast to 
cause a large change in gene expression, and a stable steady state can be reached. 
The design of the metabolator allows metabolic physiology to influence gene 
expression cycles, which is a characteristic that is typically seen in circadian 
regulation.  
The conceptual design is realised using the acetate pathway in E. Coli (Figure 
4.2). The M1 pool is AcCoA and the M2 pool consists of acetyl phosphate (AcP), 
acetate (OAc-) and its protonated form (HOAcE). AcCoA is a metabolic product of 
fatty acids, sugar and some amino acids, and is a primary component of the tri-
carobxylic acid (TCA) cycle. AcCoA is converted to AcP in E. Coli  by phosphate 
acetyltransferase (Pta), which corresponds to the enzyme E1 in Figure 4.1, and then 
to acetate through the action of acetate kinase (Ack). The protonated form of 
acetate is able to permeate the cell membrane and can be excreted into the cell 
environment. The remaining flux goes to produce either acetate or ethanol. In wild 
type E. Coli, the enzyme Acetyl co-enzyme A synthetase (Acs) is induced in the 
presence of acetate, however, this induction is under catabolic repression of glucose 
in wild-type strains so as to avoid futile cycling. In their design, Fung et al. (2005) 
utilise Acs as their secondary enzyme, E2, and re-structure the system to respond to 
the action of the M2 pool. 
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Figure 4.1: Conceptual design of the oscillatory dynamics. Solid lines indicate metabolic flux; dashed 
lines indicate positive (arrow) and negative (diamond arrow) transcriptional or translational 
regulation. 
 
 
 
Figure 4.2: In vivo realisation of the dynamic system (Figure 4.1). The blue and green boxes indicate 
the metabolic pools (M1 and M2), and the enzymes, E1 and E2, are represented by Pta and Acs 
respectively. LacI is a transcriptional factor that is designed to repress the activity of Pta. 
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Figure 4.3: E.Coli and plasmid constructs used by Fung et al. (2005). The lacI gene (LacILAA) under 
the control of the glnAp2 promoter was inserted into the E.Coli chromosome at the lambda 
attachment site (attλ) using the CRIM method (Haldimann and Wanner, 2001). The pEF3 plasmid 
expresses low stability pta (ptaLAA) and acs (acsLAA), which are controlled by the lac0-1 and glnAp2 
promoters respectively. The reporter plasmid expresses an intermediate-stability GFP variant 
(gfpmut3.1AAV) under control of the tac promoter. Crosses at the end of the pEF3 and Reporter 
indicate that the circular plasmids have been linearised for illustration. The genes for resistance to 
Kanamycin, Chloramphenicol and Ampicillin are shown by kan, cat and bla respectively. 
 
For the host strain Fung et al. (2005) constructed plasmids, which were placed in 
the E. Coli, cultured and eventually experimented with. The two plasmids, pEF3, 
which expressed Pta and Acs, and the Reporter, which expressed green fluorescence 
protein (GFP), were both under control of a tac promoter. A detailed schematic of 
the promoters and the chromosome is presented in Figure 4.3. 
As part of their research, Fung et al. (2005) solved differential equations that 
represented the dynamics of the system in MATLAB using RK4 (chapter 3, section 
3.4). Exact parameter values were determined using linear stability analysis, with 
specific interest in Hopf bifurcation, which was used to characterise the transition 
from a steady state solution to a critical periodic state (Guckenheimer and Holmes, 
1983; Looss and Joseph, 1989). In the work presented here, the system was modelled 
in GAMS (General Algebraic Modelling System) with a view to carry out a model-
based optimal design. The gene oscillator system model (Fung et al., 2005) is given 
by the following system of simultaneous ODEs: 
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 𝑑𝐴𝑐𝐶𝑜𝐴
𝑑𝑡
=
𝑘2 ∙ 𝐴𝑐𝑠 ∙ 𝑂𝐴𝑐
𝐾𝑚2 + 𝑂𝐴𝑐
−
𝑘1 ∙ 𝑃𝑡𝑎 ∙ 𝐴𝑐𝐶𝑜𝐴
𝐾𝑚1 + 𝐴𝑐𝐶𝑜𝐴
+ 𝑉𝑔𝑙𝑦
− (𝐾𝑇𝐶𝐴 ∙ 𝐴𝑐𝐶𝑜𝐴) 
(4.1) 
 𝑑𝐴𝑐𝑃
𝑑𝑡
=
𝑘1 ∙ 𝑃𝑡𝑎 ∙ 𝐴𝑐𝐶𝑜𝐴
𝐾𝑚1 + 𝐴𝑐𝐶𝑜𝐴
− (𝑘𝐴𝑐𝑘.𝑓𝐴𝑐𝑃 − 𝑘𝐴𝑐𝑘.𝑟𝑂𝐴𝑐) 
(4.2) 
 𝑑𝑂𝐴𝑐
𝑑𝑡
= (𝑘𝐴𝑐𝑘.𝑓𝐴𝑐𝑃 − 𝑘𝐴𝑐𝑘.𝑟𝑂𝐴𝑐) − (𝐶(𝑂𝐴𝑐 ∙ 𝐻 − 𝑘𝑒𝑞𝐻𝑂𝐴𝑐))
−
𝑘2 ∙ 𝐴𝑐𝑠 ∙ 𝑂𝐴𝑐
𝐾𝑚2 + 𝑂𝐴𝑐
 
(4.3) 
 𝑑𝐻𝑂𝐴𝑐
𝑑𝑡
= (𝐶(𝑂𝐴𝑐 ∙ 𝐻 − 𝑘𝑒𝑞𝐻𝑂𝐴𝑐)) − 𝑘3(𝐻𝑂𝐴𝑐 − 𝐻𝑂𝐴𝑐𝐸) 
(4.4) 
 𝑑𝐿𝑎𝑐𝐼
𝑑𝑡
= 𝑅𝐿𝑎𝑐𝑙 − 𝑅𝑑𝐿𝑎𝑐𝑙 
(4.5) 
 𝑑𝑃𝑡𝑎
𝑑𝑡
= 𝑅𝑃𝑡𝑎 − 𝑅𝑑𝑃𝑡𝑎 
(4.6) 
 𝑑𝐴𝑐𝑠
𝑑𝑡
= 𝑅𝐴𝑐𝑠 − 𝑅𝑑𝐴𝑐𝑠 
(4.7) 
 
The differential equations take into account the various factors that govern the rate 
and flux of the resulting compounds from the system. Equation (4.1) represents the 
dynamic balance for AcCoA expressed by the sum of Vacs (Acs flux), Vpta (Pta 
flux), Vgly (Glycolytic flux) and Vtca (TCA flux). Equation (4.2) relates to the 
dynamic balance equation for AcP, which is calculated by the sum of Vpta and 
Vack (Ack Flux). Equation (4.3) relates to the dynamic balance for OAc-, calculated 
from the result of Vack, Vace (Acid-base equilibrium for acetic acid) and Vacs. 
Equation (4.4) relates to HOAc, which is calculated using Vace and Vout (HOAcE 
intercellular transport rate). Equations 4.5-4.7 describe the degradation rates of the 
proteins within the system where R represents the degradation rates of the proteins 
and these are defined in table 4.1. The synthesis rates for these entities are governed 
by the following equations: 
 
 
𝑅𝐿𝑎𝑐𝐼 =
𝛼1(𝐴𝑐𝑃/𝐾𝑔1)
𝑛
1 + (𝐴𝑐𝑃/𝐾𝑔1)𝑛
+ 𝛼0 
(4.8) 
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𝑅𝐴𝑐𝑠 =
𝛼2(𝐴𝑐𝑃/𝐾𝑔2)
𝑛
1 + (𝐴𝑐𝑃/𝐾𝑔2)𝑛
+ 𝛼0 
(4.9) 
 
𝑅𝑃𝑡𝑎 =
𝛼3
1 + (𝐿𝑎𝑐𝐼/𝐾𝑔3)𝑛
+ 𝛼0 
(4.10) 
 
where 𝐾𝑔𝑥 , 𝑛 and 𝛼𝑥 are constants describing the synthesis and degradation of the 
moieties. The model parameters for these equations are given in table 4.1. One of 
the aims of this work is to apply NLMPC to dynamic systems and control their 
output, and for the metabolator this is possible by using the state variables of the 
system, which represent the main entities in the two metabolite pools. Both AcCoA 
and AcP are potential state variables in the system and can be tracked using a fixed 
path. The control variables for the system are the main entities that affect the state 
variables and in the metabolator these are glycolytic flux (Vgly) and acetate 
concentration. The work by Fung et al. (2005) simulated the system model and this 
is used as a starting point for the control. The work presented in this chapter will 
showcase how design can be achieved for the metabolator by controlling the system 
outputs. This therefore moves towards utilising synthetic biology techniques to 
engineer a new system and alter an existing system outcome. 
  
Chapter 4 A Gene Metabolator Case Study 
 
66 
 
 
Table 4.1: Model parameters for equations 4.1-4.10 (Fung et al., 2005).   
Parameter Description Value 
Km2 
Michaelis-Menten rate 
coefficient for Acs flux 
0.1 
K2 Rate coefficient for Acs flux 0.8 
Km1 
Michaelis-Menten rate 
coefficient for Pta flux 
0.06 
K1 Rate coefficient for Pta flux 80 
Ktca Rate coefficient for AcCoA 10 
Kackf 
Rate forward reaction 
converting AcP to OAc- 
1 
Kackr 
Rate backward reaction 
converting OAc- to AcP 
1 
C 
Concentration of the Acid-
Base equilibrium 
100 
H 
Concentration of Hydrogen 
ions (H+) 
10-7 
Keq 
Molar equivalence of the 
Acid-Base equilibrium 
10-4.5 
K3 
Rate coefficient for HOAc 
flux 
0.01 
HOAcE 
Amount of HOAc remaining 
after flux 
0 
Vgly Glycolytic flux 
10-4 ≤ Vgly ≤ 104 
α0 Constant 
0 
α1 Constant 0.1 
α2 Constant 2 
α3 Constant 2 
Kg1 Constant 10 
Kg2 Constant 10 
Kg3 Constant 0.001 
n 
Constant 2 
RdX (X = Lacl, Acs, Pta) Degradation rate of proteins RdX = KdX 
  Kd = 0.06 
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4.2 ANN-RK4 Simulation 
 
The system described above in equations 4.1-4.10 was simulated using the ANN-
RK4 framework described in Chapter 3, Sections 3.3 and 3.4. Results (Figure 4.4) 
match well with those achieved from the case paper (Fung et al., 2005), and it is 
noted that an increase in the glycolytic flux (Vgly, which is a combination of 
glycerol, fatty acids and sugars as presented in Figure 4.2) results in increased 
activity and oscillation of the metabolites AcCoA and AcP. 
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Figure 4.4: Oscillation of the metabolite AcCoA and its co-factor, AcP, against time using the ANN-
RK4 method, step size = 0.001, a. Vgly = 0.01, b. Vgly = 0.05, c. Vgly = 0.5.  
 
In Figure 4.4 a loss of activity is seen in the metabolite AcCoA when the glycolytic 
rate is reduced. The case for when Vgly = 0.001 was also simulated; however the 
model was unable to converge to find an optimal solution without resorting to 
negative values for activity. Therefore the step size had to be decreased from 0.01 to 
0.001 to allow the model to process lower Vgly values, which also gave results that 
were analogous to those published. Furthermore, when the acetate concentration 
was increased there was a distinct breakdown of AcCoA activity, Figure 4.5, and 
oscillations reach a steady state. This is expected as if acetate is increased there is 
an increase in the acidity of the environment, which therefore causes breakdown of 
the metabolator. This matches with the results obtained from Fung et al. (2005) as 
they showed that increasing levels of acetate will cause a loss of activity within the 
system. As the results from the ANN-RK4 model also agree with this, the model can 
effectively simulate the system dynamics.  
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Figure 4.5: Graphs to show the oscillation of the enzyme, Acetyl-CoA, at an acetate concentration of 
100mM using the ANN-RK4 model, step size = 0.01, a. Vgly = 10, b. Vgly = 100, c. Vgly = 1000. 
 
The following results detail those found when the NLMPC formulation (see equation 
3.47) was utilised. Within each change in the model a number of parameters are 
fixed and others that vary, these include: 
 
 The dimensionless time step size for each model is 0.01 
 When shown, 𝑄𝑧 and 𝑄𝑢 are the penalties on deviation of the state variables 
(AcCoA, or AcP where appropriate) and control variables (Vgly, or HOAc 
where appropriate) 
 The model does not take into account external factors that can affect the 
system, such as pH and temperature 
 
 
4.3 NLMPC Results 
 
As stated earlier one of the aims of this work is to implement control for nonlinear 
dynamic systems and for the metabolator NLMPC this can be achieved by 
controlling the output of the two main state variables, AcCoA and AcP. Controlling 
AcCoA within the system is important as it can ultimately change the level of 
acetate produced, which can affect the amount of acetate leaving the cell. If the 
system is controlled to continuously produce acetate this can then be used to 
produce plastics, nylon and used in other systems that utilise acetate such as the 
citric acid cycle and biofuels (Menezes et al., 2015). The model was then developed 
with aim to control the system using the glycolytic flux (Vgly) as presented in 
Figure 4.6. This control variable was able to successfully track the set activity for 
AcCoA that was selected for the model and results are presented in Figure 4.7. As 
shown in Figure 4.7a the system is able to track variations in the set points, and the 
resulting concentrations of Vgly are expected based on the increase or decrease in 
the set AcCoA concentrations. Further work carried out using this model involved 
a b c 
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adding a velocity constraint on Vgly. This bounded constraint, Dvgly (see Section 
3.6.3, Equation 3.56), was envisaged to allow the system to track the set points more 
closely, as well as give an outcome for Vgly that would have fewer or less fluctuation 
as the problem is constrained within a defined range. This would be advantageous in 
vivo as controlling glucose concentration (Vgly) in the media would be easier to 
achieve with fewer fluctuations. Further tests were carried out using a positive range 
for DVgly (as Vgly feeds into the system and cannot be taken out) and results are 
presented in Figure 4.8.  
 
 
 
Figure 4.6: Control block showing the metabolator optimised with Vgly as the control variable for the 
state variable AcCoA. The online concentration of AcCoA can be determined using fluorescence 
imaging, here represented as a fluorescence detector (FD) by measuring green fluorescent protein 
(GFP) from the host strain of E. Coli.  
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Figure 4.7: a. NLMPC results for AcCoA at small variations in the set points (red) and the tracking 
of the set points (green), b. Concentration of Vgly in the system showing the fluctuations required to 
track the set points. Qz = 1, Qu = 0. 
 
Figure 4.8 shows the various velocity constraints placed on Vgly and their resulting 
tracking of the set points. It is noted that the tighter the bounds for the constraints, 
the fewer sharp changes are present in the rate of Vgly. The tracking of the set 
AcCoA 
Metabolator 
FD 
a b 
Vgly 
NLMPC 
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points remains fairly consistent, however it is also noted that the results for AcCoA 
1 (where the bounds on the velocity constraint on Vgly are large) do not track the 
set points as closely as the other conditions. The resulting Vgly have also been 
displayed in Figure 4.8, which shows the distinct change in the fluctuations of the 
rate of Vgly, and clearly shows that the tightest range on velocity, Figure 4.9d 
(1x10-6 ≤ Dvgly ≤ 0.01), results in fewer sharp changes in the rate, and therefore 
indicates a profile that can be replicated experimentally. This is further illustrated in 
Figures 4.9a-c which show sharp peaks in flux. If in an experimental setup, this 
would mean sharp changes in the concentration of glucose to be added to the 
system, and for biological systems this can be too fast for the system to react to, 
especially in sharp decreases in concentration. Tight ranges were therefore employed 
to keep the velocity, and overall rate of Vgly, low. 
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Figure 4.8: a. NLMPC results for AcCoA at small variations in the set points (Red) and the tracking 
of the set points, b. The rate of Vgly in the system showing the fluctuations required to track the set 
points. Here AcCoA 1 is optimised with 1x10-9 ≤ Dvgly ≤ 10 (Vgly 1), AcCoA 2 is optimised with 
1x10-6 ≤ Dvgly ≤ 10 (Vgly 2), AcCoA 3 is optimised with 1x10-6 ≤ Dvgly ≤ 0.1 (Vgly 3) and AcCoA 4 
is simulated with 1x10-6 ≤ Dvgly ≤ 0.01 (Vgly 4). The step size is 0.01 for all simulations. 
 
Another aspect that had been investigated was the inclusion of tracking the control 
profile for Vgly as well as AcCoA. This involved including set points for the control 
variable, whereby the system would track both the control variable set point and the 
manipulated variable set point. These results are presented in Figure 4.10 where the 
decrease in the bounds of Dvgly gives tighter control and has greatly reduced the 
sharp changes in the rate. However, although Vgly is able to track the set point, 
there are still violations present, as the system cannot strictly adhere to the set 
points for both the control and state variable. The system does prefer to adhere to 
the state variable set points over the control variable set points as there are fewer 
violations. Figure 4.9c shows the tightest bounds placed on Vgly, and gives the best 
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results in terms of tracking the manipulated variable as well as the Vgly set points. 
However, when compared to results from Figure 4.8 there is little difference, and 
therefore the case for when Qu = 0 (Figures 4.7 and 4.8) are deemed to be better 
suited for the metabolator when using Vgly as a single control variable.  
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Figure 4.9: The rates of Vgly required for each simulation in Figure 4.7, where a. 1x10-9 ≤ Dvgly ≤ 10 
(AcCoA 1), b. 1x10-6 ≤ Dvgly ≤ 10 (AcCoA 2), c. 1x10-6 ≤ Dvgly ≤ 0.1 (AcCoA 3) and d. 1x10-6 ≤ 
Dvgly ≤ 0.01 (AcCoA 4). The step size is 0.01 for all simulations. 
 
Glycolytic flux (Vgly) is also used as the control variable for set point tracking of 
AcP within the metabolator due to the synergistic relationship of the process. The 
control block for this investigation of the model is shown in Figure 4.11. The results 
for this investigation are presented in Figure 4.12, where it is apparent that the rate 
of Vgly increases when there is a decrease in the set point of AcP. This relationship 
is expected as an increase in Vgly means more production of AcCoA, which in turn 
leads to less production of AcP as the relationship between the two metabolite pools 
favours this dynamic. The results for Vgly in Figure 4.12 show that it remains at a 
baseline constant level until there is a decrease in AcP, where the rate of flux also 
decreases. This simulates the stability of the system when AcCoA is produced and 
as a result there is little production of AcP. There is a threshold to this process 
however and this is achieved when there is no Vgly present, whereby the production 
of AcCoA will decrease thereby leading to an increase in AcP. This will then 
propagate the negative feedback loop in the system and cause AcP production to 
feed Acs back into the first metabolite pool containing AcCoA. This is the cyclical 
a b 
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process of the Metabolator, and the results in Figure 4.12 show the case where Vgly 
is present, therefore leading to a decrease in production of AcP.  In terms of tracking 
the set points, the system is able to track well, as shown in Figure 4.12c. 
 
 
 
0 100 200 300 400 500
0.07
0.08
0.09
0.10
0.11
0.12
0.13
M
e
ta
b
o
lic
 O
s
c
ill
a
ti
o
n
Dimensionless Time
 AcCoA Set Point
 AcCoA
     
0 100 200 300 400 500
0.5
1.0
1.5
2.0
2.5
3.0
M
e
ta
b
o
lic
 R
a
te
Dimensionless Time
 Vgly
 Vgly Set Point
 
 
0 100 200 300 400 500
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
M
e
ta
b
o
lic
 O
s
c
ill
a
ti
o
n
Dimensionless Time
 AcCoA Set Point
 AcCoA
     
0 100 200 300 400 500
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
M
e
ta
b
o
lic
 R
a
te
Dimensionless Time
 Vgly Set Point
 Vgly
 
 
0 100 200 300 400 500
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
M
e
ta
b
o
lic
 O
s
c
ill
a
ti
o
n
Dimensionless Time
 AcCoA Set Point
 AcCoA
     
0 100 200 300 400 500
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
M
e
ta
b
o
lic
 R
a
te
Dimensionless Time
 Vgly
 Vgly Set Point
 
Figure 4.10: NLMPC results for AcCoA at small variations in the set points (red) and the tracking of 
the set points (green), and the rate of Vgly against the Vgly set point in response to tracking AcCoA, 
where a. 1x10-3 ≤ Dvgly ≤ 1, b. 1x10-6 ≤ Dvgly ≤ 1x10-4 and c. 1x10-9 ≤ Dvgly ≤ 1x10-6. Qz = 1, Qu = 
1. 
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Figure 4.11: Control block showing the metabolator optimised with Vgly as the control variable for 
the state variable AcP. The online concentration of AcP can be determined using fluorescence 
imaging, here represented as a fluorescence detector (FD) by measuring green fluorescent protein 
(GFP) from the host strain of E. Coli.  
 
From the results seen in Figures 4.7-4.10 it can be noted that the system is able to 
track a set points for AcCoA, by manipulating Vgly. The results in Figure 4.12 show 
that the system can respond well when Vgly is used as the control variable for 
controlling AcP. Further investigation into adding disturbance into the system is 
presented in the following section (Section 4.4). 
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Figure 4.12: NLMPC results for AcP at small variations in the set points (blue) and the tracking of 
the set points, and the rate of Vgly in the system required to track AcP, where a. 1x10-3 ≤ Dvgly ≤ 1, 
b. 1x10-6 ≤ Dvgly ≤ 1x10-4 and c. 1x10-9 ≤ Dvgly ≤ 1x10-6. Qz = 1. 
 
 
4.4 NLMPC with Disturbance 
 
As it is noted in Fung et al. (2005) the system has many types of disturbances that 
can affect performance. Stochastic disturbance in the model was thought to be the 
reason for the discrepancy they noticed between experimental and simulated results. 
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They utilised a variation of the Langevin technique involving a Gaussian process 
and a Euler’s scheme to quantify this disturbance. It was noted that this stochastic 
noise can have great effect on the dynamics of the proteins in the system, LacI, Pta 
and AcP. Therefore, in this work, disturbance, d, was added to the system in the 
form of a uniform disturbance given over a confined range and added to the RHS of 
equation 4.1. The tracking of the set points would invariably be disrupted due to the 
disturbance as presented in Figure 4.13; however what is noted is that the system 
tries to adhere to the set points as closely as possible. Although there are violations 
from the set point the tracking tries to remain as close to the set path as possible 
despite the disturbance that is added to the system. It is important to note here 
that disturbances of up to 1000% of the nominal value of the state variables AcCoA 
and AcP has been added to the model. 
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Figure 4.13: NLMPC results for AcCoA at small variations in the set points (red) and tracking of the 
set points (green), the rate of Vgly required to track the set points and the disturbance, d, added to 
AcCoA, where d is a random disturbance with uniform distribution. a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 
and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 1x10-9 ≤ Dvgly ≤ 1x10-6 for all cases.  
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Further investigation into disturbance is also carried out for the case when Vgly is 
the control variable for AcP, by adding d to the RHS of equation 4.2. Results in 
Figure 4.14 show this case and as shown at large disturbances the tracking is lost. 
From the results presented in Figure 4.13 it can be noted that the system is still 
able to track the AcCoA set point in the presence of disturbance. Although the 
system tries to track the case for when AcP is chosen as the manipulated variable 
(Figure 4.14), there is a loss in tracking at larger disturbance (Figures 4.14b ad 
4.14c). The possibility of having this disturbance (uncertainty) in a model with two 
set points (Zone NLMPC) for combating the issues with tracking will be 
investigated in the following section as a means of preventing violation of the set 
points. 
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Figure 4.14: NLMPC results for AcP at small variations in the set points (blue) and tracking of the 
set points (red), the rate of Vgly required to track the set points and the disturbance, d, added to 
AcP, where d is a random disturbance with uniform distribution. a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and 
c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 1x10-9 ≤ Dvgly ≤ 1x10-6 for all cases.  
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4.5 Zone Model Predictive Control Results 
 
Once the NLMPC was successfully implemented, work progressed to control using 
Zone Control, where two set points were used, and the metabolator was confined 
within this range. This was trialled with and without the velocity constraint, Dvgly, 
to see if this had any effect on the performance. Different step sizes for the RK4 
convergence were also investigated to see the effect on the metabolator performance. 
The results from this investigation showed that smaller step sizes gave results 
analogous to the ANN, and in fact the same step size was used (0.01). Results for 
when Zone Control was implemented (Figure 4.15) show that the state variable, 
AcCoA, remains within the range without violation. In terms of the rate of Vgly, 
having a tight restriction on the rate, Figure 4.15c, shows less fluctuation, which is 
advantageous in trying to replicate results experimentally. Again, further 
investigation into this system utilised a set point for Vgly to decrease the 
fluctuations in the rate (Figure 4.16). As with previous results (Figure 4.10) the 
addition of set points for Vgly does not affect the tracking of the system greatly. 
However, it is positive that the system is able to adhere to the tracking of Vgly, as 
well as responding to the tracking of AcCoA (the manipulated variable). The system 
is able to track within the given range, which is promising as it allows for stricter 
control of AcCoA concentration, and as a result will control the metabolator 
performance.  
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Figure 4.15: Zone NLMPC results for AcCoA at small variations in the set points (blue and red) and 
tracking of the set points (green), and graphs to show the concentration of Vgly in the system 
showing the fluctuations required to track the set points, where a. 1x10-3 ≤ Dvgly ≤ 1, b. 1x10-6 ≤ 
Dvgly ≤ 1x10-4 and c. 1x10-9 ≤ Dvgly ≤ 1x10-6. Qz = 1, Qu = 0. 
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Figure 4.16: Zone NLMPC results for AcCoA at small variations in the set points (blue and red) and 
the tracking of the set points (green), and graphs to show the rate of Vgly against the Vgly set point 
in response to tracking AcCoA, where a. 1x10-3 ≤ Dvgly ≤ 1, b. 1x10-6 ≤ Dvgly ≤ 1x10-4 and c. 1x10-9 ≤ 
Dvgly ≤ 1x10-6. Qz = 1, Qu = 0.1. 
 
 
Zone Control was also implemented for the case where Vgly controls AcP in the 
metabolator, which is presented in Figure 4.17. Again the system is able to track 
within the given range, and the response rate of Vgly shows little change from 
Figure 4.17a-4.17c. This can also be attributed to the system dynamics, whereby the 
control of AcP using Vgly will not show the same rapid response as AcCoA due to 
a 
b 
c 
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the many stages in the reaction as shown in Figure 4.2, where Vgly enters the 
system and causes the first metabolite, AcCoA, to oscillate. This reaction causes Pta 
to be produced and this then enters the second metabolite pool, containing AcP, to 
cause this to oscillate. This three step reaction is not instantaneous and therefore 
delays the response of AcP from Vgly. 
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Figure 4.17: Zone NLMPC results for AcP at small variations in the set points (blue and red) and 
tracking of the set points (purple), and graphs to show the concentration of Vgly in the system 
showing the fluctuations required to track the set points, where a. 1x10-3 ≤ Dvgly ≤ 1, b. 1x10-6 ≤ 
Dvgly ≤ 1x10-4 and c. 1x10-9 ≤ Dvgly ≤ 1x10-6. Qz = 1, Qu = 0. 
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It is noted that Zone NLMPC yields excellent tracking of the system as there is a 
wider range for the system to track, and generally the tracking remains within the 
centre of this zone. Furthermore, decreasing the bounds of the velocity of Vgly 
results in a smoother tracking profile, as seen when comparing Figure 4.15a to 
Figure 4.15c, where not only does the rate of Vgly undergo less sharp change, but 
the tracking of the system shows greater transition from increasing and decreasing 
set points of AcCoA. The advantage of using Zone NLMPC for the metabolator is 
that it allows experimental validation of the system to be performed easily. Rather 
than with a single set point NLMPC where the resulting rate of Vgly shows sharp 
change in rate (Figure 4.10a), Zone NLMPC allows relaxation in the tracking 
problem, thereby resulting in a Vgly rate which does not change as sharply (Figure 
4.16a). Experimental validation of this system can then be performed easily as 
glucose (which can take the place of Vgly) can be added to the system to 
manipulate AcCoA to follow the set zone rather than the fixed path, which can be 
difficult to achieve in vivo. Furthermore as there is a zone for tracking, the 
concentration of AcCoA can freely vary within this zone and still perform with the 
desired user specified range and be deemed optimal. If there was a single set point 
for tracking, this may not be achieved as the biological system may deviate from the 
set path and therefore tracking may be lost, resulting in a system that is not 
meeting the user specified requirement. Instances where Zone NLMPC is favoured 
over NLMPC is shown in research from Grosman et al. (2010) where Zone NLMPC 
was used to create a region for an automated insulin monitor in diabetic patients. 
This region defined the optimal levels of insulin needed in the patient following 
typical day activities and is successful in maintaining patient’s glucose levels to the 
same levels as a normal healthy person. 
 
 
4.6 Zone Model Predictive Control with Disturbance 
 
Similarly as with the NLMPC model, disturbance was considered for the case of 
Zone NLMPC in the form of a randomised disturbance, d, added to the RHS of 
equation 4.1, in order to see what effect it has on the system dynamics. A range of 
disturbance profiles (0.01-1) were modelled and the results are presented in Figure 
4.18, where 4.18a shows that the disturbance profile has not affected tracking of the 
set points; therefore a larger disturbance was added, as shown in Figure 4.18b. Here 
it is apparent that there are some rapid fluctuation in both tracking and the 
response rate of Vgly. Increasing the range for the disturbance, Figure 4.18c, shows 
similar rapid fluctuation in the tracking and rate of Vgly. We do however see that 
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the system is still able to track within the given bounds even in a disturbance of up 
to 1000% the nominal amount of AcCoA. Figure 4.19 shows the results where Vgly 
is used as the control variable for AcP. As shown in Figure 4.19b, where disturbance 
is at its highest, there is a distinct loss of tracking at around 450 time steps, 
however this can be attributed to the scale of the disturbance. The response rate of 
Vgly is in line with previous results for this type of model (Figure 4.17) where the 
sharp peaks are also noticed. It is interesting to note that the tracking of the system, 
for Vgly and AcCoA, under disturbance seems to adhere more towards the upper 
bound of the zone. The main possibility for this is the presence of the disturbance 
itself, which causes a positive shift in the oscillatory habit of the metabolator, and 
therefore increases the amount of AcCoA.  
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Figure 4.18: Zone NLMPC results for AcCoA at small variations in the set points (red and blue) and tracking of the set points (green), the rate of Vgly 
required to track the set points and the disturbance, d, added to AcCoA, where a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 1x10-
9 ≤ Dvgly ≤ 1x10-6 for all cases.  
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Figure 4.19: Zone NLMPC results for AcP at small variations in the set points (red and blue) and tracking of the set points (purple), the rate of Vgly required 
to track the set points and the disturbance, d, added to AcP, where  a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 1x10-9 ≤ Dvgly 
≤ 1x10-6 for all cases.  
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4.7 Acetate as a Control Variable 
 
Due to the synergistic relationship of the metabolite pools in the metabolator acetate 
(HOAcE) was used as a control variable to propogate the negative feedback reaction 
via AcP (Figure 4.20). Therefore a new controller was implemented utilising acetate 
as the control variable. Similar to Vgly this model was then altered from NLMPC to 
Zone NLMPC. The results for the NLMPC and Zone NLMPC utilising acetate as a 
control variable are presented in this section. 
 
 
 
Figure 4.20: Control block showing the metabolator optimised with acetate (HOAcE), which can be 
measured using HPLC analysis as shown, as the control variable for the state variable AcP. 
 
As shown in Figure 4.21 the system does try to track the set point for AcP, however 
there is a delay. This could be due to the fact that the concentration of acetate is 
external from the cell, and the relationship between AcP and acetate does not occur 
in the same dynamic equation of the ODEs. However, the system is able to track the 
set points and decreasing the bounds on the velocity of HOAcE gives fewer sharp 
changes in its concentration and can be seen comparing Figure 4.21a and Figure 
4.21c, where the graph depicts the standard and zoomed in results for the same 
profile.  
Acetate can also be used as a control variable for AcCoA (Figure 4.22). As 
previously stated, the metabolator is cyclical and interconnected, therefore a bottom 
up reaction from acetate to AcCoA can also control the outcome of the system. 
Results from this are presented in Figure 4.23, where it is noted that the tracking for 
AcCoA does have some violation from the set points. Also the concentration of 
acetate required for the tracking changes rapidly, especially for results seen in 
Figures 4.23a and 4.23b. A reason for this can be due to the fact that the reaction 
for acetate to AcCoA has to go through multiple steps before it can have an effect, 
whereas the reaction from Vgly to AcCoA is a direct reaction. This can alter the 
tracking of the system and can explain the differences (delay) seen. Further work 
AcP 
Metabolator 
NLMPC 
HPLC 
HOAcE 
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into using acetate as a control variable progressed into using Zone NLMPC, 
presented in Figure 4.24. As shown in Figure 4.24 the system is able to track within 
the set points. 
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Figure 4.21: NLMPC results for AcP at small variations in the set points (blue) and tracking of the 
set points (red), and graphs to show the concentration of acetate (HOAcE) in the system showing the 
fluctuations required to track the set points, where a. 1 ≤ DHOAcE ≤ 10, b. 0.1 ≤ DHOAcE ≤ 1 and 
c. 1x10-4 ≤ DHOAcE ≤ 1x10-2. Qz = 1, Qu = 0. 
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Figure 4.22: Control block showing the metabolator optimised with acetate (HOAcE), which can be 
measured using HPLC analysis as shown, as the control variable for the state variable AcP. 
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Figure 4.23: NLMPC results for AcCoA at small variations in the set points (blue) and tracking of 
the set points (red), and graphs to show the concentration of acetate (HOAcE) in the system showing 
the fluctuations required to track the set points, where a. 1 ≤ DHOAcE ≤ 10, b. 0.1 ≤ DHOAcE ≤ 1 
and c. 1x10-4 ≤ DHOAcE ≤ 1x10-2. Qz = 1, Qu = 0. 
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Figure 4.24: Zone NLMPC results for AcP at small variations in the set points (blue and red) and 
tracking of the set points (purple), and graphs to show the concentration of acetate (HOAcE) in the 
system showing the fluctuations required to track the set points, where a. 1 ≤ DHOAcE ≤ 10, b. 0.1 ≤ 
DHOAcE ≤ 1 and c. 1x10-4 ≤ DHOAcE ≤ 1x10-2. Qz = 1, Qu = 0. 
 
Zone NLMPC was also applied for the case when AcCoA was tracked using acetate 
as the control variable (Figure 4.22). The results for this investigation are presented 
in Figure 4.25, where the tracking of the set points remains within the zone, and the 
concentration of acetate does now fluctuate as highly as seen in Figure 4.24. 
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Figure 4.25: Zone NLMPC results for AcCoA at small variations in the set points (blue and red) and 
tracking of the set points (green), and graphs to show the concentration of acetate (HOAcE) in the 
system showing the fluctuations required to track the set points, where a. 1 ≤ DHOAcE ≤ 10, b. 0.1 ≤ 
DHOAcE ≤ 1 and c. 1x10-4 ≤ DHOAcE ≤ 1x10-2. Qz = 1, Qu = 0. 
 
As with the profiles using Vgly as a control variable, disturbance was considered for 
both the NLMPC and Zone NLMPC model for acetate. Again the disturbance, d, 
was uniformally distributed in a given range. The results for the NLMPC models are 
shown in Figures 4.26 and 4.27, and the results for Zone NLMPC are presented in 
Figures 4.28 and 4.29. 
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Figure 4.26: The NLMPC results for AcP at small variations in the set points (blue) and tracking of the set points (red), the concentration of HOAcE 
required to track the set points and the disturbance, d, added to AcP, where  a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 1x10-4 
≤ DHOAcE ≤ 1x10-2 for all cases. 
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As presented in Figure 4.26 an increased disturbance in the system causes the 
tracking of AcP to become imbalanced with regards to adhering to the set points. 
Unlike the case where Vgly was tracking AcP without disturbance (Figure 4.14), 
where the tracking remained positive with few violations, here we see a distinct loss 
of tracking (Figure 4.26b and Figure 4.26c). Figure 4.27 shows the case where 
acetate is used to control AcCoA under disturbance also. Generally, even with large 
disturbances (Figure 4.27b) the tracking of the system is good and there is little 
violation. Where there is a reduction in the metabolic oscillation of AcCoA, there is 
an increase in the concentration of acetate, and this coincides with the behaviour of 
the metabolator (Figure 4.1). 
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Figure 4.27: NLMPC results for AcCoA at small variations in the set points (blue) and tracking of the set points (red), the concentration of acetate (HOAcE) 
required to track the set points and the disturbance, d, added to AcCoA, where  a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0 and 
1x10-9 ≤ Dvgly ≤ 1x10-6 for all cases. 
a 
b 
c 
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Zone NLMPC with disturbance was then implemented, and the results for this are 
presented in Figures 4.28 and 4.29. In Figure 4.28 the tracking within the zone has 
not been greatly affected in the presence of a small disturbance (Figure 4.28a), 
however in the presence of a larger disturbance (Figure 4.28b) there is a change in 
the tracking behaviour of the system. The system does still track within the given 
bounds, much like when disturbance was added to the simulations where Vgly was 
the control variable. Figure 4.29 shows good results for the tracking of AcCoA, and 
the result remains consistantly in the middle of the range. 
It can also be noted that the investigations whereby a set point was used for 
acetate as well as AcP (similar to the case presented in Figure 4.16 for AcCoA and 
Vgly) showed that the system did not adhere to the set point. It was noted that 
although the system was able to track the set points for AcP, the resulting 
concentrations of acetate did not adhere to their set points. The conclusion from this 
was that the system is dominated by AcCoA, and therefore was unable to track set 
points for acetate. There is also possibility that any effect on acetate concentration 
will not directly affect AcP as within the system acetate needs to undergo re-uptake 
and inter-conversion to free acetate ions before being able to affect AcP, as shown in 
Figure 4.2. This indirect reaction can also explain the behaviour of acetate in the 
system following disturbance. 
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Figure 4.28: Zone NLMPC results for AcP at small variations in the set points (red and blue) and tracking of the set points (purple), the concentration of 
acetate (HOAcE) required to track the set points and the disturbance (d) added to AcP, where, a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, 
Qu = 0 and 1x10-4 ≤ DHOAcE ≤ 1x10-2 for all cases. 
a 
b 
c 
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Figure 4.29: Zone NLMPC results for AcCoA at small variations in the set points (red and blue) and tracking of the set points (green), the concentration of 
acetate (HOAcE) required to track the set points and the disturbance (d) added to AcCoA, where, a. 0.01 ≤ d ≤ 0.1, b. 0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 
1, Qu = 0 and 1x10-4 ≤ DHOAcE ≤ 1x10-2 for all cases. 
a 
b 
c 
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4.8 Dual Control (Multiple-Input Multiple-Output) Results 
 
The addition of another input, or control variable, to the model gave rise to a new 
type of approach for the metabolator control, multiple-input multiple-output model 
based control (MIMO). Two control variables, Vgly rate and acetate concentration 
(HOAcE), were utilised to control the system dynamics (Figure 4.30). As shown 
previously, Figure 4.5, increasing acetate concentration results in a loss of activity 
for the principal metabolite, AcCoA, which is to be expected as in a highly acidic 
environment the metabolator would denature. Therefore an investigation into 
controlling the synergistic relationship of the two metabolite pools is integral to 
modelling the complete dynamics of the set points.  
 
 
 
Figure 4.30: Control block showing the metabolator optimised with Vgly and acetate (HOAcE) as the 
control variables for the state variables AcCoA and AcP. This is an example of Multiple-Input 
Multiple-Output (MIMO) model based control. Here Vgly can be measured online using fluorescence 
detection (FD) and HOAcE can be measured using HPLC analysis. 
 
 
As shown in Figure 4.31 the system is able to track both AcCoA and AcP. There is 
little violation of the set points and the predicted concentrations of Vgly and acetate 
compare well with previous results. The set points for AcCoA and AcP reflect the 
synergy between the two metabolite pools, and a decrease in the concentration of 
AcCoA results in an increased concentration of AcP and vice versa. This is 
advantageous as the model now reflects the dynamic biological processes that are 
occurring within the metabolator with respect to the flux of Vgly and acetate 
production. There are however factors that are not considered by the model. In 
order for the model to take into account the true dynamics of the set points it must 
also include cell reproduction and cell death. These are important factors as they 
AcCoA Metabolator 
Vgly 
AcP 
NLMPC 
FD 
HOAcE 
HPLC 
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govern the concentration of each moiety in the system, but are also notoriously 
difficult to model. Again this is a key investigation that should be performed with 
the experimentation and these can be measured using either green fluorescent 
protein embedded in the E. Coli genome, or by using a carbon-13 glucose source. 
As with previous models, disturbance was also considered for the dual control 
(MIMO) model (Figure 4.32). In this instance disturbance was considered for both 
equations 4.1 and 4.2 in order to present a case where disturbance was affecting both 
metabolite pools. This can be the case biologically whereby the disturbance in 
AcCoA and AcP can arise from stochasticity in the system.  
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Figure 4.31: Zone NLMPC results for AcCoA at small variations in the set points (blue and red) and 
tracking of the set points (green), the concentration of Vgly in the system showing the fluctuations 
required to track the set points of AcCoA, the Zone NLMPC results for AcP at a decreasing 
concentration, with set points (blue and red) and tracking of the set points (purple) and the 
concentration of acetate in the system showing fluctuations required to track the set points of AcP. 
Qz = 1, 1x10-9 ≤ Dvgly ≤ 1x10-6, 1x10-4 ≤ DHOAcE ≤ 1x10-2. 
 
When comparing results from Figures 4.31, 4.15 and 4.23 it can be noted that 
MIMO control of the metabolator yields better results than Single-Input Single-
Output (SISO) implementation (as shown in Figures 4.15 and 4.23). In terms of AcP 
tracking it is noted that MIMO control results in a much better profile of acetate 
where the concentration levels show much less sharp changes when comparing 
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results from Figures 4.31 and 4.23, however, the tracking of AcP is lost. The 
resulting concentration of AcP does not follow the trend of the set points, but does 
remain within the set zone. This is advantageous as this can be replicated easily in 
experimentation by altering the concentration of acetate in the cell media. The 
results in Figure 4.31 show an optimum performance of the metabolator and 
highlight its synergistic relationship between the two metabolite pools. An increase 
in the activity of AcCoA results in a decrease in activity for AcP and vice versa 
(Figure 4.1).  
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Figure 4.32: Zone NLMPC results for AcCoA at small variations in the set points (red and blue) and 
tracking of the set points (green), the rate of Vgly required to track the set points and the 
disturbance (d) added to AcCoA, where d is a random disturbance with uniform distribution, the 
Zone NLMPC results for AcP at small variations in the set points (red and blue) and tracking of the 
set points (purple), the concentration of HOAcE required to track the set points and the disturbance 
(d) added to AcP, where d is a random disturbance with uniform distribution. a. 0.01 ≤ d ≤ 0.1, b. 
0.1 ≤ d ≤ 1 and c. 0.01 ≤ d ≤ 1. Qz = 1, Qu = 0, 1x10-9 ≤ Dvgly ≤ 1x10-6 and 1x10-4 ≤ DHOAcE ≤ 
1x10-2 for all cases.   
a 
b 
c 
Chapter 4 A Gene Metabolator Case Study 
 
100 
 
The results in Figure 4.32 show that the increase in disturbance affects mainly 
AcCoA within the system, where frequent sharp changes are present in its optimal 
activity. However, it is noted that the system does not violate the given bounds of 
the Zone NLMPC in both AcCoA and AcP, which shows that the system can 
effectively track even in the presence of disturbance. This is profound as the 
disturbance added to the system is up to 1000% of the nominal concentrations of 
AcCoA and AcP, and this is typically higher than what would normally be 
considered as disturbance for the metabolator (Fung et al., 2005).  
 
 
4.9 Concluding Remarks 
 
The metabolator has been successfully modelled using various approaches, ranging 
from ANN-RK4 validation to Zone Control with multiple inputs (MIMO). The 
system has been shown to react to disturbance, and still adhere to the control 
systems applied to it. This level of control is profound as it allows the biological 
system to alter its response depending on the user specified constraints placed on it. 
Results from all investigations showcase how adaptable the metabolator is and how 
responsive it can be towards subtle changes in design, such as altering the control 
set point or having large disturbance present in the system. Although some results 
do violate the control system, such as results in Figures 4.13c and 4.26c when using 
a single control set point under disturbance, this can be mitigated using Zone 
NLMPC as shown in Figures 4.18c and 4.28c for the same conditions. Furthermore 
control using just one entity, Vgly, is novel for this type of system as it typically will 
have other feed sources. Control using multiple inputs, Vgly and acetate (Figures 
4.31 and 4.32), shows that the system is able to be controlled using both the positive 
feed-forward and negative feedback nature of the metabolator.  
One key element of NLMPC is that one can measure or estimate the state 
variables at each time interval and then use the data obtained to compute the 
control variable at each time interval. In an experimental setup this would involve 
online detection of the concentrations of AcCoA and AcP to then estimate the levels 
of Vgly and acetate within the system. This can be achieved in many different ways 
depending on the experimental setup. If one takes Vgly to be glucose, which is a 
correct assumption as glucose is part of the flux that goes into the first metabolite 
pool (Figure 4.2), then a simple glucose detector, such as the abcam glucose assay 
kit (abcam n.d.), can be used in the media around the cells. This will indicate the 
level of glucose and from there it can be calculated how much glucose has been 
taken into the cells, therefore increasing AcCoA concentration. Detection of AcCoA 
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can also be achieved using reverse phase ion-exchange chromatography as shown in 
research from Yamato et al. (1992). The method described in this research utilises 
an immobilised enzyme reactor in the post column which specifically detects AcCoA. 
This can then be used to calculate the concentration of AcCoA in the solution. In 
terms of an experimental setup with the metabolator this will involve taking a 
sample and centrifuging the cells down to lyse their internal contents, then testing 
this solution for AcCoA. Unfortunately there is not a way, to tis researches 
knowledge, of methods that can detect the levels of AcCoA without causing harm to 
the cell, and therefore whilst detection of AcCoA can be performed it will not be 
completely on-line, due to the nature of taking a sample to destroy the cells. 
Research from Klein et al. (2007) showcased a thin layer chromatography (TLC) 
approach for the detection of AcP through quantifying the amount of phosphorous 
taken up by the cell. This again involved centrifuging down the sample and snap 
freezing to stop any further reaction. This detection method is useful, but again 
causes damage to the cell. These methods are as close to on-line detection methods 
that one can get without altering the metabolator or changing reactions by adding 
new solutions. The detection of AcCoA and AcP will need to be carefully monitored 
when performing experiments on the metabolator in future work. 
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5.  A Comparative Analysis of Nonlinear Solution 
Techniques for Dynamic Problems 
 
As mentioned previously (Chapter 3) dynamic models can be converted to algebraic 
equations and solved using GAMS. However this is one of many techniques that can 
be applied to simulate and optimise dynamic process models. A method that can be 
applied is Orthogonal Collocation on Finite Elements (OCFE) (Carey and 
Finlayson, 1975), which employs a simultaneous solution strategy for dynamic 
optimisation. Unlike neural networks which transform the differential equations 
through their hidden layer and solve for the domain, OCFE divides the domain into 
smaller subdomains, termed finite elements. The residuals are set to zero at the 
collocation points interior to the elements. This ensures continuation of the trial 
function between each node and the boundary points. The process can be considered 
as an extension to the double collocation method proposed by Villadsen and 
Sorensen (1969) where again the domain is divided into elements, but in the case of 
nonlinear equations the algebraic equations involve terms in one of the finite 
elements and not for the whole domain. The general outline of OCFE is presented in 
Chapter 3, Figure 3.4. It is best used for problems that have steep gradients and 
shows best applicability on time dependent problems. It can be seen as a more 
complex solution methodology when compared to other techniques using a 
combination of ODEs and algebraic equations such as RK4. This Chapter will look 
into investigating which method, OCFE or the ANN-RK4 framework, gives the most 
optimal results for synthetic biology systems and control problems. The main 
benefits of each technique will be discussed and conclusions will be drawn based on 
performance of the models and results. This chapter will show the strengths and 
weaknesses of the developed meshless ANN framework and will ultimately discuss its 
validity as a viable solution method for nonlinear problems. It will also solidify the 
use of the framework for the prominent case study, the Metabolator (Fung et al., 
2005). 
 
 
5.1 Uses of OCFE 
 
Orthogonal collocation on finite elements (OCFE) provides a computationally 
efficient and accurate approach to solve both ODEs and partial differential equations 
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(PDEs) as presented in research by Babuska et al. (2007). Therefore it has 
applicability in many different dynamic processes ranging from biological systems 
(Rogers and McCulloch, 1994) to fuel cells (Ziogou et al., 2013), where NLMPC was 
combined with OCFE to provide an on-line user interface to control power 
generation of a polymer electrolyte membrane fuel cell (PEMFC). Collocation 
methods can also be combined with other solution techniques that aid in optimising 
highly nonlinear systems with irregular domains, such as biological systems and 
processes as presented in work by Saucerman and McCulloch (2004) and can also be 
used to approximate ODEs in control problems (Kawathekar et al., 2007). 
Furthermore collocation methods can be imposed in systems that have previously 
shown great computational expense, such as the pseudo two-dimensional (P2D) 
model for lithium ion cells (Doyle et al., 1993; Fuller et al., 1994) as shown by Cai 
and White (2012).  
The following section (Section 5.2) will present a number of ways in which 
OCFE can aid in modelling dynamic systems, with most representation showing that 
it is a fast and efficient solution technique that gives highly accurate results. The 
methodology of OCFE will be applied to a number of case studies and the merits of 
this technique will be discussed and compared to the developed ANN-RK4 method 
discussed in Chapters 3 and 4. 
 
5.2 Comparative case studies for OCFE and the ANN-RK4 methods 
5.2.1 An Isothermal CSTR Example 
 
An isothermal CSTR model (Sistu and Bequette, 1995) was considered for 
simulation using the ANN framework and OCFE (see Chapter 3, Section 3.5.1). For 
this example with the ANN formulation the prediction horizon is set at 0.002 hours, 
the horizon length is 5, 𝛾1 = 𝛾2 = 1000 and 𝛾3 = 1. The results for the ANN and 
OCFE implementations for this model are presented in Figure 5.1. From the results 
in Figure 5.1 it is shown that both ANN and OCFE based implementations of 
NLMPC are able to track the set points easily and maintain a steady state. The 
total run times for each show that the OCFE model takes less than half the time to 
solve. The average number of CPU seconds for each time interval for the ANN 
model is 0.424, whereas with the OCFE model it is 0.049.  
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Figure 5.1:  a. b. c. Results from the ANN simulation of the CSTR in GAMS optimised with 7 nodes 
in the hidden layer and a total run time of 49 seconds for 100 iterations, d. e. f. results for the OCFE 
simulation of the CSTR in GAMS optimised with 3 collocation points and a total run time of 15 
seconds for 100 iterations. CPU: Intel Core™2 Duo E7400 2.8GHz. 
 
 
5.2.2 Lower order distillation column 
 
A distillation column described by Rasmussen and Jorgensen (1999) and Prasad and 
Bequette (2003) was chosen as the next example problem. The distillation tower 
consists of five trays which includes the total condenser and reboiler. The system of 
ODEs governing this system is given by equations 5.1-5.5. 
 
 𝑑𝑥1
𝑑𝑡
=  
1
𝐻𝑟
((𝐿 + 𝐿𝑓)(𝑥2 − 𝑥1) + 𝑉 (𝑥1 − (
𝛼𝑥1
1 + (𝛼 − 1)𝑥1
))) 
(5.1) 
 𝑑𝑥2
𝑑𝑡
=  
1
𝐻𝑡
((𝐿 + 𝐿𝑓)(𝑥3 − 𝑥2) + 𝑉 (
𝛼𝑥1
1 + (𝛼 − 1)𝑥1
− (
𝛼𝑥2
1 + (𝛼 − 1)𝑥2
))) 
(5.2) 
 
𝑑𝑥3
𝑑𝑡
=  
1
𝐻𝑡
((𝐿𝑓𝑥𝑓 + 𝐿𝑥4) − (𝐿 + 𝐿𝑓)(𝑥3)
+ 𝑉 (
𝛼𝑥2
1 + (𝛼 − 1)𝑥2
− (
𝛼𝑥3
1 + (𝛼 − 1)𝑥3
))) 
(5.3) 
a b c 
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𝑑𝑥4
𝑑𝑡
=   
1
𝐻𝑡
(𝐿(𝑥5 − 𝑥4) + 𝑉 (
𝛼𝑥3
1 + (𝛼 − 1)𝑥3
− (
𝛼𝑥4
1 + (𝛼 − 1)𝑥4
))) 
(5.4) 
 
𝑑𝑥5
𝑑𝑡
=  
1
𝐻𝑡
(𝑉 ((
𝛼𝑥3
1 + (𝛼 − 1)𝑥3
) − 𝑥5)) 
(5.5) 
 
where 𝑥1, 𝑥2, 𝑥3, 𝑥4 and 𝑥5 are the state variables of the column and represent the 
liquid mole fraction of the light component at the reboiler, second tray, third tray 
(feed), fourth tray and the condenser respectively. The molar holdup on the reboiler, 
trays and condenser are represented by 𝐻𝑟, 𝐻𝑡 and 𝐻𝑐. Feed flow rate into the 
column is shown by 𝐿𝑓 and the light component feed composition is given by 𝑥𝑓. 
Finally 𝐿 and 𝑉 represent the liquid reflux flow and vapour flow rate back into the 
column respectively. Parameters used for the model are presented in table 5.1. 
 
 
Table 5.1: Model parameters for the distillation column (Prasad and Bequette, 2003). 
Parameter Value 
𝐻𝑐 30 mol 
𝐻𝑟 30 mol 
𝐻𝑡 20 mol 
𝛼 5 
𝐿𝑓 10.0 mol min
-1 
𝑥𝑓 0.5 
𝐿 27.3755 mol min
-1 
𝑉 32.3755 mol min
-1 
 
 
The system was then modelled using the ANN and OCFE frameworks. The control 
problem was then implemented whereby the value for 𝑥5, the distillate, was set and 
controlled using the vapour flow rate (Figure 5.2). A schematic of the column is 
presented in Figure 5.3. The results for the ANN and OCFE implementation are 
presented in Figures 5.4 and 5.5, and the implementation of both formulations using 
NLMPC are presented in Figure 5.6.  
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Figure 5.2: Control block showing the lower order distillation column optimised with V (vapour flow 
rate) as the control variable for the state variable 𝒙𝟓, which is the mole fraction in the condenser and 
its concentration can be measured using a pH meter. 
 
 
 
Figure 5.3: Schematic of the distillation column 
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Figure 5.4: ANN-RK4 simulation results for the distillation column using the solvers SNOPT, 
CONOPT3 and KNITRO in GAMS. Total CPU time for SNOPT = 10 minutes 59 seconds, 
CONOPT3 = 19 minutes 25 seconds and KNITRO = 26 minutes 8 seconds for 3400 iterations, step 
size = 0.01. CPU: Intel Core™2 Duo E7400 2.8GHz. 
 
As presented in Figures 5.4 and 5.5 the results for each solver provide the exact 
same solution. For the ANN formulation (Figure 5.4) SNOPT outperforms the other 
solvers in terms of CPU time, and in the OCFE formulation (Figure 5.5) SNOPT 
also outperforms the others. It is apparent that generally the OCFE formulation is 
much faster than the ANN. Further analysis of the system looks at incorporating 
control, where the level of 𝑥5 is set at 0.98. The results for the ANN-NLMPC and 
OCFE-NLMPC control simulations are presented in Figure 5.6.  
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Figure 5.5: OCFE simulation results for the distillation column using the solvers SNOPT, CONOPT3 
and KNITRO in GAMS. Total CPU time for SNOPT = 6 minutes 37 seconds, CONOPT3 = 7 
minutes 58 seconds and KNITRO = 10 minutes 22 seconds for 3400 iterations, step size = 0.01. CPU: 
Intel Core™2 Duo E7400 2.8GHz. 
 
From the results in Figure 5.6 it is noted that both formulations (ANN and OCFE) 
are able to track the set point for 𝑥5, with the OCFE-NLMPC formulation 
performing slightly faster for SNOPT and KNITRO and the ANN-NLMPC 
formulation performing better for CONOPT3. The OCFE-NLMPC results also show 
that there is a deviation from the set point in the order of 5 x 10-4 and as such the 
system does not actually achieve the set point. Taking this into consideration both 
formulations are comparable for model based control, but as there is relatively little 
difference between the CPU times it can be argued that the ANN-NLMPC 
formulation is the better choice. 
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Figure 5.6: a. ANN-NLMPC based control results for the distillation column for SNOPT, CONOPT3 
and KNITRO solvers in GAMS. Total CPU time for SNOPT = 10 minutes 20 seconds, CONOPT3 = 
9 minutes 32 seconds and KNITRO = 18 minutes 42 seconds for 3400 iterations, step size = 0.01, b. 
OCFE-NLMPC based control results for the distillation column for SNOPT, CONOPT3 and 
KNITRO in GAMS. Total CPU time for SNOPT = 8 minutes 13 seconds, CONOPT3 = 10 minutes 
36 seconds and KNITRO = 18 minutes 20 seconds for 3400 iterations, step size = 0.01. CPU: Intel 
Core™2 Duo E7400 2.8GHz. 
 
The next problem deals with a more complex system of ODEs that govern a 
biological system termed the metabolator (Fung et al., 2005), previously shown in 
Chapter 4.  
 
 
5.2.3 The Metabolator 
 
The metabolator (Fung et al., 2005) which was simulated and controlled using ANN 
in Chapter 4 is now revisited and modelled with OCFE based techniques. The 
results for both frameworks, ANN and OCFE, are compared using three solvers in 
GAMS: SNOPT, CONOPT3 and KNITRO (for more information about how these 
solvers function the reader is referred to Chapter 3, Section 3.6.4). The control 
problem remains the same as previous work in this thesis and results for the 
NLMPC approach controlling AcCoA are presented in Figure 5.7. It can be seen 
that both the ANN and OCFE formulations are able to adhere to the set points, 
however the computational effort for the OCFE model is greater than the ANN 
model. This difference in time shows that whilst the OCFE formulation is capable of 
modelling problems with less nonlinearity faster than the ANN formulation, it lacks 
the ability to model highly nonlinear systems as easily. However, the adherence to 
the set points is closer than the ANN formulation. Whilst the results for the ANN 
from CONOPT3 and KNITRO solvers deviate from the set points, the results from 
SNOPT adhere much more closely. This shows that whilst both generally show some 
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adherence to the set points, the ANN formulation can be considered better for 
SNOPT solver. The increased computational effort can mean that using the OCFE-
NLMPC formulation, especially when using the KNITRO solver would mean that 
although the control results are more favourable, the ANN-NLMPC formulation can 
also achieve adequate results and therefore could be used as an alternative. Overall 
given the information gained from these results it can be said that the ANN-
NLMPC formulation solved using SNOPT is the best choice in terms of speed and 
accuracy, especially if one is looking at gaining an optimal solution quickly.  
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Figure 5.7: a. ANN-NLMPC results for the metabolator for SNOPT, CONOPT3 and KNITRO 
solvers in GAMS. Total CPU time for SNOPT = 1 minute 41 seconds, CONOPT3 = 1 minute 58 
seconds and KNITRO = 4 minutes 34 seconds for 500 iterations, step size = 0.01, b. OCFE-NLMPC 
results for the metabolator for SNOPT, CONOPT3 and KNITRO in GAMS. Total CPU time for 
SNOPT = 4 minutes 46 seconds, CONOPT3 = 1 minutes 49 seconds and KNITRO = 6 minutes 3 
seconds for 500 iterations, step size = 0.01. CPU: Intel Core™2 Duo E7400 2.8GHz. 
 
5.2.3.1 Zone control 
 
With NLMPC the objective function has one set of values to track, however one can 
set a ‘zone’ between two sets of values for the system performance, and this is 
termed as zone model predictive control (Zone MPC). The set zone or band allows 
the system to perform freely within the controlled region, which can have beneficial 
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applications for systems like the automated diabetes control monitor (Grosman et 
al., 2010) as there is less restriction on the system performance which the same for 
single set control. With the metabolator a zone can be set so that the system can 
oscillate within the region and therefore alter the production of acetate by 
manipulating glycolytic flux (sugars, fatty acids and glycerol – Vgly). Figure 5.8 
presents the results for the Zone MPC formulation, where both the ANN and OCFE 
formulations are able to adhere to the set zone. There is little variation in the results 
for different solvers, except when looking at the response rate of Vgly. For KNITRO 
in the OCFE-Zone MPC formulation the response rate fluctuates rapidly in order to 
produce the desired response within the set zone. Also for both the ANN and OCFE 
formulations it is the solver that takes the longest to solve. Again it can be noted 
that the ANN formulation is faster overall, with the best results achieved using the 
SNOPT solver. This indicates that the OCFE takes longer for  both single set point 
control (NLMPC) (Chapter 3, Section 3.6), and Zone NLMPC (Chapter 3, Section 
3.6.2) for this example. The following section will consider disturbance in the system 
analyse its effect for both single set control and dual set (zone) control profiles.  
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Figure 5.8: a. ANN-Zone NLMPC Control results for the metabolator showing the tracking of AcCoA 
using Vgly as the control variable for SNOPT, CONOPT3 and KNITRO solvers in GAMS. Total 
CPU time for SNOPT = 1 minute 43 seconds, CONOPT3 = 1 minute 23 seconds and KNITRO = 5 
minutes 29 seconds for 500 iterations, step size = 0.01, b. OCFE-Zone NLMPC control results for the 
metabolator showing tracking of AcCoA using Vgly as the control variable for SNOPT, CONOPT3 
and KNITRO solvers in GAMS. Total CPU time for SNOPT = 1 minute 49 seconds, CONOPT3 = 2 
minutes 50 seconds and KNITRO = 5 minutes 37 seconds for 500 iterations, step size = 0.01.  
 
 
5.2.3.2 Control with disturbance 
 
In the previous Section the metabolator was modelled as a deterministic system with 
no disturbances. However, its action in vivo can involve disturbances from factors 
like cell death, temperature and pH. These factors can be determined 
experimentally, quantified and incorporated in the model in order to achieve a more 
biologically feasible outcome. Within their work, Fung et al (2005) explained how 
stochastic disturbance is present in the system and explained the discrepancies they 
noticed between the simulated and experimental results. It was noted that this had 
great effect on the three proteins LacI, Acs and Pta. As such a uniform disturbance 
(𝑑) over a range was added to the RHS of equation governing AcCoA concentration 
(Chapter 4, Equation 4.1) and the results were analysed for zone control. In this 
Section disturbance for the case of single set-point tracking is first considered and 
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the results are presented in Figures 5.9 and 5.10. Disturbance is then considered for 
the case where Zone NLMPC strategies are employed and the results for this 
investigation are presented in Figures 5.11 and 5.12. For all simulations (Figures 5.9-
5.12) a restriction on the velocity of Vgly was added, where 1 × 10−6 ≤ 𝐷𝑉𝑔𝑙𝑦 ≤ 10.   
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Figure 5.9: ANN-NLMPC results for the metabolator showing the tracking of AcCoA using Vgly as 
the control variable for SNOPT, CONOPT3 and KNITRO solvers in GAMS. a. total CPU time 
(hours) for SNOPT = 00:02:18, CONOPT3 = 00:03:20 and KNITRO = 00:05:40, b. total CPU time 
(hours) for SNOPT = 00:18:56, CONOPT3 = 00:02:56 and KNITRO = 00:04:21, c. total CPU time 
(hours) for SNOPT = 00:03:29, CONOPT3 = 00:05:28 and KNITRO = 00:07:58. All simulations run 
for 500 iterations, step size = 0.01, 0.01 ≤ d ≤ 1.0 for all simulations. 
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Figure 5.10: OCFE-NLMPC results for the metabolator showing the tracking of AcCoA using Vgly as 
the control variable for SNOPT, CONOPT3 and KNITRO solvers in GAMS. a. total CPU time 
(hours) for SNOPT = 00:07:34, CONOPT3 = 00:01:41 and KNITRO = 00:05:06, b. total CPU time 
(hours) for SNOPT = 00:04:05, CONOPT3 = 00:01:49 and KNITRO = 00:06:21, c. total CPU time 
(hours) for SNOPT = 00:04:25, CONOPT3 = 00:02:53 and KNITRO = 00:06:14. All simulations run 
for 500 iterations, step size = 0.01, 0.01 ≤ d ≤ 1.0 for all simulations. 
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Figure 5.11: ANN-Zone MPC results for the metabolator showing the tracking of AcCoA using Vgly 
as the control variable for SNOPT, CONOPT3 and KNITRO solvers in GAMS. a. total CPU time 
(hours) for SNOPT = 00:01:59, CONOPT3 = 00:05:20 and KNITRO = 00:08:12, b. total CPU time 
(hours) for SNOPT = 00:02:44, CONOPT3 = 00:03:21 and KNITRO = 00:08:36, c. total CPU time 
(hours) for SNOPT = 00:02:25, CONOPT3 = 00:04:42 and KNITRO = 00:08:47. All simulations run 
for 500 iterations, step size = 0.01, 0.01 ≤ d ≤ 1.0 for all simulations. 
a 
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Figure 5.12: OCFE-Zone MPC results for the metabolator showing the tracking of AcCoA using Vgly 
as the control variable for SNOPT, CONOPT3 and KNITRO solvers in GAMS. a. total CPU time 
(hours) for SNOPT = 00:03:56, CONOPT3 = 00:02:26 and KNITRO = 00:06:29, b. total CPU time 
(hours) for SNOPT = 00:02:39, CONOPT3 = 00:02:59 and KNITRO = 00:16:53, c. total CPU time 
(hours) for SNOPT = 00:02:22, CONOPT3 = 00:02:53 and KNITRO = 00:10:02. All simulations run 
for 500 iterations, step size = 0.01, 0.01 ≤ d ≤ 1.0 for all simulations. 
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The results presented in Figure 5.9 show the case when the ANN framework has 
been used for single-set tracking (NLMPC) of the state variable AcCoA using Vgly 
as the control. Results show that for SNOPT and KNITRO the control under 
disturbance does not deviate from the set points, however this is not the case when 
using CONOPT3 where a distinct loss of tracking is noticed for both small 
disturbance (i.e. 𝑑 =  0.01 − 0.1) (Figure 5.9a) and larger disturbance (i.e. 𝑑 =  0.1 −
1) (Figure 5.9b). The SNOPT solver performs fastest for cases when disturbance is 
low (i.e. 𝑑 =  0.01 − 0.1) (Figure 5.9a) and when the full range of disturbance (i.e. 
𝑑 =  0.01 − 1) is implemented (Figure 5.9c). In general the SNOPT solver performs 
the best as it shows the greatest accuracy in adhering to the set points, and bar the 
effect of large disturbance (i.e. 𝑑 =  0.1 − 1) (Figure 5.9b) it performs the fastest. 
This further reinforces this technique, ANN-NLMPC, as an effective framework 
when used with the SNOPT solver. However, when comparing with the results for 
this solver using the OCFE-NLMPC technique (Figure 5.10), it is shown to have 
better tracking when the ANN is not utilised. Results for this investigation show 
that for the OCFE-NLMPC formulation CONOPT3 gives better results. All three 
solvers show great accuracy when adhering to the set points, except for KNITRO 
when the full range of disturbance (i.e. 𝑑 =  0.01 − 1) is implemented (Figure 5.10c) 
where there is slight deviation from the set points at around 50-80 time steps. It can 
be concluded from these results (Figure 5.9 and Figure 5.10) that for the ANN-
NLMPC formulation the SNOPT solver is best and for the OCFE-NLMPC 
formulation the CONOPT3 solver is best.  
When analysing results for the Zone NLMPC formulations (Figures 5.11 and 
5.12) it is apparent that KNITRO is unable to handle larger disturbances in the 
system and tracking within the zone is lost for the OCFE-Zone MPC strategy when 
disturbance is high (i.e. 𝑑 =  0.1 − 1) (Figure 5.12b) and when the full range of 
disturbance (i.e. 𝑑 =  0.01 − 1) (Figure 5.12c) is implemented. The ANN-Zone 
NLMPC formulation (Figure 5.11) however is able to adhere to the set points even 
when the disturbance is up to 1000% the nominal amount of AcCoA. Tracking 
within the zone however does fair better for the OCFE-Zone NLMPC formulation 
(Figure 5.12). With the exception of KNITRO for larger disturbances (i.e. 𝑑 =  0.1 −
1 and 𝑑 =  0.01 − 1), the oscillation of AcCoA remains steadily within the middle of 
the zone, whereas for the ANN-Zone NLMPC formulation tracking tends to favour 
the upper limit of the zone. The OCFE-Zone NLMPC strategy may remain in the 
middle of the zone as it is in the family of implicit RK methods and is inherently a-
stable (Hairer and Wanner, 1999) and therefore will optimise to the most stable 
point within the zone. The ANN however may overshoot this stable point, and ways 
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to combat this include training the ANN to respond to large disturbances. It is 
unknown however why KNITRO suddenly loses the ability to track within the set 
points. Analysis of the disturbance values for the case where 𝑑 = 0.1 − 1 shows that 
the values where the oscillations deviate from the zone are less than the maximum 
disturbance throughout the entire 500 time steps, however the computational 
resources used by the solver increases dramatically. Figure 5.13 shows the 
computational resources used for KNITRO for the cases where 𝑑 = 0.1 − 1 and 
𝑑 = 0.01 − 1 and compares them with the computational resources for SNOPT for 
the same conditions. As can be seen there are clear spikes in the number of seconds 
for the iterations when the system fails to adhere to the set points.  
The OCFE-Zone NLMPC formulation performs much better for SNOPT and 
CONOPT3, and the total CPU times are less than for the ANN-Zone NLMPC 
formulation. As the resulting profile for AcCoA remains within the middle of the 
zone it performs better than using the ANN formulation. The OCFE-Zone NLMPC 
formulation shows little variation from the set point for AcCoA and can be deemed 
the better solution technique. The results show that whilst the ANN-Zone NLMPC 
strategy is better when disturbance is not present, the OCFE-Zone NLMPC is 
favoured when disturbance is present. This is due to the nature of OCFE, which 
discretises over the finite elements, and therefore integrates the solution to the set 
point more frequently that the ANN-Zone NLMPC strategy. This therefore means 
that there will be less deviation from the set points as the system is inherently 
trying to force the system to stay within the bounds. Whilst this can also be 
achieved with the ANN, by using a smaller step size, it will increase computational 
effort. This means that if one solely wants to control the system then using the ANN 
is better as the results are adequate and can quickly determine the performance of 
the system using zone control, but if one wants to consider disturbance too then the 
OCFE formulation is favoured as the system generally can handle disturbances 
better. 
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Figure 5.13: The number of CPU seconds per iteration for the metabolator solved using the OCFE-
Zone MPC with disturbance formulation with SNOPT and KNITRO solvers in GAMS, a. d = 0.1-
1.0, b. d = 0.01-1.0 for 500 iterations, step size = 0.01. CPU: Intel Core™2 Duo E7400 2.8GHz. 
 
 
5.2.3.4 Multiple-Input Multiple-Output (MIMO) Control 
 
Due to the nature of the metabolator it is possible to control using both Vgly and 
acetate concentration (HOAcE). It was noted by Fung et al. (2005) that high levels 
of acetate caused the system to denature and oscillations were lost. This is expected 
as E. Coli does not thrive in acidic environments. However the reverse reaction from 
the secondary metabolite pool containing AcP to the first pool containing AcCoA 
can be controlled by setting a profile for the external concentration of acetate. The 
concept of MIMO control therefore aims to control the system using both of these 
inputs, with the system trying to attain a steady state. The set profiles for both 
metabolites ideally would be in synergy with one other, as when AcCoA is oscillating 
AcP is not, and vice versa. The results for this are presented in Figures 5.14-5.16. 
As shown in Figure 5.14 the results for MIMO control show that both the 
ANN and OCFE formulations are capable of tracking within the set points. There 
are however some deviations from the set point for the OCFE formulation at around 
200 time steps. This is not the case for the ANN formulation. Furthermore, the 
optimal solution for the OCFE-MIMO Control formulation (Figure 5.13a) shows 
that HOAcE is not present within the system, which is usually found in the external 
a b 
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media of the cell once it has permeated the cell wall. The absence of HOAcE within 
the system shows that there is no flux of HOAcE to the external media of the cell, 
and therefore means that HOAcE is not presented in the system. The cell may be 
going through internal feedback, which can occure given the dynamics of the 
Metabolator, and could be the case found by OCFE. The ANN-MIMO Control 
shows that Vgly is present at specific intervals within the time frame and HOAcE 
fluctuates in level throughout. Both were optimised using KNITRO however the 
results were extremely poor, with the average CPU time to solve in the order of 5 
hours. Disturbance was added to the system and results for this presented in Figures 
5.15 and 5.16. 
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Figure 5.14: a. ANN-MIMO Control results for the metabolator using Vgly and HOAcE as the 
control variables for SNOPT and CONOPT3 solvers in GAMS, total CPU time (hours) for SNOPT 
= 00:03:22 and CONOPT3 = 00:02:30, b. OCFE-MIMO Control results for the metabolator using 
Vgly and HOAcE as the control variables for SNOPT and CONOPT3 solvers in GAMS, total CPU 
time (hours) for SNOPT = 00:02:43 and CONOPT3 = 00:02:10. All simulations run for 500 
iterations, step size = 0.01. 
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Figure 5.15: ANN-MIMO Control results for the metabolator using Vgly and HOAcE as the control 
variables for SNOPT and CONOPT3 solvers in GAMS, a. d = 0.01-0.1, total CPU time (hours) for 
SNOPT = 00:03:16 and CONOPT3 = 00:06:17, b. d = 0.1-1, total CPU time (hours) for SNOPT = 
04:16:34 and CONOPT3 = 00:06:50, c. d = 0.01-1, total CPU time (hours) for SNOPT = 00:04:58 
and CONOPT3 = 00:06:41. All simulations run for 500 iterations, step size = 0.01. 
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Figure 5.16: OCFE-MIMO Control results for the metabolator using Vgly and HOAcE as the control 
variables for SNOPT and CONOPT3 solvers in GAMS, a. d = 0.01-0.1, total CPU time (hours) for 
SNOPT = 00:03:19 and CONOPT3 = 00:04:15, b. d = 0.1-1, total CPU time (hours) for SNOPT = 
00:01:56 and CONOPT3 = 00:02:17, c. d = 0.01-1, total CPU time (hours) for SNOPT = 00:02:54 
and CONOPT3 = 00:02:29. All simulations run for 500 iterations, step size = 0.01. 
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Both Figures 5.15 and 5.16 show that at higher levels of disturbance tracking is lost 
for AcP in both formulations. The system dynamics are compromised and violation 
of the set zone is seen throughout. This could be due to the fact that the disturbance 
added to these profiles (Figure 5.15b and 5.15c and Figure 5.16b and 5.16c) can 
reach up to 1000% of the nominal values of AcP and AcCoA. However both 
formulations are capable of optimising with low levels of disturbance. In terms of 
which formulation performs better, the ANN does as the results for AcCoA are more 
favourable than the OCFE results. Both SNOPT and CONOPT3 perform similarly, 
with SNOPT, bar a few exceptions, performing faster for both formulations.  
 
 
5.3 Summary of Results 
 
Results in this chapter show that the OCFE formulation outperforms the ANN when 
the problems are of a small scale, however the ANN formulation is better suited 
towards highly nonlinear problems such as the metabolator. Problems that are less 
complex indicate that OCFE can solve the models quickly and provide highly 
accurate results, but can deviate from set point tracking during control. 
Traditionally when using neural networks, fine tuning of the weight and matrices of 
the network must be performed offline through parameter estimation, however in the 
formulation used here these are computed as part of the NLMPC formulation. 
OCFE can also eliminate the need for offline fine tuning as the collocation points are 
well defined. There is possibility and scope to use the 5 collocation points method, 
but this will increase computational effort, and is unlikely to give better results for 
the two small case studies in Sections 5.2.1 and 5.2.2 than the 3 collocation points 
method used. For the metabolator case study (Section 5.2.3) the ANN-NLMPC 
formulation performs faster in terms of set point tracking, and therefore is better 
suited to more complex dynamic systems. However in the case when disturbance is 
added (Section 5.2.3.2) the OCFE formulation is favoured as it handles disturbances 
better, with exception of the KNITRO solver, and can track safely within the set 
zone (Figure 5.11). When the system is modelled using MIMO Control the ANN 
formulation performs better in general. A summary of the computational effort and 
times for the isothermal CSTR and the distillation column examples are presented in 
table 5.2, and a summary of the computational times for the metabolator example 
are shown in table 5.3.  
As mentioned previously the results indicate that there is a difference in using 
ANNs and OCFE as solution methods for solving ODEs. It has been shown that 
OCFE outperforms the ANN when the problem contains fewer ODEs and are 
simpler in nature, however fails to solve highly nonlinear models in short time 
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frames. The ANN on the other hand provides faster solutions for highly nonlinear 
problems. When replicating results of the metabolator (Fung et al., 2005) the ANN-
RK4 model was capable of reproducing the results found in their MATLAB model. 
The OCFE formulation also replicated the results but the difference in the solution 
times outweighs the benefits of using OCFE for this type of problem. The more 
complex the model is the more computational effort is required for the OCFE, which 
is typical as it needs to discretise through more points in the domain space. The 
trade-off in this case is the level of accuracy from the OCFE compared to the ANN. 
The ANN formulation provides accurate results for more nonlinear problems, 
especially when using MIMO control, but the OCFE formulation performs better 
when Zone NLMPC is utilised.  
 
 
 
 
Table 5.2: Summary of the total CPU times (minutes) for the isothermal CSTR and distillation 
column case studies and their solution methods. CPU: Intel Core™2 Duo E7400 2.8GHz. 
Case 
Study 
Solver Solution Method (CPU Time – Minutes) 
  ANN/Simulation OCFE/Simulation ANN-
NLMPC 
OCFE-
NLMPC 
Isothermal 
CSTR 
SNOPT   00:49 00:20 
Low order 
distillation 
column 
SNOPT 
CONOPT3 
KNITRO 
10:59 
19:25 
26:08 
06:37 
07:58 
10:22 
10:20 
09:32 
18:42 
08:13 
10:36 
18:20 
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Table 5.3: Summary of the total CPU times (minutes) for the metabolator case study and its solution methods. CPU: Intel Core™2 Duo E7400 2.8GHz. d = 
disturbance added to the system. 
Case Study Solver Solution Method (CPU Time – Minutes) 
  
ANN-NLMPC OCFE-NLMPC ANN-Zone NLMPC OCFE-Zone NLMPC 
Metabolator SNOPT 
CONOPT3 
KNITRO 
01:41 
01:58 
04:34 
04:46 
01:49 
06:03 
01:43 
01:23 
03:29 
01:49 
02:50 
05:37 
 
Metabolator/Disturbance 
     
d = 0.01 – 0.1 SNOPT 
CONOPT3 
KNITRO 
 
02:18 
03:20 
05:40 
07:34 
01:41 
05:06 
01:59 
05:20 
08:12 
03:56 
02:26 
06:29 
d = 0.1 – 1.0 SNOPT 
CONOPT3 
KNITRO 
 
18:56 
02:56 
04:21 
04:05 
01:49 
06:21 
02:44 
03:21 
08:30 
02:39 
02:59 
16:53 
d = 0.01 – 1.0 SNOPT 
CONOPT3 
KNITRO 
03:29 
05:28 
07:58 
04:25 
02:53 
06:14 
02:25 
04:42 
08:47 
02:22 
02:53 
10:02 
 
Metabolator/MIMO 
 
SNOPT 
CONOPT3 
   
03:22 
02:30 
 
02:43 
02:10 
 
Metabolator/MIMO/Disturbance 
    
d = 0.01 – 0.1 SNOPT 
CONOPT3 
 
  03:16 
06:17 
03:19 
04:15 
d = 0.1 – 1 SNOPT 
CONOPT3 
 
  256:34 
06:50 
01:56 
02:17 
d = 0.01 – 1 SNOPT 
CONOPT3 
  04:58 
06:41 
02:54 
02:29 
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5.4 Conclusion of Techniques 
 
A comparison between solving ordinary differential equations using artificial neural 
networks (ANNs) and orthogonal collocation on finite elements (OCFE) has been 
presented in this Chapter. Result findings suggest that whilst both are able to deal 
with systems of ordinary differential equations, orthogonal collocation on finite 
elements provides better results for problems where disturbances are present in the 
system, whereas artificial neural networks are better suited towards highly dynamic 
problems without disturbance. In the case of multiple-input multiple-output control 
however, the neural network framework outperforms the collocation method. User 
preference will dictate which of the two solution techniques is best used. The trade-
off is the level of accuracy required, where the neural network framework does 
provide accurate results for less complex problems, but the collocation method 
formulation has a greater level of accuracy for highly nonlinear problems. In terms of 
computational effort both methods are comparable to one another, with the neural 
network formulations in general performing faster than their collocation method 
counterparts. From results found when using each of the solvers it can be said that 
the results obtained from SNOPT can be regarded as superior, and therefore justifies 
the use of this solver in previous work (Chapter 4). Due to the fact that the neural 
network outperforms the collocation method when utilising multiple-input multiple-
output control, it can be deemed the better choice for modelling the nonlinear 
systems. This further reinforces the development and use of this framework 
throughout this thesis.  
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6. Systems Architecture 
 
 
As mentioned previously there is scope to use the developed framework for systems 
architecture problems, which are problems where a standard list of well 
characterised biological parts are presented and the framework selects parts to form 
biological circuits. The developed framework has already shown to be effective in 
simulating and controlling nonlinear systems, and so work progressed onto one of 
the many avenues that this could be applied to. This chapter showcases how the 
developed framework can be applied to these problems by highlighting how the 
framework can optimally find suitable biological circuits. There has been much 
advancement in synthetic biology and its use to help find optimal system 
architectures that can provide useful products. With the standardisation of 
biological parts (MIT, 2005) this is now becoming a reality as well characterised 
parts can effectively be put in sequence to either enhance or create new products. 
This type of research looks to provide a pseudo plug-and-play approach to genetic 
systems, as modelling is required to show the optimal configurations and 
experiments are crucial to test the feasibility of these architectures. However, 
automated biological circuit design tools have not yet been realised despite the 
advances in part availability. Recent advances include adaptations of electrical 
engineering concepts such as Boolean optimisation and Carnaugh maps to provide 
biological circuits with digital functions (Marchisio and Stelling, 2011). There have 
also been approaches that translate user-defined specifications into genetic circuits, 
which adhere to digital logic (Pedersen and Phillips, 2009; Densmore et al., 2010; 
Beal et al., 2011) as software for future consideration. The more traditional or 
‘analogue’ method of synthetic circuit design typically employs heuristic methods 
such as evolutionary algorithms (Francois and Hakim, 2004; Wu et al., 2011) and 
simulated annealing (Rodrigo et al., 2007).  
More relevant approaches looked at exploring functional space from a given 
library (Rodrigo et al., 2011) and global sensitivity analysis to determine which 
mutation sites are required to achieve functionality (Feng et al., 2004). Mixed 
integer non-linear programming (MINLP) is widely used for the application of 
selecting appropriate circuits for genes and biological systems. Binary variables can 
be used to model sequences, candidates, existence and non-existence of units, 
whereas variables can be used for example in biological systems to indicate different 
cells. Finally continuous variables are used to model the input-output and 
interaction relationships among the system units as well as any interconnected 
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system to these. This chapter will detail two methods, one deterministic and one 
automated, that showcase how MINLP can be used to obtain biological circuits with 
desired function, as well as how the developed meshless ANN framework detailed in 
Chapter 3, Section 3.3, can be applied to such problems.  
 
 
6.1 Formulations of MINLP Problems 
 
There are many forms of MINLP problems ranging from generalised benders 
decomposition models (Sahinidis and Grossman, 1991) to outer approximation 
models (Duran and Grossman, 1986). Each type of formulation has its own 
advantages in modelling MINLP problems and will be discussed in this section. 
 
 
6.1.1 Generalised Benders Decompositions 
 
Generalised benders decompositions (GBD) are a class of MINLP solution 
algorithms that impose the upper and lower bound of the MINLP problem at each 
iteration, which are updated to allow the problem to converge within a finite 
number of iterations. Generally, the upper bound is found from the primal problem, 
with fixed 𝑦 variables and the lower bound is found from the master problem using 
duality theory. As the problem iterates the upper bounds no longer increase and the 
lower bounds no longer decrease therefore allowing the problem to converge within a 
finite number of iterations. Use of GBD has been seen in research by Sharif et al. 
(2001). Here an efficient method for minimising energy loss over time was 
investigated. The proposed method had four main advantages, the total energy loss 
within the system is minimised, the number of physical plant changes is kept low, 
the number of controls variables are reduced and the likelihood of an infeasible 
solution is minimised when compared to older models using power loss minimisation 
(Elkady et al., 1986). The problem is transformed in two parts, the power loss 
minimisation (PLM) model and the energy loss minimisation (ELM) model. The 
PLM model is used at the beginning of the VAr (volt-ampere reactive) dispatches 
from interval two onwards. The ELM model is executed at the beginning of each 
interval, and is solved using GBD. It was found that the ELM gives a smoother 
voltage profile than the PLM method. It was also noted that the energy loss was 
reduced over time whilst ensuring that the important control variables are not 
altered during the process.  
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The concept of optimal power flow (OPF) has also been studied by Khodr 
and Martínez-Crespo (2009). Here a new and efficient method is investigated using 
optimal power flow and GBD. OPF has been used extensively in power systems in 
the generation or transmission level to denote the difficulty in finding an optimal 
value for the control variable when minimising the total operation cost, whilst still 
adhering to the technical constraints of the network and equipment. Recent 
developments of these types of systems have led to the introduction of uncertainty 
within the models, which may contribute to voltage control and optimisation. The 
concept of distribution optimal power flow (DOPF) is introduced as a means to 
integrate all of the decision problems in a unified model, which can reconfigure the 
model to find the optimal operating point for the distribution network. The decision 
problem (master problem) is formulated as an MINLP model that uses a slave 
problem in the form of an NLP model. The NLP model is used to define the 
feasibility of the master problem through use of OPF, and gives information to 
formulate the linear Benders cuts that transfer information from the slave to the 
master problem. This feasibility seeking aspect of the Benders algorithm is shown to 
be efficient at reconfiguring the OPF of large scale distribution models with little 
computation time. This is known as the reconfiguration integrated with optimal 
power flow (ROPF) model, and has proven to give better results than previous 
literature (Khodr and Martínez-Crespo, 2009).  
Power optimisation is one of the main areas where GBD can be utilised to 
solve complex problems. Issues such as congestion in network systems have been 
looked at by Shrestha and Fonseka (2006). Here a framework was created to look at 
alleviation of congestion in networks using network expansion and flexible AC 
transmission systems (FACTS). It was noted that simple addition of new line 
capacities was not necessarily the best way to deal with time-dependant congestion 
in various lines of the network as there is a lack of control over grid flows. Therefore 
the idea of using FACTS posed as a solution to this issue as this is able to give 
adjustable line capacities. The work proposed here was deemed a continuation of 
previous work (Shrestha and Fonseka, 2004), which looked at long-term network 
planning solutions. The long-term problem can be coupled into the master problem 
(investment problem) and the operational sub-problem of power dispatch. This 
partitioning process allows relaxation of the nonlinearities within the flow equations 
of the model. This may not always guarantee a precise optimal solution, but a near 
optimal solution may be obtained within the user specified bounds. The investment 
problems ran on a yearly time scale and investment decisions are made based on the 
operational sub-problem, which is estimated using an annual load duration curve 
(LDC). The operational sub-problem provided the expected values of annual 
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congestion costs and shadow prices corresponding to the line capacity, the phase 
shifter capacity and the series compensation limits to be used in the Bender’s cuts of 
the master problem. This allowed the inclusion of time-varying bidding details of 
supply and demand into the expansion planning model. Practice models showed 
robust results and the network improvement costs were justified against the long-
term congestion cost savings. The method can be developed further to provide 
network reinforcement schemes, which are time-ordered sets of investment decision 
that can be used for the network planner. It was also seen that although the model 
was capable to solving the practice model (IEEE bus 24 model), the implementation 
of the model to a practical system would require more realistic data.  
 
 
6.1.2 Outer Approximation 
 
Outer approximations (OA) methods are used in modelling to help solve mixed 
integer problems. This approach involves solving approximations to a mathematical 
problem, where the approximation contains the original feasible region. This 
approach is capable of solving complex problems with relatively small amounts of 
sub-problems. Research by Viswanathan and Grossmann (1990) looked into a 
combined penalty function and OA algorithm capable of optimising an MINLP 
problem. The model contained an equality relaxation (OA/ER) (Duran and 
Grossmann, 1986), which featured an exact penalty function that allowed violations 
of the linearisation of non-convex constraints. The OA/ER algorithm relies on the 
convexity of the functions within the model, as well as the quasi-convexity of 
nonlinear equality constraints (Kocis and Grossmann, 1987). When these conditions 
are met the algorithm is able to find the optimal solution. However, if these are not 
met then the NLP sub-problems may only solve for the local optimum, and the 
linearisation of the master problem can cut into the feasible region, leading to a sub-
optimal solution (Kocis and Grossmann, 1988). In order to overcome this issue, 
Kocis and Grossmann (1988), developed a two-phase strategy. The first phase 
involved the OA/ER algorithm, and the second phase identified the linearisations of 
non-convex functions by using local and global testing, thereby relaxing the master 
problem. This scheme allowed for obtaining the global optimum in 80% of a set of 
test problems.  
Viswanathan and Grossmann (1990) expanded this algorithm to incorporate 
an augmented penalty function, which detects violations of the linearisation of the 
nonlinear functions. This AP/OA/ER function does not require an initial set of 0-1 
variables as the algorithm begins with a solution to a relaxed NLP problem. 
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Whereas the OA/ER function has been proven to be successful (Kocis and 
Grossmann, 1980), it relies on the assumptions made of the convexities within the 
algorithm. Whereas the AP/OA/ER function does not rely on such assumptions, as 
the new master MILP problem uses linear approximations instead. The MILP 
problem however does not produce valid lower bounds for the objective function, 
and therefore a termination criterion was added that allowed the function to be 
stopped based on the progress of the NLP sub-problems. Although the algorithm has 
provisions in place to optimise the function, it cannot guarantee a global solution. 
This is due to the fact that if the NLP sub-problems have multiple local solutions, 
the function will converge to a sub-optimal solution. Also if the NLP sub-problems 
for fixed binary values have different local optima, the algorithm may be trapped 
into a local solution. Despite this, computational efforts with the algorithm are 
promising. The proposed AP/OA/ER function was implemented using the 
DICOPT++ program in GAMS. It was tested on a set of 20 MINLP problems, 
which involved up to 60 0-1 variables, 709 continuous variables and 719 constraints. 
It was noted that 11 of these 20 MINLP problems were non-convex, and the results 
obtained for these showed great robustness as they correlated with the global 
optimum.  
The OA algorithm is capable of finding the global optimum of a problem, 
provided there are convexities within the function. However, when a problem 
contains non-convex functions it needs to be transformed to allow the OA/ER solver 
to find an optimal solution. Constraint violations must be allowed within the MILP 
master problem through the introduction of slack variables to the linearised 
constraints. The termination criterion must also be modified, as through the 
introduction of the slack variables we have lost the properties of the outer 
approximate. The DICOPT++ program allows the function to be solved using 
OA/ER if the problem is transformed from a non-convex to a convex function 
accordingly. This can be highlighted with research from Bergamini et al. (2008). 
Here they looked at how OA could be used to find global optimum solutions to 
MINLP problems involving bilinear and concave terms. The model, extended from 
previous research (Bergamini et al., 2005), can solve for both MINLP and 
generalised disjunctive programming (GDP) problems. The model follows the same 
general principle in that the first stage involves initialisation of the upper bound, 
followed by optimisation of the outer values. The bounds of the variables involved in 
the non-convex terms are then contracted. If at least one if these is infeasible, the 
algorithm must find a new outer. If however there are feasible the global optimal 
solution can be calculated. This was tested using GAMS and the solvers CONOPT3, 
for the NLP and LP problems, and CPLEX for the MINLP problems. The algorithm 
was successful in finding solutions to complex bounded MINLP problems. However it 
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has been noted that the MILP sub-problems have increased in size due to the nature 
of the algorithm. This increases computing effort, even though each successive MILP 
problem only differs by addition of some grid points. It has been proposed that a 
possible solution to this could be to simultaneously solve the MILP problems and 
update the grids within the same iteration.  
Other methods of optimising processes can include the use of R-graphs 
(Farkas et al., 2008). Here research was conducted using R-graphs in constructing a 
new distillation column, which would later be optimised using OA and MINLP. R-
graphs are graphical simulations of models that utilise R-programming languages. 
They are particularly useful for linear and nonlinear modelling, time series analysis 
and statistical testing. The objective of the research was to design the optimal 
configuration for a distillation column, which required the least amount of 
annualised cost. It was noted that the computational difficulty in modelling the 
MILP/MINLP problem is greatest with increasing numbers of binary variables. 
Therefore it was noted that in order to reduce these variables the model could either 
be modified or the appropriate superstructure could be calculated. Difficulties arose 
when the researchers tried to apply the model to known examples. It was noticed 
that with the most complex of distillation systems the algorithm could not use 
traditional programs to solve i.e. GAMS, SBB or DICOPT MINLP solvers. This is 
due to the system containing large amounts of nonlinear equations and this led to 
the systems being deemed infeasible. There is however a feasible solution, so the 
models were altered so that the initial values for the NLP sub-problems were 
substituted in an effort to reduce the number of equations. A new step was inserted 
between the MILP master problem and the NLP sub-problems. Each appropriate 
value for the variables is calculated between each stage of the model using the 
binary vector obtained from the master problem. This reduces solution time greatly 
as the NLP problems have a good initial value. When comparing the model to 
previous research by Yeomans and Grossmann (2000), it is seen that the 
computation time has decreased greatly and the local optima is more indicative of 
the true optimal solution. Once the difficulties with regards to computation were 
addressed the final model was able to provide good solutions for processes containing 
as many as 160 stages in the distillation process.  
 
 
6.1.3 Branch Reduce and Bound 
 
Initial problems containing non-convexities arising from discreteness used the 
branch-reduce and bound (BRB) method, which has since been extended to allow for 
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global optimisation (Cheon et al., 2006). The scheme acts by recursively branching 
(partitioning) the feasible region in search for a global optimal solution. For any 
given partition element, bounds on the optimal solution are used to determine 
whether to examine the partition or to discard it from further consideration 
(bounding). This method is particularly useful in modelling discrete and 
combinatorial optimisation problems. The use of BRB is heavily focussed in work by 
Balasubramanian and Grossmann (2002), which looked at the problem of scheduling 
a flowshop plant with uncertain processing times. Flowshop plants involve plants 
where the jobs associated with the manufacturing of products use the same units 
and machines in the same order. A possible solution to this can involve specifying 
the order of the process, and essentially there are many different possible solutions. 
The uncertainty of the processing times was modelled using discrete probability 
distributions. However this can lead to combinatorial explosion of the state space, 
and when this is coupled with the sequencing can generate a difficult model to 
optimise. The BRB method poses as a solution to this issue as it can possibly select 
the sequence with the minimum makespan. As the models can be difficult to 
optimise the proposed solution was to couple the BRB method with a disaggregation 
step, henceforth known as BBD. This potentially gave the ability to reduce the 
uncertainties within the model and therefore allow for a more robust solution. 
However the BBD model required refining in order to be applicable to practical 
problems. A proposed MILP model was therefore created and tested on a UIS 
flowshop plant. This model derived from the analytical expression for the expected 
makespan of the stochastic zero-wait flowshop plant. It gave near optimal solutions 
and in a reasonable computation time.  
The BRB algorithm has also been used to optimise the pharmaceutical 
process and this can be seen in work carried out by Siddhaye et al. (2004). Here they 
researched the use of BRB coupled with MILP to create a two-step model for 
designing new molecules. The first step uses topological indices to develop structure 
activity relationships (SAR) for the properties of interest. The second step uses 
MILP programming to solve the model and optimise the molecule design. In order to 
develop SAR structures a comprehensive knowledge is required for the molecules 
topological properties. Research by Kier and Hall (1976) described these indices and 
how they can be applied to the field of medicinal chemistry. In order to obtain an 
accurate SAR model the zeroth and first order connectivity indices are used to 
develop linear correlations for three physical properties of interest, the octanol-water 
partition coefficient, the melting point and the water solubility. The MILP included 
a linear objective function, the property correlations and linear structural 
constraints, which ensure that the optimum solution is a stable and connected 
molecule. The result found an optimum solution containing an aromatic ring and a 
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carboxyl group. The correlation is acceptable and the molecule had estimated 
properties closest to the desired physical properties of interest.  
The concept of BRB and MILP modelling has also been of particular use in 
economics as highlighted by research from Amaro and Barbosa-Póvoa (2009). This 
work focussed on the supply chain issues that arise from decisions made in response 
to demand in the pharmaceutical industry. The main aims of the research were to 
reduce the global operating costs, whilst maximising the profit realised from the 
supply. An MILP model was then created, which focussed on the planning 
constraints of the system with a means to optimise the whole supply chain process. 
The variables were organised into three groups, the variable bounds, the modelling 
events and the material balances. In order to visualise the effect of uncertainty three 
cases were considered, a single product family and market position (soft-tablet 
medicines), the effect of combined market positions for the same uncertain final 
product demand and the effect of different final product uncertainties at the same 
market level. The planning was performed under market demand or price 
uncertainties, whilst accounting for different partnership structures. The approach 
considered the simultaneous integration of operational, economical and market 
aspects. Although the results of the model are promising, further work is needed in 
extending the demand to price variable to larger planning horizons with different 
periods of occurrence. This will give a more comprehensive overview of the 
cumulative effect of demand uncertainties induced by price change.  
 
 
6.2 Deterministic Optimisation 
 
It has been widely regarded that building circuits to meet multiple inducer 
requirements is challenging (Hasty et al, 2002; Sprinzak and Elowitz, 2005; Endy, 
2005). The fact that many of the interactions between parts have not been fully 
described, as well as the number of ways one can choose to interconnect the 
components, leads to increased complexity. There have been several small-scale 
circuits constructed to meet specific functionality such as the genetic toggle switch 
(Gardener et al, 2000), the repressilator (Elowitz and Liebler, 2000), the metabolator 
(Fung et al, 2005) and programmable cells (Kobayashi et al, 2004). The potential for 
using modelling and computational tools to better understand the function of 
biological circuits has been recognised and several models have been proposed to 
describe the interactions between genetic elements (Hasty et al, 2001; Gilman and 
Arkin, 2002; Glass et al, 2005). There have however been several studies that 
describe how a circuit can fail to exhibit desired functionality due to improper 
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assembly of its basic elements. Work conducted by Tuttle et al (2005) confirmed 
that repressilator circuits constructed with wild-type promoters do not result in 
oscillations. Furthermore, studies conducted by Hooshangi et al (2005) revealed that 
the behaviour of transcriptional cascade depends on the promoter leakiness and 
expression levels at the previous stage. To alleviate the difficulties found in building 
circuits that can meet inducer requirements, a deterministic optimisation framework 
by Dasika and Maranas (2008) was proposed. This framework, called OptCircuit, 
utilises ordinary differential equations, but is general enough to also accommodate 
stochastic simulations, and has two major advantages: 
 
I. It can automatically identify the circuit components from a list and the 
connections required to bring forth the desired functionality 
II. It can rectify or redesign an existing (non-functional) biological circuit and 
restore its functionality by modifying an existing component (e.g. through 
modification of the kinetic parameters) and/or identify additional components 
to append the circuit 
 
Literature sources were used to create a comprehensive list of promoter-protein, 
protein-protein and protein-inducer pairs and the desired circuit response is given as 
a maximisation/minimisation of an objective function. The process is also iterative, 
and thus can yield an ensemble of circuits that all display the same functionality, 
thereby allowing the user to choose whichever they see fit. A comparison can be 
made from electrical circuits to biological circuits, and synthetic biology utilises both 
of these fields to generate new synthetic circuits. Two choice examples of this 
integration are presented in Figure 6.1, which details the natural (biological) and 
electrical circuits whose principals were combined to form the genetic toggle switch 
(Gardner et al., 2000) and the Repressilator (Elowitz and Leibler, 2000). The toggle 
switch takes inspiration from set-reset circuits (SR circuits) (Shirakawa et al., 1995) 
and the Repressilator takes inspiration from LC (tuned) circuits (Shieh et al., 1997). 
OptCircuit utilises a different framework as it selects parts from a standardised list 
of compatible biological parts and forms new circuitry from this. The overall concept 
of OptCircuit can be seen in Figure 6.2, where R and S represent reset and set 
respectively, cro and cI are genes that code for the proteins PI and PII, cI-ts is a bi-
stable repressor, Ptet2 is a gene coding for the tet protein, lacI is a protein that is 
induced by IPTG within the circuit, GFP is a gene coding for green fluorescent 
protein.  For the oscillator, C and L represent the capacitor and inductor 
respectively, kai(x) represent the genes that are found in cyanobacteria that are 
needed for circadian rhythm, Kai(x) are the proteins form from the genes, PttetOI 
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and PtlacOI are promotors within the circuit coding for tet and lacI proteins and 
finally cI is a gene coding for the inducer of the circuit cI.  
 
 
 
Figure 6.1: An illustration of how synthetic biology combines electrical circuits with natural circuits, 
showing the genetic toggle switch (Gardner et al., 2000) and the Repressilator (Elowitz and Leibler, 
2000). Each gene, inducer, protein and promotor is described in the main text of Section 6.2. Lines 
ending with a bar represent induction of the circuit, arrows represent protein formation and dashed 
arrows represent protein-protein interaction. 
 
 
Three examples were used to show the various architectures that can be obtained 
using the OptCircuit framework, the first of which is an investigation into designing 
a circuit that can discriminate between inducer molecules, which is described in 
Section 6.1.1.  
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Figure 6.2: An illustration of the OptCircuit framework. Three main components of the framework 
are the basic genetic elements (i.e. the promoters, transcripts and inducers), the underlying 
mechanisms that drive the circuit and finally the desired behaviour of the circuit. Integration of these 
components is achieved using an optimisation based framework embedded into OptCircuit.  
 
 
6.2.1 Design of Circuits with Inducer-Specific Responses 
 
Within this example generating circuit designs whose responses are contingent on 
the presence/absence of different inducer molecules tested the OptCircuit 
framework. In order to determine if the architectures were feasible, the results were 
compared to well-known designs (Gardner et al., 2000). The pre-requisites for the 
circuit were that in the presence of anhydrotetracycline (aTC) only lacI should be 
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expressed, and in the presence of IPTG the circuit must only express tetR. This 
desired circuit response is imposed through Equation 6.1, by maximising the scaled 
difference between the expression of the desired and undesired fluorescent protein in 
response to the two different inducers. 
 
 
 
𝑀𝑎𝑥𝑖𝑚𝑖𝑠𝑒 𝑧 = ((
𝑝𝑙𝑎𝑐𝐼
𝑎𝑇𝐶 − 𝑝𝑙𝑎𝑐𝐼
𝐼𝑃𝑇𝐺
𝑝𝑙𝑎𝑐𝐼
𝑎𝑇𝐶 ) + (
𝑝𝑡𝑒𝑡𝑅
𝐼𝑃𝑇𝐺 − 𝑝𝑡𝑒𝑡𝑅
𝑎𝑇𝐶
𝑝𝑡𝑒𝑡𝑅
𝐼𝑃𝑇𝐺 )) /2 
(6.1) 
 
 
Where: 𝑝𝑙𝑎𝑐𝐼
𝑎𝑇𝐶 and 𝑝𝑡𝑒𝑡𝑅
𝑎𝑇𝐶  represent the levels of the transcripts lacI and tetR in the 
presence of inducer aTC. Similarly, 𝑝𝑙𝑎𝑐𝐼
𝐼𝑃𝑇𝐺 and 𝑝𝑡𝑒𝑡𝑅
𝐼𝑃𝑇𝐺 represent the levels of lacI and 
tetR in the presence of inducer IPTG respectively. Different architectures were 
identified using OptCircuit (Figure 6.3) with up to two promoter-transcript pairs, 
with the best circuit shown in Figure 6.3a. The configuration is reminiscent of the 
genetic toggle switch (Gardener et al., 2000) and is in line with its dynamics, as in 
the presence of aTC, the activity of the protein tetR is supressed (Figure 6.3b), 
which leads to the expression of lacI from Ptet2 promoter (as tetR supresses 
expression from Ptet2). In the presence of IPTG (Figure 6.3c) the activity of protein 
lacI is supressed, which enables the expression of tetR from the Plac1 promoter. Once 
the search was performed for circuits with only two promoter-transcript pairs was 
successful, the framework was utilised for more complex architectures containing 
three or four promoter-transcript pairs. The resulting circuits (Figure 6.4) show that 
OptCircuit is capable of giving both simple and intuitive designs as well as non-
intuitive designs with added complexity, thereby increasing the opportunity for 
kinetic parameter tuning.  
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Figure 6.3: a. The simple circuit identified by OptCircuit which is reminiscent of the genetic toggle 
switch, b. activity of the circuit in the presence of aTC, which supresses the activity of tetR so lacI is 
expressed, c. activity of the circuit in the presence of IPTG, which supresses lacI so tetR is expressed. 
The triangles with open circles at the vertices represent the promoter elements. The triangles with 
open circles at the vertices represent the promoter elements and arrows with a circular end represent 
inducers. 
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Figure 6.4: Alternative circuits proposed by OptCircuit indicating that OptCircuit is able to identify 
more complex architecture to realise a specified outcome. The triangles with open circles at the 
vertices represent the promoter elements. 
 
The ODEs used to model this system can be seen in Equations 6.2-6.7. The 
equations provide a mechanistic description that governs the time evolution of the 
protein levels in the system. The binary variables, Yij, determine if a transcript 
(protein) is expressed from a promoter.  
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 𝑑[𝑙𝑎𝑐𝐼]
𝑑𝑡
=  ∑ 𝑌𝑃𝑙𝑎𝑐(𝑖),𝑙𝑎𝑐𝐼
𝑎𝑙𝑎𝑐
1 + 𝐾𝑙𝑎𝑐𝑟(𝑖). [𝑙𝑎𝑐𝐼]4
𝑖=1,…,4
+ 𝑌𝑃𝜆𝑙𝑎𝑐𝐼
𝑎𝜆
1 + 𝐾𝜆. [𝑐𝐼]2
+ ∑ 𝑌𝑃𝑡𝑒𝑡(𝑖),𝑡𝑒𝑡
𝑎𝑡𝑒𝑡
1 + 𝐾𝑡𝑒𝑡(𝑖). [𝑡𝑒𝑡𝑅]2
𝑖=1,2
+ 𝑌𝑃𝑎𝑟𝑎𝑙𝑎𝑐𝐼
𝑎𝑎𝑟𝑎
1 + 𝐾𝑎𝑟𝑎𝐶 . [𝑎𝑟𝑎𝑐]2
− 𝐾𝑓 . [𝑙𝑎𝑐𝐼]. [𝐼𝑃𝑇𝐺] + 𝐾𝑏[𝑙𝑎𝑐𝐼 − 𝐼𝑃𝑇𝐺]
− 𝐾𝑑𝑒𝑐𝑎𝑦. [𝑙𝑎𝑐𝐼] 
(6.2) 
 
 𝑑[𝑙𝑎𝑐𝐼 − 𝐼𝑃𝑇𝐺]
𝑑𝑡
=  𝐾𝑓 . [𝑙𝑎𝑐𝐼]. [𝐼𝑃𝑇𝐺] − 𝐾𝑏[𝑙𝑎𝑐𝐼 − 𝐼𝑃𝑇𝐺]
− 𝐾𝑐𝑝𝑥
𝑑𝑒𝑐𝑎𝑦. [𝑙𝑎𝑐𝐼 − 𝐼𝑃𝑇𝐺] 
(6.3) 
 
 𝑑[𝑡𝑒𝑡𝑅]
𝑑𝑡
=  ∑ 𝑌𝑃𝑙𝑎𝑐(𝑖),𝑡𝑒𝑡𝑅
𝑎𝑙𝑎𝑐
1 + 𝐾𝑙𝑎𝑐𝑟(𝑖). [𝑙𝑎𝑐𝐼]4
𝑖=1,…,4
+ 𝑌𝑃𝜆𝑡𝑒𝑡𝑅
𝑎𝜆
1 + 𝐾𝜆. [𝑐𝐼]2
+ ∑ 𝑌𝑃𝑡𝑒𝑡(𝑖),𝑡𝑒𝑡𝑅
𝑎𝑡𝑒𝑡
1 + 𝐾𝑡𝑒𝑡(𝑖). [𝑡𝑒𝑡𝑅]2
𝑖=1,2
+ 𝑌𝑃𝑎𝑟𝑎𝑡𝑒𝑡𝑅
𝑎𝑎𝑟𝑎
1 + 𝐾𝑎𝑟𝑎𝐶 . [𝑎𝑟𝑎𝑐]2
− 𝐾𝑓 . [𝑡𝑒𝑡𝑅]. [𝑎𝑇𝐶] + 𝐾𝑏[𝑡𝑒𝑡𝑅 − 𝑎𝑇𝐶]
− 𝐾𝑑𝑒𝑐𝑎𝑦. [𝑡𝑒𝑡𝑅] 
(6.4) 
 
 𝑑[𝑡𝑒𝑡𝑅 − 𝑎𝑇𝐶]
𝑑𝑡
=  𝐾𝑓 . [𝑡𝑒𝑡𝑅]. [𝑎𝑇𝐶] − 𝐾𝑏[𝑡𝑒𝑡𝑅 − 𝑎𝑇𝐶]
− 𝐾𝑐𝑝𝑥
𝑑𝑒𝑐𝑎𝑦. [𝑡𝑒𝑡𝑅 − 𝑎𝑇𝐶] 
(6.5) 
 
 𝑑[𝑐𝐼]
𝑑𝑡
=  ∑ 𝑌𝑃𝑙𝑎𝑐(𝑖),𝑐𝐼
𝑎𝑙𝑎𝑐
1 + 𝐾𝑙𝑎𝑐𝑟(𝑖). [𝑙𝑎𝑐𝐼]4
𝑖=1,…,4
+ 𝑌𝑃𝜆𝑐𝐼
𝑎𝜆
1 + 𝐾𝜆. [𝑐𝐼]2
+ ∑ 𝑌𝑃𝑡𝑒𝑡(𝑖),𝑐𝐼
𝑎𝑡𝑒𝑡
1 + 𝐾𝑡𝑒𝑡(𝑖). [𝑡𝑒𝑡𝑅]2
𝑖=1,2
+ 𝑌𝑃𝑎𝑟𝑎𝑐𝐼
𝑎𝑎𝑟𝑎
1 + 𝐾𝑎𝑟𝑎𝐶 . [𝑎𝑟𝑎𝑐]2
− 𝐾𝑑𝑒𝑐𝑎𝑦. [𝑐𝐼] 
(6.6) 
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 𝑑[𝑎𝑟𝑎𝐶]
𝑑𝑡
=  ∑ 𝑌𝑃𝑙𝑎𝑐(𝑖),𝑎𝑟𝑎𝐶
𝑎𝑙𝑎𝑐
1 + 𝐾𝑙𝑎𝑐𝑟(𝑖). [𝑙𝑎𝑐𝐼]4
𝑖=1,…,4
+ 𝑌𝑃𝜆𝑎𝑟𝑎𝐶
𝑎𝜆
1 + 𝐾𝜆. [𝑐𝐼]2
+ ∑ 𝑌𝑃𝑡𝑒𝑡(𝑖),𝑎𝑟𝑎𝐶
𝑎𝑡𝑒𝑡
1 + 𝐾𝑡𝑒𝑡(𝑖). [𝑡𝑒𝑡𝑅]2
𝑖=1,2
+ 𝑌𝑃𝑎𝑟𝑎𝑎𝑟𝑎𝐶
𝑎𝑎𝑟𝑎
1 + 𝐾𝑎𝑟𝑎𝐶 . [𝑎𝑟𝑎𝑐]2
− 𝐾𝑑𝑒𝑐𝑎𝑦. [𝑎𝑟𝑎𝐶] 
(6.7) 
 
 
where: 𝑎𝑥 is the transcriptional efficiency of the promoters (lac, tet, λ and ara), 𝐾
𝑥 
is the cumulative constants representing protein dimerization and binding to the 
promoters, 𝐾𝑑𝑒𝑐𝑎𝑦 is the decay rates of the proteins, 𝐾𝑐𝑝𝑥
𝑑𝑒𝑐𝑎𝑦
 is the decay rate of the 
protein-inducer complex, 𝐾𝑓 is the association constant for lacI-IPTG/tetR-aTC 
binding and 𝐾𝑏 is the dissociation constant for lacI-IPTG/tetR-aTC binding. The 
values for these parameters can be found in Table 6.1. 
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Table 6.1: Model parameters for the genetic toggle switch example, Equations 6.2-6.7 (Dasika and 
Maranas, 2008). 
Parameter Description Value 
𝑎𝑙𝑎𝑐 Transcriptional efficiency of Plac promoter 1.215 
𝑎𝑡𝑒𝑡 Transcriptional efficiency of Ptet promoter 1.215 
𝑎𝜆 Transcriptional efficiency of Pλ promoter 2.92 
𝑎𝑎𝑟𝑎 Transcriptional efficiency of Para promoter 1.215 
𝐾𝜆 
Cumulative constant representing cI dimerization and 
binding to Pλ promoter 
0.33 nm-2 
𝐾𝑡𝑒𝑡1 
Cumulative constant representing tetR dimerization and 
binding to Ptet promoter 
0.014 nm-2 
𝐾𝑡𝑒𝑡2 
Cumulative constant representing tetR dimerization and 
binding to Ptet promoter 
1.4 nm-2 
𝐾𝑙𝑎𝑐1 
Cumulative constant representing lacI tetramerization 
and binding to Plac1 promoter 
10 nm-3 
𝐾𝑙𝑎𝑐2 
Cumulative constant representing lacI tetramerization 
and binding to Plac2 promoter 
0.01 nm-3 
𝐾𝑙𝑎𝑐3 
Cumulative constant representing lacI tetramerization 
and binding to Plac3 promoter 
0.001 nm-3 
𝐾𝑙𝑎𝑐4 
Cumulative constant representing lacI tetramerization 
and binding to Plac4 promoter 
0.00001 nm-3 
𝐾𝑎𝑟𝑎 
Cumulative constant representing araC dimerization and 
binding to Para promoter 
2.5 nm-2 
𝐾𝑑𝑒𝑐𝑎𝑦 Decay rates of proteins 
cI – 0.0693 s-1 
lacI – 0.0346 s-1 
tetR – 0.0346 s-1 
araC – 0.0115 s-1 
𝐾𝑐𝑝𝑥
𝑑𝑒𝑐𝑎𝑦
 
Decay rate of protein-inducer complex 
0.0693 s-1 
𝐾𝑓 
Association constant for lacI-IPTG/tetR-aTC binding 0.05 nm-1 s-1 
𝐾𝑏 
Dissociation constant for lacI-IPTG/tetR-aTC binding 0.1 
 
 
6.2.2 OptCircuit Modelling Framework  
 
Using the basic elements that constitute a genetic circuit (promoter elements, 
inducers and protein/transcript molecules) OptCircuit is defined using the following 
sets and variables: 
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Sets:     Variables: 
𝐼 =  {𝑖} = Set of promoters 𝑃𝑗(𝑡) = Protein level of transcript j at time t 
𝐽 =  {𝑗} = Set of transcripts  𝑌𝑖𝑗 {
1
0
 
𝐾 =  {𝑘}  = Set of inducers   
𝑇 =  {𝑡} = Time     
 
Where: 𝑌𝑖𝑗 = 1 if transcript j is expressed from promoter i and 𝑌𝑖𝑗 = 0 if otherwise. 
In genetic circuits, as opposed to digital or binary circuits, the presence/absence of a 
particular set of interactions alone is insufficient to accurately predict all possible 
responses. To this effect, kinetic description of each element is embedded into the 
OptCircuit framework. More specifically for each transcript, j, the ODE that governs 
the time evolution of the protein is given by equation 6.8. The first term accounts 
for the cumulative rate of production of the protein j from the promoter elements 
and the second term represents the first order decay of the protein. A note to 
remember is that the production of protein j from promoter i is turned ON if the 
binary variable Yij is equal to one. 
 
 𝑑𝑃𝑗
𝑑𝑡
=  ∑ 𝑌𝑖𝑗[𝑅𝑎𝑡𝑒 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑗 𝑓𝑟𝑜𝑚 𝑖] −  𝐾𝑑𝑒𝑐𝑎𝑦
𝑗 𝑃𝑗(𝑡)𝑖     
∀𝑗 
(6.8) 
 
For the optimisation, the desired responses are partitioned into inducer-dependent 
and inducer-free and are translated into the circuit design. For all cases the objective 
function is the minimisation of the sum of the squared departures from the target 
responses at all time points, as highlighted by equation 6.9, Where: 𝑃𝑗∗
𝑒𝑥𝑝
 denotes the 
experimentally observed profile. 
 
 
𝑚𝑖𝑛𝑖𝑚𝑖𝑠𝑒 𝑍 =  ∑(𝑃𝑗∗(𝑡) − 𝑃𝑗∗
𝑒𝑥𝑝(𝑡))2
𝑡
 
(6.9) 
 
 
6.2.3 OptCircuit Optimisation Model 
 
The problem of designing a circuit that exhibits a desired response was formulated 
using mixed integer dynamic optimisation (MIDO) (Bansal et al., 2003; Flores-
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Tlacuahuac and Biegler, 2004). Here the objective function (Equation 6.10) models 
the circuit response imposed by the designer as seen below. 
 
 𝑚𝑖𝑛/ max 𝑍 = 𝑓 (𝑃𝑗(𝑡)) 
(6.10) 
 
Subject to: 
 𝑑𝑃𝑗
𝑑𝑡
=  ∑ 𝑌𝑖𝑗[𝑅𝑎𝑡𝑒 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑗 𝑓𝑟𝑜𝑚 𝑖] −  𝐾𝑑𝑒𝑐𝑎𝑦
𝑗 𝑃𝑗(𝑡)𝑖     
∀𝑗 
(6.11) 
 
 
∑ 𝑌𝑖𝑗 ≤ 𝑃
𝑚𝑎𝑥       ∀𝑖
𝑗
 
(6.12) 
 
 
∑ 𝑌𝑖𝑗 ≤ 𝑇
𝑚𝑎𝑥
𝑖
       ∀𝑗 
(6.13) 
 
 
∑ ∑ 𝑌𝑖𝑗 ≤ 𝑀𝑚𝑎𝑥
𝑗𝑖
 
(6.14) 
 
Where: 𝑃𝑚𝑎𝑥 denotes an upper limit on the number of transcripts a particular 
promoter 𝑖 can express, 𝑇𝑚𝑎𝑥 denotes an upper limit on the number of times a 
particular transcript 𝑗 can be expressed from different promoters and 𝑀𝑚𝑎𝑥 imposes 
a limit on the total number of promoter-transcript pairs within the circuit. The 
Boolean constraints highlighted in Equations 6.12-6.14 offer flexibility in 
incorporating the design of an existing biological circuit to determine its behaviour.  
The OptCircuit framework was then applied with the developed meshless 
ANN-RK4 framework. In order to determine if the ANN-RK4 framework could be 
applied the OptCircuit model was analysed as an NLP formulation. The result of 
this investigation is presented in the next section.  
 
 
6.3 Application of the ANN-RK4 Framework to OptCircuit 
  
The OptCircuit framework detailed a system of ODEs that can be exploited in order 
to determine the most optimum structure from a list of parts. In order to determine 
how effective the developed meshless ANN-RK4 model could simulate the 
OptCircuit framework, the system of ODEs were modelled as an NLP problem. The 
binary inducer-promotor relationships were fixed for each given structure (Figure 
6.3), with each structure modelled separately. Each structure was analysed and the 
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binary-relationships for it to form were inferred then simulated as separate NLP 
problems. This resulted in three models where the inferred binary relationships were 
fixed and optimised. The ANN-RK4 framework can be utilised for MINLP problems, 
however the study of systems architecture problems is considered to be preparation 
for future work of this thesis, and so the MINLP was converted to an NLP for ease 
of optimisation. The measures of success for the results were the levels of IPTG and 
aTC within the systems. Structure A details a system that produces LacI from the 
𝑝𝑡𝑒𝑡2 promotor. The inducers, IPTG and aTC, are not present within this system, 
therefore the results from the optimisation of this structure (Figure 6.5) should 
reflect this. This means that for structure A to form both the promotor and 
proteinmust be present, but the inducers should be absent. Each structure that was 
found from OptCircuit in its initial search was tested with the ANN-RK4 
framework. The results for structure A are presented in Figure 6.4, structure B in 
Figure 6.6 and structure C in Figure 6.7. Each corresponding structure from Figure 
6.3 is presented with the results for direct comparison.  
From the results presented in Figure 6.5 it is noted that the ANN-RK4 
framework can accurately identify the necessary proteins needed to form structure 
A, which are tetR and LacI. The levels of the two promotors, LacI and tetR, 
increase with every iteration, which is to be expected as the optimum structure 
(Figure 6.5e) has both of these proteins expressed. The levels of the inducers IPTG 
and aTC remain at zero with every iteration, which is also expected as they cannot 
be present in order for structure A to exist. If aTC was present it would supress 
tetR from forming, and therefore would alter the structure of the circuit. Similarly if 
the inducer IPTG is present it would supress LacI from forming, and again would 
alter the structure. The promotor-inducer relationships that are expected in order 
for structures B and C to assemble are shown in Figures 6.6 and 6.7 respectively. 
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Figure 6.5: The ANN-RK4 simulation results for structure A found by OptCircuit. The results show 
the iterative evolution of search for the optimum concentration levels of each protein, a. The 
concentration levels of tetR, b. the concentration levels of aTC, c. The concentration levels of LacI, d. 
The concentration levels of IPTG and e. Structure A found from OptCircuit. The model was run for 
50 iterations and solved using CONOPT3, total CPU time = 9 seconds, CPU: Intel Core™2 Duo 
E7400 2.8GHz. 
 
 
 
 
 
 
 
 
lacI 
IPTG 
aTC 
tetR 
Plac1 Ptet2 lacI 
a. b. 
c. d. 
e. 
Chapter 6 Systems Architecture 
 
150 
 
 
 
 
 
0 10 20 30 40 50
-1.0
-0.8
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
C
o
n
c
e
n
tr
a
ti
o
n
 (
A
U
)
Iteration
 tetR
   
0 10 20 30 40 50
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
C
o
n
c
e
n
tr
a
ti
o
n
 (
A
U
)
Iteration
 aTC
 
0 10 20 30 40 50
0.0
0.1
0.2
0.3
0.4
0.5
C
o
n
c
e
n
tr
a
ti
o
n
 (
A
U
)
Iteration
 LacI
   
0 10 20 30 40 50
-1.0
-0.8
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
C
o
n
c
e
n
tr
a
ti
o
n
 (
A
U
)
Iteration
 IPTG
 
 
 
 
 
Figure 6.6: The ANN-RK4 simulation results for structure B found by OptCircuit. The results show 
the iterative evolution of search for the optimum concentration levels of each protein, a. The 
concentration levels of tetR, b. the concentration levels of aTC, c. The concentration levels of LacI, d. 
The concentration levels of IPTG and e. Structure B found from OptCircuit. The model was run for 
50 iterations and solved using CONOPT3, total CPU time = 7 seconds, CPU: Intel Core™2 Duo 
E7400 2.8GHz. 
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Figure 6.7: The ANN-RK4 simulation results for structure C found by OptCircuit. The results show 
the iterative evolution of search for the optimum concentration levels of each protein, a. The 
concentration levels of tetR, b. the concentration levels of aTC, c. The concentration levels of LacI, d. 
The concentration levels of IPTG and e. Structure C found from OptCircuit. The model was run for 
50 iterations and solved using CONOPT3, total CPU time = 7 seconds, CPU: Intel Core™2 Duo 
E7400 2.8GHz. 
 
 
The results presented in Figures 6.6 and 6.7 conform to the schematic of the 
structures found from OptCircuit. Both show the respective promotors absent within 
the structures due to their corresponding inducer acting upon them. For example, 
the concentration level of tetR in Figure 6.5a is zero and this is due to the action of 
aTC (Figure 6.6b). When aTC is present the tetR protein is supressed and this then 
P
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leads to the expression of LacI from the 𝑝𝑡𝑒𝑡2 promotor. The inducer-promotor 
relationship is also seen in results presented in Figure 6.7, where LacI is not present 
due to the action of IPTG.  
 
6.4 Conclusion 
 
From the results presented in Figures 6.5-6.7 it is apparent that the ANN-RK4 
framework is capable of simulating systems architecture problems for fixed 
structures. Each of the results conforms to those found in the initial study of 
OptCircuit (Dasika and Maranas, 2008). This further enhances the validity of the 
findings from utilising the developed meshless framework in Chapters 4 and 5, and 
also shows that it is a viable option for various types of systems modelling. Further 
work into utilising this framework can be to optimise the structures from a list of 
well-characterised, biologically compatible parts, as well as to form new structures. 
This would invariably return this model to a mixed integer nonlinear programming 
model and would require optimisation of the ANN-RK4 framework to deal with 
binary problems.  The work presented in this chapter shows the possible capabilities 
of the developed ANN-RK4 framework and how it can be utilised for synthetic 
system identification.  
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7. Concluding Remarks and Future Work 
7.1 General Perspective  
 
Over recent years the field of synthetic biology has seen a striking increase in the 
complexity of the models under investigation. However, close collaborations between 
modellers and experimentalists are still rare, leading to a decreased availability of 
data for dynamic modelling. Whilst it can be difficult to obtain full models of 
biological systems, the examples given in this thesis were found to be the most 
comprehensive. However, as shown in Chapter 4, error in relaying dynamic 
equations can render data ill-suited for inference. The situation is further 
exacerbated by the fact that the biological questions we wish to answer necessitate 
models of a certain complexity. Interestingly this gives rise to various approaches for 
mathematical modelling. Some modellers believe that all model structures and 
associated parameters can be defined a priori and that additional parameter 
estimation or uncertainty analysis is not necessary, as the predictions are based on a 
physically correct model of reality. Here model parameters are often taken from 
literature or estimated using various experiments. In this paradigm, any shift from 
the model predictions constitutes a failure of the model and results in extending or 
changing the model. Moreover, parameter values in literature are rarely reported 
along with an assessment of their identification. An additional complication with 
this approach is that enzymes and proteins tend to behave differently in vivo than in 
vitro (Teusink et al., 2000). Whether this is attributable to missing interaction 
mechanisms (Teusink et al., 2000), the composition of the experimental medium 
(Vanlier et al., 2009) or variations between cells (Kalita et al., 2011) is unclear.  
Another popular approach is to make subjective decisions on which 
parameters are considered adjustable and perform parameter estimation and model 
sensitivity analysis over pre-defined physiological ranges (Schmitz et al., 2010; van 
Eunen et al., 2010). This form of uncertainty analysis is highly pragmatic and can 
work well if one ensures that all uncertainties relevant to the problem are 
sufficiently probed, and the assumptions regarding the physiological ranges are 
justified. However, the effects of such assumptions are rarely reported in literature 
and more often than not the information reported is insufficient in reproducing 
analyses. Despite the difficulties it proposes, the future of synthetic biology depends 
on accurately exploring and reporting the uncertainties present in our mathematical 
models, inferences and predictions. It has been shown that the uncertainties in the 
developed mathematical models can be accounted for by using disturbances, and 
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experimentally these disturbances can be quantified. This thesis provides some 
practical approaches particularly suitable for modelling dynamic biological systems. 
 
 
7.2 Summary 
 
The applicability of using a meshless framework through the use of artificial neural 
networks (ANNs) for numerical integrations of dynamic process models has been 
demonstrated in this thesis. This integration scheme allows for nonlinear model 
predictive control (NLMPC), which can then be further evolved to zone control. 
This can not only control the system output, but can also react to randomised 
disturbances, which is key for future experimental validation of some of the 
examples shown. The novelty of controlling a biological system using a single control 
variable, as well as MIMO control of a system from both feedback loops has also 
been shown. The main contributions of this work are as follows: 
 
1. Dynamic Process Simulation: In Chapter 3 (Section 3.3) the ANN 
integration method for process system models was presented. Solving an 
NLP problem in GAMS tested the use of ANNs as a solution approach. 
This approach showcases the best aspects of the ANNs by providing 
succinct solutions as well as capturing highly nonlinear characteristics of 
such processes. The accuracy of the ANN is determined through the 
hidden layer, and optimisation of this provides the least prediction error 
and reduced computational time. Results from the ANN solution were 
validated using MATLAB and comparison with dynamics seen in Chapter 
3 (Section 3.4.1) show similar results over the entire simulation. This 
validation of the ANN implementation highlights its usefulness for solving 
process system ODEs. The optimal ANN topology was then used for 
control of the dynamic systems. 
 
2. Nonlinear Model Predictive Control (NLMPC): In Chapter 3 (Section 
3.5.1) the mathematical formulation for NLMPC is presented. The ANN 
formulation was embedded within the NLPMC optimisation framework 
and is solved as an NLP problem. Setting a pre-defined tolerance for the 
ANN prediction error ensures the accuracy of the model solution. 
Validation for the use of this approach within controllers is achieved by 
implementing RK4 to verify the results provided by the ANN. The 
controller was proficient at set point tracking, zone control and 
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disturbance rejection as shown in Chapter 4. The overall NLMPC scheme 
based on ANN implementation has shown good performance in meeting 
control objectives.  
 
3. Comparison with OCFE: Chapter 5 has detailed how the developed 
meshless framework compares with traditional methods of solving ODE 
systems, in particular OCFE. It was shown that the new framework gives 
positive results and in many ways the models developed were better, in 
terms of accuracy and computational effort, than their OCFE 
counterparts. These findings solidified the use of the developed framework 
throughout this thesis. 
 
4. Systems Architecture: Chapter 6 detailed how the ANN-RK4 framework 
can be applied to systems architecture problems where biological 
structures can be simulated to show how compatible parts can form useful 
structures. It further enhances the validity of the developed meshless 
model. The chapter also states how future work on the framework can 
develop it into an MINLP optimiser for biological structures. 
 
To conclude, this work shows how ANNs can be used to simulate dynamic biological 
systems through integration. The examples shown in Chapters 4 and 5 show how 
ANNs can be embedded within an NLMPC controller, and in Chapter 6 can be 
utilised to simulate NLP forms of MINLP models for systems architecture problems. 
 
 
7.3 Future Work 
 
There are various avenues that can be explored when furthering this work. Whilst 
the work conducted so far has shown success in terms of modelling the systems in 
the examples, further investigation is required to showcase the validity of these 
findings. This section will focus on future steps to help validate this work. 
 
7.3.1 Experimental Validation 
 
Previously in Chapter 4 the first case study from Fung et al. (2005) was introduced, 
discussed and simulated in GAMS using the ANN-RK4 and NLMPC models. 
Limitations in experimentally validating this case study were due to the fact that 
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the original authors (Fung et al., 2005) had misplaced the biological samples 
containing the bacteria when they moved offices. This loss of the metabolator meant 
that re-creating it would be difficult, as the promotors used were hard to source. 
However, there is possibility of re-creating the metabolator and performing 
experiments with a view to validate the results from the control models. Using the 
NLMPC results to dictate the levels of glucose (glycolytic flux) to be added to the 
system it is possible to have a relatively simple experimental setup (Figure 7.1). 
Both glucose entering the system and samples leaving the system will need to be 
measured in order to see the effect of having a controlled glucose profile. From 
researching the possible ways the experiment can occur it became apparent that 
sampling of the reaction mixture would occur quite heavily around the intervals 
where glucose feed is entering, in order to see how quickly it is being taken in by the 
E. Coli cells, and samples taken after this interval will show the depletion of glucose 
back to baseline. The NLMPC control models can be altered to have any profile for 
AcCoA activity that the user requires. Initially it can be planned that a simple step-
up and step-down set point for AcCoA can be modelled. This will allow for a simpler 
profile of glucose to be added to the experimental system, and this will gauge how 
easily samples can be taken, as well as the rate of glucose uptake. Once these factors 
are determined a more complex set point (such as those seen in Figures 4.7 and 
4.31) can be implemented. The challenge here is to determine how the efficiency of 
the in silico models can be translated in vivo.  
 
 
Figure 7.1: Proposed schematic visualisation of the experimental setup 
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Due to the nature of the experiment, whereby glucose is fed into the system to try 
and control the activity of AcCoA and ultimately the level of acetate produced, it is 
important to have a glucose limited medium for the cells to react within. This is 
important as any residual glucose in the media will greatly alter the results as the 
cells will have a feed source already present in the reactor. Whilst there are a few 
types of glucose limited media available, the media selected for this experiment is a 
mineral media (Hornsten, 1995; Schneebeli and Egli, 2013). Whilst a mineral 
medium does contain some glucose, the idea is to have it present in limited quantity, 
and to know the concentration so it can be used to calculate bacterial growth. It is 
essential to have the E. Coli grow in a glucose rich media, then to suspend them into 
the mineral media after. This ensures that the bacteria will initially propagate and 
grow in normal conditions, but then starve in the new media due to the low levels of 
glucose (carbon feed) present. Therefore, when glucose is added to the media as part 
of the experiment, the cells are likely to uptake the feed source quickly, ensuring 
that acetate is also produced quickly as a result. It is envisaged that once these 
experiments are achieved a more comprehensive analysis of the uncertainties in the 
system can be put back into the model to ensure biological feasibility. 
 
7.3.2 Mixed Integer Modelling 
 
Whilst the framework for a mixed integer model has been presented in Chapter 6, 
actual simulation of the model needs to be carried out. Although it is envisioned 
that this will not be a difficult task, there are challenges that arise with using the 
ANN approach with mixed integer linear models. Although the metabolator is well 
defined, there is possibility that another metabolite pool when combined with 
AcCoA could lead to other useful products. Using the MINLP formulation one could 
select from a range of pathways and choose the best yielding product to engineer. 
There is also possibility to have multiple pathways present, and to switch between 
them to give a cell that can produce multiple products at various schedules 
depending on the system input. This can combine the principles of the multiple-
input multiple-output model and evolve it to having separate inputs at different 
time points. 
 
 
7.3.3 Uncertainty 
 
Uncertainty will be added to both the metabolator and experimental models from 
data obtained from experiments. Uncertainties that can be present in the 
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experimental model could arise from the flux of glucose into the cell from the 
surrounding media. This process is not instantaneous, and this delay with need to be 
accounted for when trying to model the system. Assumptions will be made on the 
cell samples that are analysed, for instance the amount of acetate produced is 
directly correlated across the whole batch, which may not be the case as cell to cell 
variability can occur. Furthermore, cells can expire due to the amount of acetate 
present in the reactor, which can lower the pH past the optimum for E. Coli growth 
and maturation. Intrinsic noise within the metabolator can result in the amplitude 
of the oscillations to be less than those determined in silico.  
 
7.4 Future Scope 
 
There is much scope for this work to help aid in many different issues faced 
currently in many industries. This section will detail exciting avenues that can use 
this work at their foundation and help to tackle key issues and challenges that are 
being researched presently, as well as potentiating future projects.  
 
7.4.1 Total Cell Model 
 
Chapter 4 showcased the metabolator and presented the control of a system using 
glycolytic flux. The main metabolite in this system, AcCoA, is present in many 
biochemical reactions within a cell. It is therefore of interest to explore these 
reactions and try to forge a total cell model. This has applications within the 
pharmaceutical industry as it can potentially give way to new drug targets and 
explain physiological changes of a drug in vivo. This type of research can shift the 
boundaries of synthetic and systems biology, as it will require knowledge of both 
fields to be successful. As a grand challenge of modern times, the development of a 
predictive model of a living cell can also help in the understanding of how cancers 
develop. It has already been shown that AcCoA is part of the tricarboxylic acid 
(TCA) cycle in cells, and this can be simulated and controlled using NADH, calcium 
and citrate. Research from Wu et al. (2007) showed a comprehensive computer 
model of the TCA cycle and it is possible to utilise the ANN-NLMPC scheme to 
simulate and control this model. This can then be coupled to the metabolator that 
has already been simulated in this work, and will build upon the idea of having a 
total cell model. It is then envisioned that other processes in the cell can be 
simulated in the same way. 
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7.4.2 Materials 
 
The main product from the metabolator (Chapter 4) is acetate. Acetate can be 
utilised in many industries to make useful products such as fabrics, plastics, filters 
and even surgical products. With many uses it is a viable option to have a fully 
biologically synthesised acetate fibre, as it will circumvent the need to treat cellulose 
with chemicals in order to produce a fibre. Using E. Coli as a chassis it is possible to 
also model other production pathways and produce other materials, such as ethanol 
(Boumba et al., 2013). Research from Ro et al. (2006) have already shown how 
synthetic biology can be used to create an antimalarial precursor, Arteminisin, and 
create new products from the cells themselves, which can be exploited to create 
drugs in situ. This can also be explored with the framework developed here to help 
control the amount of drug produced from cells, and could potentially lead to higher 
yields than chemical based methods of production. Other organisms can also be 
exploited using synthetic biology such as yeast for the production of alcohols, which 
are useful in many industries and even algae and fungi for biofuel production. 
Essentially the kinetics and dynamics of the system need to be known and the 
framework built here can model the system to control production and can shift 
dynamics to a continuous phase of product formation. 
 
7.4.3 Experimental Regulation 
 
Both the metabolator and the experimental model propose systems that are able to 
be controlled using just glucose. If results from the experimental validation of the 
metabolator are positive, as it is envisioned, this will herald a remarkable discovery 
in terms of biological regulation. To regulate a dynamic process using a simple 
controller (glucose) will give great insight into how a biological system can be 
trained. The theory can then be applied to other biological constructs within a cell 
chassis, which can then lead to continuous production of a useful products, or give 
rise to new products of yet unknown use.  
 
 
7.4.4 Biological Transistors 
 
The scope for Zone NLMPC (Chapter 4) with the metabolator can lead to the idea 
of having a tuneable biological cell that acts like a transistor in a circuit. Transistors 
are used to amplify or switch electronic signals and electrical power. As an amplifier 
the usefulness of a transistor comes from its ability to use a small signal applied 
between a pair of its terminals to control a much larger signal at another pair of 
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terminals. As a switch a transistor can be used to turn current on or off in a circuit 
where the amount of current is determined by other circuit elements. Whilst 
traditional transistors have many advantages some key disadvantages include that 
they can age and fail, they are not applicable (or preferred) in systems with high 
power, high frequency operation (such as televisions) and they are susceptible to 
damage from very brief electrical and thermal events. The metabolator can be key to 
creating a biological transistor due to the fundamentals involved in its design. 
Essentially parts can be created that can fit together in a circuit and placed within a 
biological chassis. The resulting construct could utilise the cells innate physiology 
and metabolic processes to create energy, which can be fine-tuned using an auto 
regulatory profile governed by a Zone NLMPC problem. This however will need to 
be heavily researched as it is in a very early theoretical stage.  
 
 
7.5 Concluding Remarks 
 
Control of biological systems is a challenging task as trying to control a dynamic 
process in silico may not necessarily translate to the same level of control in vivo. 
Biological variability ensures that uncertainties need to be accounted for and this 
data utilised within models generate more feasible results. However, the work 
presented here shows that the theory of control can be applied to biological systems 
with relative success. This work presents the first step in allowing for feasible 
biological control of systems, and marks a new avenue to try and generate computer 
models that behave sympathetically with cellular experiments.  
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